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Preface
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and of reform and policy initiatives in progress or under development in a 
specific country. Each review is produced by country experts in collaboration 
with the Observatory’s staff. In order to facilitate comparisons between 
countries, reviews are based on a template, which is revised periodically. The 
template provides detailed guidelines and specific questions, definitions and 
examples needed to compile a report.
HiTs seek to provide relevant information to support policy-makers and 
analysts in the development of health systems in Europe. They are building 
blocks that can be used:
• to learn in detail about different approaches to the organization, 
financing and delivery of health services and the role of the main 
actors in health systems;
• to describe the institutional framework, the process, content and 
implementation of health-care reform programmes;
• to highlight challenges and areas that require more in-depth analysis;
• to provide a tool for the dissemination of information on health systems 
and the exchange of experiences of reform strategies between policy-
makers and analysts in different countries; and
• to assist other researchers in more in-depth comparative health 
policy analysis.
Compiling the reviews poses a number of methodological problems. In many 
countries, there is relatively little information available on the health system and 
the impact of reforms. Due to the lack of a uniform data source, quantitative 
data on health services are based on a number of different sources, including 
Health systems in transition  Italyvi
the World Health Organization (WHO) Regional Office for Europe’s European 
Health for All database, data from national statistical offices, Eurostat, the 
Organisation for Economic Co-operation and Development (OECD) Health 
Data, data from the International Monetary Fund (IMF), the World Bank’s 
World Development Indicators and any other relevant sources considered 
useful by the authors. Data collection methods and definitions sometimes vary, 
but typically are consistent within each separate review. 
A standardized review has certain disadvantages because the financing 
and delivery of health care differ across countries. However, it also offers 
advantages, because it raises similar issues and questions. HiTs can be used to 
inform policy-makers about experiences in other countries that may be relevant 
to their own national situation. They can also be used to inform comparative 
analysis of health systems. This series is an ongoing initiative and material is 
updated at regular intervals.
Comments and suggestions for the further development and improvement 
of the HiT series are most welcome and can be sent to info@obs.euro.who.int. 
HiTs and HiT summaries are available on the Observatory’s web site 
http://www.healthobservatory.eu. 
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Abstract
Italy is the sixth largest country in Europe and has the second highest average life expectancy, reaching 79.4 years for men and 84.5 years for women in 2011. There are marked regional differences for both men and 
women in most health indicators, reflecting the economic and social imbalance 
between the north and south of the country. The main diseases affecting the 
population are circulatory diseases, malignant tumours and respiratory diseases. 
Italy’s health-care system is a regionally based national health service that 
provides universal coverage largely free of charge at the point of delivery. 
The main source of financing is national and regional taxes, supplemented 
by co-payments for pharmaceuticals and outpatient care. In 2012, total health 
expenditure accounted for 9.2% of GDP (slightly below the EU average of 9.6%). 
Public sources made up 78.2% of total health-care spending. While the central 
government provides a stewardship role, setting the fundamental principles and 
goals of the health system and determining the core benefit package of health 
services available to all citizens, the regions are responsible for organizing 
and delivering primary, secondary and tertiary health-care services as well as 
preventive and health promotion services. 
Faced with the current economic constraints of having to contain or even 
reduce health expenditure, the largest challenge facing the health system is to 
achieve budgetary goals without reducing the provision of health services to 
patients. This is related to the other key challenge of ensuring equity across 
regions, where gaps in service provision and health system performance persist. 
Other issues include ensuring the quality of professionals managing facilities, 
promoting group practice and other integrated care organizational models in 
primary care, and ensuring that the concentration of organizational control by 
regions of health-care providers does not stifle innovation.
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Executive summary
Introduction
With a population of almost 61 million (in 2012), Italy is the sixth most populous country in Europe. The country is made up of 20 regions, which are extremely varied, differing in size, population and levels of 
economic development. Since the early 1990s, considerable powers, particularly 
in health-care financing and delivery, have been devolved to this level of 
government. The regions are subdivided into provinces, which are made up 
of municipalities (comuni). Italy has about 8100 municipalities, which range in 
size from small villages to large cities such as Rome.
A range of indicators shows that the health of the population has improved 
over the last decades. Average life expectancy reached 79.4 years for men and 
84.5 years for women in 2011, the second highest in Europe (compared with 
77.4 years for men and 83.1 years for women for the EU as a whole). Italy has 
one of the lowest total fertility rates in the world: in 2011, it was 1.4 births per 
woman, far below the replacement level of 2.1. The population growth rate is, 
therefore, very low (0.3% in 2012), one of the lowest in the EU, and immigration 
is the source of most of this growth. 
In almost all demographic and health indicators, there are marked regional 
differences for both men and women, reflecting the economic and social 
imbalance between the north and south of the country. For example, there 
is a gap of 2.8 years in life expectancy between the longest and shortest-
lived regions, for both genders. The main diseases affecting the population 
are circulatory diseases, malignant tumours and respiratory diseases, while 
smoking and rising obesity levels, particularly among young people, are major 
health challenges. 
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Organization and governance
Italy’s health-care system is a regionally organized National Health Service 
(Servizio Sanitario Nazionale, SSN) that provides universal coverage largely 
free of charge at the point of delivery. At national level, the Ministry of Health 
(supported by several specialized agencies) sets the fundamental principles 
and goals of the health system, determines the core benefit package of health 
services guaranteed across the country, and allocates national funds to the 
regions. The regions are responsible for organizing and delivering health care. 
At local level, geographically based local health authorities (Aziende Sanitarie 
Locali) deliver public health, community health services and primary care 
directly, and secondary and specialist care directly or through public hospitals 
or accredited private providers.
Patient empowerment and patient rights are not specified by a single law but 
are present in several pieces of legislation, starting with the Italian Constitution 
and the founding law of the national health system. Over the last 20 years, 
several tools have been introduced for public participation at all levels but no 
systematic strategy exists and implementation varies across the country, as 
does the satisfaction of citizens with the quality of health care. Over the last 
few years, measures have been taken to tackle excessive recourse to legal action 
against doctors and to prevent defensive medicine practices.
Financing
The National Health Service is largely funded through national and regional 
taxes, supplemented by co-payments for pharmaceuticals and outpatient care. 
In 2012, total health expenditure accounted for 9.2% of GDP (slightly below 
the EU average of 9.6%). While this reflects a process of upward convergence 
towards the EU average over the last couple of decades, part of this apparent 
increase is also due to relatively weak GDP growth for Italy over that period. 
Public sources made up 78.2% of total health-care spending, with private 
spending, mainly in the form of out-of-pocket (OOP) payments (17.8%), 
accounting for the remainder – these OOP payments are mainly for diagnostic 
procedures (laboratory tests and imaging), pharmaceuticals, specialists 
visits and for unjustified (non-urgent) interventions provided in hospital 
emergency departments. Only about 1% of total health-care expenditure is 
funded by private health insurance. The production, distribution and pricing of 
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pharmaceuticals are strictly regulated by a national agency, and provisions are 
made progressively more complex by repeated attempts at cost-containment of 
pharmaceutical expenditure.
Since the early 2000s the health-care system has been undergoing a process 
of fiscal devolution from the central government to the regions. Within Italy 
there are substantial differences in funding between regions, with per capita 
expenditure ranging from 10.2% below the national average to 17.7% above. 
Although most funding is pooled at national level and redistributed to regions, 
there is scope for significant regional variation in tax rates (in particular 
through taxing corporations and a regional surcharge on income tax). The 
resulting financing system has an unevenly distributed tax base, smaller room 
for manoeuvre for poorer regions and a need for poorer regions to increase 
tax rates more than high-income regions, with consequent disincentives for 
business location, for example.
In recent years there have been attempts to place stricter controls over 
regions’ health spending after a few incurred considerable deficits (mainly in 
the central and southern parts of the country). Moreover, in light of the global 
economic and financial crisis, tighter cost-containment measures on public 
health expenditure have been proposed and are being slowly implemented 
(e.g. caps on specific spending areas). At the same time, higher co-payments 
for outpatient/ambulatory care, diagnostics and drugs have been introduced, 
adding to private spending on health.
Health care is delivered mainly by public providers, with some private or 
private-public entities. Although reforms in 1992 aimed to introduce a quasi-
market system with patients free to choose any provider, in practice these 
arrangements vary across regions and, in some regions, are barely present. Only 
in the regions of Lazio, Campania, Molise and Lombardy is there a relatively 
high level of private care, with around 30% of total hospitalization supplied by 
private providers. 
In general, doctors employed by the National Health Service are salaried 
and have civil servant status, although general practitioners and paediatricians 
are independent professionals, paid via a combination of capitation and fee-for-
services for some interventions. All salaried doctors are allowed to practise 
privately and can earn additional income on a fee-for-service basis; they are 
encouraged to do so within National Health Service facilities, and then pay a 
proportion of their income to that facility. 
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Payment rates for hospital and outpatient care are determined by each 
region, with national rates (determined by the Ministry of Health) as a reference. 
Payment for hospital care (ordinary and day hospital treatments) is based 
on DRG tariffs, although it is generally complemented with other payment 
methods (lump sum or global budget) while outpatient care is reimbursed using 
a tariff per unit of care. There are considerable inter-regional variations in the 
prospective payment system adopted by each region, such as how the fees are 
set, which services are included, and the tools employed to influence patterns 
of care.
Physical and human resources
Over the last five years, Italy has decreased investment in expensive 
infrastructure and has even halted some projects due to cost-cutting measures, 
although in 2013 the government announced 162 new capital investment 
plans totalling nearly €1.5 billion. In addition, in a period of increasing 
decentralization and recent national-level cost-containment measures, the 
regions have sought additional sources of funding for health infrastructure. 
Sources include ad hoc regional funds, European funds, self-financing by local 
health service organizations, traditional and non-traditional forms of financing 
such as mortgages or project financing.
In terms of hospital sector infrastructure, in 2012 Italy had 3.4 hospital beds 
per 1000 people; 80% of which are dedicated to acute care (higher than the EU 
average of 69%).
The importance of medical technology has generally grown over time. The 
number of MRI units, CT scanners and PET units is constantly rising, at least 
doubling over the last 10 years to become one of the highest per capita in the EU, 
albeit with great regional variability. E-health initiatives are promoted by the 
government and current development is focused on increasing online services, 
electronic health records (EHRs) and the digitalization of medical prescriptions 
and certificates.
With 3.7 practising doctors per 1000 people, Italy is slightly above the 
EU average of 3.4 – though the number of nurses is relatively low, at 6.3 per 
1000 people, and the ratio of nurses to doctors (roughly 1:1) is among the lowest 
in the EU – the average is 2.5 nurses to every doctor. This is despite an increase 
in the number of health-care professionals over the last 25 years, especially 
practising nurses and midwives, with the former becoming more active in the 
Health systems in transition  Italy xxi
management of patients with chronic conditions. In terms of health worker 
mobility, Italy is predominantly a destination country, with higher levels of 
inflows for certain categories of health professionals such as nurses and care 
assistants (both legal and illegal), largely due to chronic nursing shortages, 
which have shifted attention to recruitment from abroad. In contrast, emigration 
mostly affects medical doctors. 
Provision of services
The Ministry of Health is the main institution responsible for public health at 
the national level. Immunization and screening programmes are considered to 
be priorities. In addition to the mandatory and voluntary routine immunization 
programmes, pap tests, mammography and colorectal screening are offered 
free of charge to target populations nationally. 
Primary care services are delivered by health districts, the operative 
branches of local health authorities. Over the last 15 years, there have been 
attempts to reorganize the delivery of primary care, with the objective of moving 
from the traditional model of GPs and other health professionals working in 
single practices to an integrated care model that connects different health care 
professionals and bridges the gap between front-line staff and patients, though 
change has been slow.
Inpatient care is provided through a network of accredited public and 
private hospitals, with general practitioners and paediatricians (who usually 
treat children up to the age of 6 or if parents so wish, up to the ages of 14–16) 
playing a gatekeeping role. In recent years there has been a progressive increase 
in Accident and Emergency Department admissions, some of which are due to 
inappropriate use by patients (e.g. for minor illnesses or prevention interventions 
that could have been treated by primary care physicians) for which co-payments 
of €25 are imposed (see above). 
Medicines are grouped into three main classes: Class A are essential 
medicines that are reimbursable (but require a co-payment, that varies by 
region) and include those indicated for the treatment of severe, chronic or 
acute illnesses. Class C includes non-reimbursable pharmaceutical products 
(though some regions opt to offer some reimbursement). Class H includes 
pharmaceutical products delivered only within hospitals. To contain 
pharmaceutical expenditure, the 2012 Spending Review reduced the budget for 
drugs used in non-hospital settings from 13.3% of total health-care expenditure 
Health systems in transition  Italyxxii
to 11.35% in 2013. However, in the last decade, the cost of pharmaceuticals 
delivered by hospitals has significantly increased due to new expensive products 
and the delivery by hospital pharmacies of products that are then used outside 
hospital settings. 
With regard to mental health care, the 1978 Basaglia Law marked the switch 
from institutional care to community mental health services. Subsequently, 
specific departments of mental health have been established within local 
health authorities. A priority remains closing the gap between the northern 
and southern regions with regard to the provision and quality of services, which 
remains a major challenge.
Health-care delivery to vulnerable or excluded groups has undergone 
a recent change in policy. After several years without specific regulations, 
legislation has now been defined to guarantee that immigrants (both legal and 
temporarily undocumented) are eligible to receive the same public health-care 
services that are available to Italian citizens. 
The central issue with health service delivery is the heterogeneity of regional 
arrangements. In general, northern and central regions appear to keep pace 
with institutional, organizational and professional developments aligned with 
best international practices and in line with central government orientations, 
while southern regions appear to lag behind. The gaps between northern and 
southern regions mainly reflect socioeconomic and cultural factors that are far 
beyond the health-care system. However, it is also likely that decentralization 
policies introduced in the last two decades have not favoured the homogeneity 
of regional systems as they have provided opportunities for improvement to the 
best institutionally equipped regions while leaving southern regions with less 
central support to cope with more difficult social contexts. 
Principal health reforms
The National Health Service was established with a radical reform in 1978 and 
modified in the 1990s and early 2000s. The first reform clearly designed an 
NHS-type system, fully implemented in the 1980s, that guaranteed universal 
access to health care. With a 1992 reform, backed by the 2001 constitutional 
reform that redistributed powers to the regions, the National Health Service 
was regionalized. Now most health policies are developed and implemented 
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by regions, with an increasing heterogeneity of institutional arrangements, 
provider payment rules and levels of performance in terms of the quantity and 
quality of care offered to citizens. 
The 1992 reform also envisaged a quasi-market based on patients’ choice 
and competition between public and private providers but this was mitigated 
over time with measures that give strong control to regional authorities over 
the allocation of resources between providers. Another priority was the 
‘managerialization’ of health service organizations; here again, in the last 
decade regional authorities have centralized administrations, reduced the 
discretion of management and not fully supported management development 
in public organizations.
Overall, the last decade has been dominated by two intertwined issues: 
regional fragmentation and the need to maintain financial control within 
regional health systems. Italy’s fiscal crisis has put the health system under 
strain; the central government has acted to control total health expenditures but 
performance in terms of health protection is increasingly governed at regional 
level, with large variations, mainly but not exclusively between the northern 
and southern parts of the country. 
Assessment of the health system
Italy currently spends less than the OECD average on health care in relation 
to its GDP (9.2% in comparison to the OECD average of 9.3%), though 
public spending is increasing at a faster pace than total private spending and 
OOP expenditure.
 Despite the country’s federal structure, most regions cannot fund health 
care with their own resources, relying on the central transfers to compensate for 
the differences in regional incomes. Regions also allocate their funds differently, 
with some southern regions still suffering large deficits and with secondary care 
favoured over primary and community health services. 
While equitable access to health care is one of the statutory objectives of 
the health system, severe inequities in health status and health-care provision 
appear to exist across socioeconomic population groups. A significant part of 
these inequities stem from geographical differences: inter-regional disparities 
in population wealth, health-care resources and efficiency of care are 
especially evident between northern and southern regions. This pattern is also 
substantially echoed in the geographical distribution of satisfaction levels with 
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the health-care system and its performance. Generally, however, over the last 
few years there has been a general decrease in satisfaction levels, and problems 
such as long waiting times for outpatient and diagnostic services exist across 
the country. The current system of specialists providing both public and private 
care might be contributing to waiting lists as well as favouring the wealthier 
over the poorer in terms of access to specialist care. 
Life expectancy of Italians is one of the highest in the world and their 
mortality profile is comparable to that of the other high-income countries. 
Prevention policies have been successful in increasing coverage for the most 
important vaccinations. Estimates of avoidable mortality suggest a progressive 
improvement, and care for chronic conditions compares well at an international 
level. However, the prevalence of risk factors such as overweight and obesity is 
significant, and health-care outcomes are inequitable across regions, genders 
and socioeconomic groups.
National funds are distributed to regions using formulas that aim to ensure 
coverage of the full scope of public health care, including primary care, hospital 
care and community health services; the age structure of the local population 
and health needs are also considered. However, the allocation formulas have 
been changed frequently and further reforms are currently ongoing. Despite 
increasing financial controls, the costs per patient treated, per service provided 
and per input units (e.g. costs per hospital bed) in secondary care have not 
decreased over the last 25 years but have actually increased and are higher 
than in most other OECD countries. The best explanation available for this 
is the disproportionately high number of small hospitals. The median size of 
Italian hospitals is one-third less than that of Germany, France and Austria, 
and around half that of UK hospitals. This could be due to small hospitals 
compensating for poor community health services such as home care and 
long-term care, especially in non-urban areas. Data from primary care also 
suggest wide geographical variations in technical efficiency. The use of generic 
pharmaceuticals has been increasing as a result of targets but their market 
penetration is still lower than in most other OECD countries. Inter-regional 
differences in awareness among the public and general practitioners are also a 
hindrance to greater use of generics.
The national policy agenda has become increasingly aware that availability 
of data is vital to identify problems, monitor performance and ensure 
accountability in the health system. Accordingly, several recent interventions 
have been directed at improving existing information systems and making data 
available to the public but their implementation has been slow in the absence 
of systematic monitoring.
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Conclusion
In the last five years the National Health Service has been targeted by a number 
of policies aimed at containing or even reducing health expenditure without 
reducing the provision of health services to patients. To date these efforts have 
been largely successful in that regional deficits are now under control and health 
services continue to be delivered according to the prescribed national benefit 
package. However, with current fiscal constraints putting a strain on health 
services, Italy also faces a number of entrenched health system challenges. 
These include the risk that the highly decentralized regional health systems 
will continue to perform differently in terms of service delivery and that the 
gap between the southern and the northern parts of the country will continue 
to widen. 
In terms of health system organization and service delivery, three main 
issues deserve to be highlighted. The first concerns the relationship between 
politics and top management. While national health service organizations have 
experienced increasing professionalism at management level, the appointment 
of general managers, health directors and administrative directors still appears 
to be mainly driven by local and political considerations, which can constrain 
ambitious tasks such as the closure of small hospitals, the development of new 
integrated systems of care or the redesign of hospitals. A second major issue 
concerns primary care, which is still mainly based on solo-practice GPs or 
general paediatricians. The ongoing efforts to promote group practice and 
other organizational models based on a variety of health professionals working 
together in primary care teams should be promoted and incentivized. Thirdly, 
efforts should be made to ensure that current trends towards (re)integration 
of national health service facilities under regional or local control does not 
stifle innovation. Currently, most regional policies seem to have returned to 
integration, namely through the reattribution of some independent hospitals to 
local health authorities, the concentration of purchasing activities in regional 
or supra-organizational entities and the enlargement of the size of local health 
authorities. In addition, most regions have strengthened control over their 
providers, which in turn, have lost most of their organizational autonomy. While 
this trend is probably motivated by the search for savings as well as by the need 
to find better integrated care pathways and care coordination, experimenting, 
evaluating and disseminating good practices in this respect should be developed 
from the bottom up, mindful of local experiences and contexts, rather than by 
utilizing a top-down approach.
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1. Introduction1
With a population of almost 61 million (2012), Italy is the sixth most populous country in Europe. The country is made up of 20 regions, which are extremely varied, differing in size, population and 
levels of economic development. Since the early 1990s, considerable powers, 
particularly in health-care financing and delivery, have been devolved to this 
level of government. The regions are subdivided into provinces made up of 
municipalities (comuni). Italy has about 8100 municipalities, which range in 
size from small villages to large cities such as Rome.
A range of indicators shows that the health of the population has improved 
over the last decades. Average life expectancy reached 79.4 years for men and 
84.5 years for women in 2011, the second highest in Europe (compared with 
77.4 years for men and 83.1 years for women for the EU as a whole). Italy has 
one of the lowest total fertility rates in the world: in 2011 it was 1.4 births per 
woman, far below the replacement level of 2.1. The population growth rate is, 
therefore, very low (0.3% in 2012), one of the lowest in the EU, and immigration 
is the source of most of this growth. 
In almost all demographic and health indicators, there are marked regional 
differences for both men and women, reflecting the economic and social 
imbalance between the north and south of the country. For example, there is a 
gap of 2.8 years in life expectancy between the longest and shortest lived regions, 
for both genders. The main diseases affecting the population are circulatory 
diseases, malignant tumours and respiratory diseases, while smoking and rising 
obesity levels, particularly among young people, are major health challenges. 
1 The majority of the text in this section is based on and updates Chapter 1 of the previous Health System Review on 
Italy (see Lo Scalzo et al., 2009).
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1.1 Geography and sociodemography
Italy is a parliamentary republic in Southern Europe, with a population 
of almost 61 million in 2012, making it the sixth most populous country in 
Europe. The country covers 301 340 km2 and extends from the north where 
it borders France, Switzerland, Austria and Slovenia to the south where it 
includes the Mediterranean islands of Sardinia and Sicily and a cluster of 
other smaller islands. The country has 20 regions (the region of Trentino-Alto-
Adige is split into the Autonomous Province of Trento and the Autonomous 
Province of Bolzano). In addition, enclaves within mainland Italy include the 
countries of San Marino and the Holy See, a papal state mostly enclosed by 
Rome, Italy’s capital (Fig. 1.1). Five out of the 20 regions (namely Valle d’Aosta, 
Friuli-Venezia Giulia, Province of Trento, Province of Bolzano, Sicily and 
Sardinia) are granted home rule; the Constitution (article 116) acknowledges 
their powers in relation to legislation, administration and finance. In return, 
these regions have to finance their health-care and education systems, and most 
public infrastructure through their own means. These particular institutional 
arrangements were designed to take into account cultural differences and 
protect linguistic minorities. In fact, Italian is the major language throughout 
the country, although there are small areas in which German (in parts of 
Trentino-Alto-Adige), French (in Valle d’Aosta) and Slovene (in the Trieste-
Gorizia area) are spoken. The dominant religion is Roman Catholicism but the 
Constitution guarantees freedom of worship to religious minorities, which are 
primarily Protestant, Muslim and Jewish.
About 77% of the country is mountainous or hilly and 23% is forested. 
Northern Italy consists of a vast plain with the Alps in the north and is the 
richest part of the country, with the best farmland and largest industrial 
centres. Central Italy has great historical and cultural centres, such as Rome 
and Florence, and a flourishing tourist trade. Southern Italy is the poorest and 
least developed area (Lo Scalzo et al., 2009). Gross national income (GNI) per 
capita (measured in current international $PPP) in 2012 was 34 070, compared 
to an average of 40 613 for high income OECD countries (IMF, 2013).
Population density on average is 206.4 inhabitants per km2 and most of 
the population clusters around metropolitan areas and along the coasts (urban 
population accounts for 69% of total population). The structure of the population 
changed significantly between 1980 and 2012 owing to marked declines in 
fertility rates (from 1.6 to 1.4 births per woman) and increases in life expectancy 
at birth (from 74 to 82 years). Italy has one of the lowest total fertility rates 
in the world: in 2011, it was 1.4 births per woman, far below the replacement 
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Fig. 1.1
Map of Italy  
Source: www.mapsoftheworld.com, 2013.
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level (Table 1.1). The average population growth rate is, therefore, very low 
(0.3 in 2012), one of the lowest in the European Union (EU), and immigration 
is the source of most of this growth (World Bank, 2013). The population is also 
aging quite rapidly: in 2012 the proportion of the population aged 65 or over 
was 20.8%.
Table 1.1
Trends in population/demography indicators, 1980–2012 or latest available year
 1980 1990 1995 2000 2005 2012
Population, total (millions) 56.4 56.7 56.8 56.9 58.6 60.9
Population, female (% of total) 51.5 51.5 51.6 51.6 51.4 51.4a
Population ages 0–14 (% of total) 22.2 16.5 14.9 14.3 14.1 14.0
Population ages 65 and above (% of total) 13.4 14.9 16.7 18.3 19.6 20.8
Population growth (average annual %) 0.2 0.1 0.0 0.0 0.7 0.3
Population density (people per sq km) 191.9 192.9 193.3 193.6 199.2 206.4a
Fertility rate, total (births per woman) 1.6 1.3 1.2 1.3 1.3 1.4a
Birth rate, crude (per 1 000 people) 11.3 10.0 9.2 9.3 9.5 9.0a
Death rate, crude (per 1 000 people) 9.8 9.4 9.7 9.7 9.7 9.8a
Age dependency ratio (% of working-age population) 55.3 45.8 46.2 48.3 50.9 53.5
Mortality rate, infant (per 1 000 live births) 14.3 8.4 6.4 4.7 3.7 3.2
Life expectancy at birth, total (years) 73.9 76.9 78.0 79.4 80.6 82.1a
Urban population (% of total) 66.6 66.7 66.9 67.2 67.6 68.6
Source : World Bank, 2013.
Note : a2011 data.
1.2 Economic context
Italy has an open economy and is a founding member of the EU. It is also a 
member of major multilateral economic organizations such as the Group of 
Seven Industrialized Countries (G-7), the Group of Eight (G-8), OECD, the 
World Trade Organization and the International Monetary Fund (IMF). In 2012, 
according to IMF data, Italy was the ninth largest economy in the world and 
the fifth largest in Europe in terms of nominal gross domestic product (GDP). 
Its annual GDP (in current prices) accounts for 12.1% of the European Union’s 
total GDP. Nevertheless, per capita income (measured in current international 
$PPP; see Table 1.2) is 33.8% lower than in the United States and nearly 20% 
lower than the average among European Union countries.
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Table 1.2
Macroeconomic indicators 
 1980 1990 1995 2000 2005 2012
GDP (current US$), millions 459 830 1 138 091 1 131 770 1 104 009 1 786 275 2 013 263
GDP, PPP (current international $), 
millions
520 909 999 589 1 203 934 1 466 461 1 657 399 2 017 025 
GDP per capita (current US$) 8 148 20 065 19 910 19 388 30 479 33 049
GDP per capita growth (annual %) 3.43 1.99 2.89 3.65 0.93 -2.37
GDP per capita, PPP 
(current international $)
9 230 17 623 21 179 25 753 28 279 33 110
Real interest rate (%) -1.48 5.45 7.92 4.98 3.43 3.56
Central government debt, total 
(% of GDP)
0.00 0.00 121.12 118.67 112.80 110.89
Agriculture, value added (% of GDP) 6.02 3.48 3.29 2.78 2.19 1.90
Manufacturing, value added 
(% of GDP)
28.93 23.20 22.12 20.83 18.37 16.74
Industry, value added (% of GDP) 38.07 31.99 30.12 28.24 26.72 25.26
Services, etc, value added 
(% of GDP)
55.91 64.52 66.58 68.98 71.09 72.84
Official exchange rate 
(LCU per US$, period average)
856.45 1 198.10 1 628.93 n.a. n.a. n.a.
Labour force, total n.a. 23 784 644 22 772 910 23 271 088 24 670 885 n.a.
Unemployment, total 
(% of total labour force)
7.50 9.80 11.70 10.80 7.70 8.40
Source : World Bank, 2013.
Note : n.a. = data not available
The basis of Italy’s economy is processing and manufacturing goods, 
primarily in small and medium-sized firms. Its major industries are precision 
machinery, industrial machinery and equipment, transportation equipment, 
motor vehicles, chemicals, pharmaceuticals, electric and electronic equipment, 
fashion, clothing, leather, jewellery and shoes. Italy has few natural resources, 
with no substantial deposits of iron, coal or oil. Natural gas reserves are located 
mainly in the Po Valley and offshore in the Adriatic Sea. Most raw materials 
for industry and over 79% of energy requirements have to be imported (World 
Bank, 2013). In 2012, the agricultural sector employed 4.7% of the workforce, 
although it accounted for only 2.2% of GDP; industry employs 28.5% of the 
population and represents 26.7% of GDP; the service sector employs 67.8% of 
the population and comprises 71.1% of GDP. Tourism represents an important 
part of the economy, with nearly 46 million incoming visitors in 2011, an 
increase of 11% since 2005. 
Since the end of the Second World War, Italy’s economic structure has 
completely changed from being agriculturally based to industrially based, 
with about the same total and per capita output as France and the United 
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Kingdom. Italy experienced its ‘economic miracle’ from 1958 to 1963 when 
industrial output peaked at over 19% per year, investment levels reached 27% 
of GDP (in 1963) and the country enjoyed full employment. The country did, 
however, suffer considerably from the two economic crises of the last quarter 
of the 20th century. After 1963, the economy slowed down, and after 1973, it 
experienced a severe downturn. The oil shocks of the 1970s hit Italy’s economy 
particularly hard, given the reliance on foreign sources of energy. An extended 
period of high inflation and large budget deficits ensued during the 1980s, 
as the industrial complex restructured to meet the challenges posed by the 
new context. In addition, during the international economic crisis of the early 
1990s, the rate of GDP growth decreased markedly, unemployment rose and 
inflation peaked, increasing to more than 6%. Severe financial unrest forced 
monetary officials to withdraw the lira (its legal tender prior to joining the 
single European currency) from the European monetary system when it came 
under extreme pressure in currency markets (Lo Scalzo et al., 2009).
From 1992, after learning that Italy might not qualify to join the European 
Economic and Monetary Union, the authorities made a significant effort to 
address the most pressing economic issues. Economic policies were launched to 
tackle the fiscal and monetary imbalances that had developed over the previous 
years, aiming to re-establish an environment of sound finance, a stable currency 
and low interest rates. The government adopted fairly strict budgets, ended 
its highly inflationary wage indexing system and started to reduce its social 
welfare programmes, specifically focusing on pension and health-care benefits. 
In addition, the private sector was increasingly emphasized as the primary 
engine of growth: to this end, a broad array of deregulation measures was 
enacted, and from 1994, a massive privatization programme for state-owned 
enterprises was implemented to reduce the presence of the state, which, at 
the time, played a major role in the economy by owning large industrial and 
financial companies. The most significant effect of such initiatives was a 
progressive, continuous decrease in inflation rates throughout the 1990s. In 
addition, unemployment declined and GDP growth rates increased substantially 
during the mid-1990s, although they were somewhat reversed during the late 
1990s. The success of the corrective action undertaken during the 1990s led to 
Italy adopting the common European currency, the Euro, from its introduction 
on 1 January 1999 (Lo Scalzo et al., 2009).
Some of the most remarkable, specific weaknesses of Italy’s economy in 
the late 1990s were related to its labour market structure. In 2000, for instance, 
27.5% of all unemployed people were younger than 25, one of the highest 
proportions in the EU (18.1% on average). Although it decreased to 20.3% in 
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2007, it started increasing again in 2009 and reached 35.3% in 2012 (OECD, 
2014a). Total unemployment – expressed as percentage of the total labour force – 
was 8.7% in 2012. Currently, women only account for 39% of the workforce 
(latest data are from 2010), one of the lowest rates among EU countries and, 
above all, a percentage that sharply declines with movement up the hierarchical 
scale, with top positions both in the public and private sectors usually being 
the domain of the male workforce. In addition, temporary jobs continue to play 
an increasingly important role within Italy’s economy, primarily in the south. 
There is also a major underground economy that accounts for an estimated 
14–20% of GDP. This includes many nominally unemployed people, as well 
as undocumented immigrants, especially in difficult agricultural work in the 
rural south. 
In the 2000s, priorities for the Italian economy included the need to address 
proposed fiscal reform, revamp its communication system, reduce pollution 
in major industrial centres and adapt to the new competitive environment 
related to the ongoing process of economic integration and expansion of the 
EU (Lo Scalzo et al., 2009). Following the onset of the global economic crisis 
in 2008, Italy’s economy went into recession in early 2009 and has continued 
to struggle with achieving economic growth. At the time of writing, the 
most recent data show that Italy’s economy was still stagnating in 2014, with 
an estimated GDP growth rate of 0.7% (IMF, 2014). Priorities now include 
reversing sharp decreases in investment and export markets, tackling rising 
unemployment (8.7% in 2012) and implementing cut back measures in the 
public sector to manage a widening public debt. 
1.3 Political context
The Italian state is a parliamentary, democratic republic with a multi-party 
political system. Italy has been a democratic republic since 2 June 1946, when 
the monarchy was abolished by popular referendum. The political system is 
based on the 1948 Constitution. The Chamber of Deputies (630 members) and 
the Senate (315 members) form the bicameral parliament, whose members 
are directly elected for five years by universal suffrage. The President of the 
Republic is elected for seven years by a joint session of the Chamber and Senate 
and is the formal head of the state. The Prime Minister must be endorsed by, and 
have the confidence of, both parliamentary houses and is ultimately nominated 
by the President. The Prime Minister is usually the leader of the party that has 
Health systems in transition  Italy8
the largest representation in the Chamber of Deputies. The judiciary system is 
independent of the executive and the legislative branches and is headed by the 
High Council of the Judiciary.
Italian politics has been characterized by high levels of government turnover 
since the beginning of the republic; indeed, there have been 62 governments 
since 1946. From 1948 until the late 1970s the Prime Minister was consistently 
from the Christian Democratic Party. Coalition governments with roughly 
the same party configurations promoted a relative period of continuity and 
stability to Italy’s political situation during much of the post-war period, with 
the clear intention of keeping the Italian Communist Party (PCI) out of power 
in order to maintain Cold War equilibrium in the region. During 1976–1979, 
the Communist Party voted in support of the government (which included the 
Christian Democratic Party, the Socialist Party, the Social Democratic Party 
and the Republican Party) for the first time, although it did not formerly enter 
the government coalition. 
Starting in 1979, a new alliance was formed, also headed by the Christian 
Democrats. As part of the formation of this government (known as the five-party 
coalition), the Communist Party ceased to support the government and the 
minority rightist Liberal Party was incorporated. The Minister for Health was 
from the Liberal Party during most of the 1980s and until 1993 (Lo Scalzo et al., 
2009). During the early 1990s, persistent government instability, mounting 
economic pressure and especially a series of corruption scandals implicating all 
governing parties in illegal party financing prompted a profound political crisis. 
By September 1993, many political leaders were under criminal prosecution 
(known as the ‘Clean Hands’ (Mani Pulite) investigation) by the courts and 
the whole power structure faltered. Seemingly indestructible parties, such as 
the Christian Democrats and the Socialist Party, disbanded; the Communist 
Party changed its name to the Democratic Party of the Left and took the role 
of the previous Socialist Party as the country’s main social democratic party. 
A non-partisan (‘technocratic’) government, led by the former president of the 
Bank of Italy (Carlo Azeglio Ciampi), was put in charge of ruling the country 
during the transition period, which lasted until March 1994. 
This transition period was followed by the so-called Second Republic. 
From 1992 to 1997, Italy faced significant challenges, as voters, disenchanted 
with past political paralysis, massive government debt, extensive corruption 
and organized crime’s considerable influence demanded political, economic 
and ethical reforms. Major political parties beset by scandal and loss of voter 
confidence underwent far-reaching changes and the proportional electoral 
system was reformed into a majoritarian system. New political forces and new 
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alignments of power emerged in the March 1994 national elections. This election 
saw a major turnover in the new parliament, with 452 out of 630 deputies and 
213 out of 315 senators elected for the first time. The new parties developed 
around two poles: the conservative coalition ‘Pole of Liberties’ was formed by 
the leading Forza Italia party, the regionalist Lega Nord (Northern League) 
party and the radical right-wing group Alleanza Nazionale (National Alliance) 
and on the other hand, several centre-left, leftist and green parties (including 
the ex-communists) joined to form an alliance initially called the Progressives 
and later L’Ulivo (the Olive Tree). For nearly 15 years, governments tended 
to alternate between these two poles. Since 1995 the alternation between 
centre-right and centre-left coalitions corresponded to the succession of 
four governments led by Silvio Berlusconi and five by the centre-left (led by 
Romano Prodi twice, Massimo D’Alema twice and Giuliano Amato). A political 
crisis occurred in November 2011 following the resignation of the then Prime 
Minister, Silvio Berlusconi, as well as parliamentary approval of austerity 
measures designed to meet the severe challenges of the economic crisis facing 
the Italian economy. A technocratic government led by Mario Monti steered 
the administration for 18 months before elections were held in early 2013. 
Italy was then governed by a grand coalition government led by Enrico Letta,2 
and following his resignation in early 2014, Italy’s current prime minister is 
Matteo Renzi. 
The Constitution organizes Italy’s territory into 20 regions, which are 
extremely varied. They differ in size (Piedmont is 25 000 km2, while Valle 
d’Aosta is only 3000 km2), population (Lombardy has 15% of the total population, 
whereas Molise has less than 1%) and levels of economic development. The 
regions also differ in population age distribution. For example, an average of 
20.8% of Italy’s population is aged 65 years or older; southern Italy has fewer 
(19.5%) and central and northern Italy has more (22.4%). Each region is governed 
by an Executive and a Regional Council, both of which are democratically 
elected. The regions have exclusive legislative power with respect to any matter 
not expressly reserved under national law (Constitution article 117). Yet their 
financial autonomy is quite modest: they hold 20% of all levied taxes, mostly 
used to finance the regionally based health-care systems. This is the result of 
the reform passed in 1997 – known as the Bassanini Law – that significantly 
extended the powers transferred to regions through the principle of subsidiarity. 
In particular, responsibility for regulating, planning and organizing health-care 
2 A snap general election was held in February 2013, without any party emerging as the clear winner. Votes were 
divided into three parts: the Centre-left alliance (29.5% in the Chamber of Deputies), the Centre-right Coalition 
(29.1%), and the new anti-establishment Five Star Movement (25.5%), whose leader is Beppe Grillo, a popular 
activist, comedian and blogger.
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delivery has been transferred to the regions, and the central government retains 
responsibility over the basic principles and institutional rules of the system and 
as such functions by approving the National Health Plan, allocating funding 
and defining clinical and accreditation guidelines. The gradual devolution of 
political power during the 1990s runs parallel to the fiscal reform passed in 
2000, which (in theory) granted regions significant autonomy over revenue 
in the regional budget and complete autonomy over the allocation of funds 
(Constitutional Law N. 3/2001) (see Chapters 3 and 7). However, the autonomy 
over revenue has been modest so far. 
The 20 regions are subdivided into 110 provinces. The provinces are led 
by a president and a council, both of which are elected by city mayors and 
city council representatives of the respective provinces. Provincial councils 
comprise a minimum of 24 members and a maximum of 45 depending on 
population density. In addition, each province has a prefect who represents – and 
is appointed by – the national government. The basic unit of local government 
is a municipality (comune), which may range in size from a small village to a 
large city such as Rome. Italy has about 8100 municipalities, many of which 
are small villages with an ancient tradition of independent self-government; 
only 8% of total municipalities have more than 15 000 inhabitants. A council 
elected for a five-year term by universal suffrage governs each municipality 
and mayors of cities and towns are also elected.
1.4 Health status
The majority of the Italian population has a high standard of living and quality 
of life resulting, in part, from well-established health policies and welfare 
measures. Over the last four decades, the health status of Italians has improved, 
with a particularly remarkable increase in life expectancy at birth, which, after 
Switzerland, is the second highest in Europe (2011). On average, life expectancy 
has increased by about 12 years since 1960 and currently stands at 84.5 years 
for women and 79.4 years for men (Table 1.3) – compared with 77.4 years for 
men and 83.1 years for women for the EU as a whole (Eurostat, 2014). These 
results can be attributed to multiple factors such as improved standards of living, 
more widespread education, better-quality health care and increased access to 
health services. However, there is still a substantial gender difference in life 
expectancy (+5.1 years for women compared to men) and a high variability 
among regions (with a gap of 2.8 years, for both genders, between the highest 
and lowest performing region).
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Table 1.3
Mortality and health indicators, selected years 
Indicators 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Life expectancy at birth
Female 83.0 82.8 83.7 83.5 84.0 84.0 84.1 84.1 84.5 84.5
Male 77.1 77.2 77.9 77.8 78.4 78.7 78.8 79.0 79.4 79.4
Mortality rate
Female adults 
(per 10 000 inhabitants)
77.1 80.0 71.3 72.9 68.7 69.4 69.5 69.3 – –
Male adults 
(per 10 000 inhabitants)
127.0 129.5 118.5 119.4 112.6 111.9 110.9 109.4 – –
Sources : Osservatorio Nazionale sulla Salute nelle Regioni Italiane, selected years; ISTAT, 2013a. 
Over the last 30 years (between 1980 and 2010) mortality has decreased 
by 53%. The highest contribution to this large reduction is due to the falling 
incidence in cardiovascular diseases, with a decrease for both men (127.00 vs 
109.41 per 10 000) and women (77.05 vs 69.31 per 10 000) in the period 
2002–2009 (Ministero della Salute, 2012a). Cancer has emerged as the most 
frequent cause of death for people under 64, followed by circulatory diseases 
(Table 1.4). While breast cancer is still the most common cancer among women 
in Italy (42%), breast cancer mortality trends showed a decreasing rate between 
1989 (38.59 per 100 000) and 2010 (23.62 per 100 000). 
Table 1.4
Main causes of death (people aged 19–64, per 10 000 inhabitants), selected years 
Causes 2006 2007 2008 2009 2010
Malignant neoplasm
Female 8.0 8.0 7.9 7.9 7.7
Male 11.5 11.1 10.8 10.5 10.2
Circulatory diseases 
Female 2.1 2.0 1.9 1.8 1.8
Male 6.1 5.8 5.8 5.5 5.2
Violent causes
Female 0.9 0.8 0.8 0.8 0.8
Male 3.8 3.8 3.6 3.5 3.2
Digestive diseases
Female 0.6 0.6 0.6 0.5 0.5
Male 1.6 1.5 1.5 1.4 1.4
Sources : Osservatorio Nazionale sulla Salute nelle Regioni Italiane, selected years; ISTAT, Indagine sui decessi e cause di morte, 
selected years. 
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Italy has low infant and neonatal mortality rates, with a significant decrease 
over the last 40 years compared with other European countries, eliminating 
the existing gaps and reaching levels of excellence (see Table 1.1). Biological 
determinants and skilled assistance at delivery are particularly significant in 
explaining the trend in neonatal mortality.
The sharp decline of the total fertility rate over the last 30 years is a matter 
of concern in Italy, as for other Western countries. In the last decade a reversal 
has been observed, partially due to the effect of immigration, and fertility rates 
have gradually increased. However, in 2012 the fertility level was 1.4 births per 
woman (Table 1.1), still below the 2.1 replacement level. The reasons behind 
this process are complex and could be explained by the delay in transition to 
adulthood and the difficulties experienced by Italian women in combining work 
and raising children (Rosina & Caltabiano, 2012). At the end of 2010, foreign 
nationals accounted for 7.5% of the Italian population. The number of legal 
documented (regular) immigrants showed an increasing trend and varied across 
the country with higher numbers in northern and central regions and smaller 
numbers in the south. The largest foreign communities, for both genders, are 
represented by Romanians, Albanians and Moroccans. There has been a steady 
increase over time of births in which either one or both parents are foreigners. 
In 2011, more than one-third of the adult population (35.8%) was overweight, 
while 1 out of 10 (10%) was obese (Table 1.5), with a higher prevalence 
registered in the southern regions. At national level, 2011 data seem to be stable 
compared to 2010. Moreover, the proportion of overweight or obese people 
increases proportionally with age, before declining slightly among the elderly. 
The proportion of smokers among the population aged 15 and over was 
22.3% in 2011. In 2003, before the approval of Law 3/2003 to ban smoking in 
public spaces, the prevalence rate was 23.8%. Smoking cigarettes was found to 
be more common in young adults, particularly in the 25–34 age group and more 
prevalent among men (28.7%) than women (16.7%). Data for non-smokers and 
former smokers are inversely distributed among the two genders. Thus, there 
is a higher prevalence of non-smokers in females (65.1%) than in males (39.4%), 
while the percentage of former smokers among men is almost double (30.5%) 
that of women (16.7%).
In terms of alcohol consumption, prevalence rates for those drinking a 
standard number of units per week show a significant gap between genders 
(11.53% for men vs 2.72% for women aged over 15 who consume alcohol more 
than once a week) and geographical differences (lower values in the south and 
Italy’s islands).
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Table 1.5
Morbidity and factors affecting health status, selected years
Indicators 2002 2009 2010 2011
Obese (%) (people aged 18+ years)
Female 8.2 9.3 9.6 9.4
Male 8.7 11.2 11.1 10.7
Overweight (%) (people aged 18+ years)
Female 25.4 27.7 27.6 26.7
Male 44.2 45.2 44.3 45.5
Smokers (%) (people aged 15+ years)
Female 17.2 17.1 17.1 16.7
Male 31.3 29.9 29.5 28.7
Alcohol consumers (%) (people aged 15+ years)*
Female 2.6 2.6 2.7 2.7
Male 12.0 10.8 11.3 11.5
Source : ISTAT, selected years.
Note : *people aged 15 or older who consume alcohol more than once a week.
Notwithstanding the important results gained in health status, geographical 
differences remain in terms of health conditions and lifestyles, as well as 
in the supply and quality of services. Southern regions still score lower in 
life expectancy, lifestyles, access to care and quality of services. Moreover, 
many concerns are being raised on the sustainability of the system as Italy is 
undergoing an economic and financial crisis, which requires cost containment 
and resources reallocation policies. These measures are expected to have 
a marked impact on health care in the years to come, possibly generating 
inequalities in access to care, sharpening existing differences in the quality of 
care among regions and affecting the most vulnerable groups of the population. 

2
.
 O
rg
a
nization
 a
nd
 go
v
e
rn
a
n
c
e
2. Organization and governance
Italy’s health-care system is a regionally organized National Health Service (Servizio Sanitario Nazionale, SSN) that provides universal coverage largely free of charge at the point of delivery. At national level, the Ministry 
of Health (supported by several specialized agencies) sets the fundamental 
principles and goals of the health system, determines the core benefit package 
of health services guaranteed across the country and allocates national funds 
to the regions. The regions are responsible for organizing and delivering health 
care. At local level, geographically based local health authorities (Aziende 
Sanitarie Locali) deliver public health, community health services and primary 
care directly, and secondary and specialist care directly or through either public 
hospitals or accredited private providers.
Patient empowerment and patient rights are not specified by a single law but 
are present in several pieces of legislation, starting with the Italian Constitution 
and the founding law of the national health system. Over the last 20 years, 
several tools have been introduced for public participation at all levels but no 
systematic strategy exists and implementation varies across the country, as 
does the satisfaction of citizens with the quality of health care. Over the last 
few years, measures have been taken to tackle excessive recourse to legal action 
against doctors and to prevent defensive medicine practices.
2.1 Overview of the health system
Italy’s health-care system is a regionally based National Health Service (Servizio 
Sanitario Nazionale, SSN) that provides universal coverage, largely free of 
charge at the point of service. The system is organized into three levels: national, 
regional and local. The national level is responsible for ensuring the general 
objectives and fundamental principles of the SSN. Regional governments, 
through their regional health departments, are responsible for ensuring the 
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delivery of a package of benefits through a network of population-based ‘local 
health authorities’ (aziende sanitarie locali, ASLs) and public and private 
accredited hospitals. Fig. 2.1 summarizes the main organizational actors and 
the relationships between them.
Fig. 2.1
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2.2 Historical background 
The 1978 reform (Law No. 833/1978) that created the SSN introduced universal 
health-care coverage for Italian citizens and those legally residing in Italy. It 
established human dignity, health needs and solidarity as the guiding principles 
of the system. The main aims of the reform were to guarantee everyone equal 
access to uniform levels of care, irrespective of income or location; to develop 
disease prevention schemes; to control health spending; and to guarantee public 
democratic control. A mixed financing scheme was established that combined 
general taxation and statutory health insurance contributions, progressively 
moving to a fully tax-based system. The new health-care system was partly 
decentralized, with national, regional and local administration levels. The central 
government was responsible for financing, namely defining the criteria for the 
distribution of funds to the regions, attempting to progressively reduce regional 
imbalances and distributing funds; it was also responsible for planning through 
a three-year National Health Plan (Piano sanitario Nazionale – PSN). Regional 
health authorities were responsible for local planning according to health 
objectives specified at the national level, for organizing and managing health-care 
services and for allocating resources to the third tier of the system, then known as 
‘local health units’ (Unità Sanitarie Locali – USLs). The USLs were operational 
agencies responsible for providing services through their own facilities or through 
contracts with private providers. They were run by management committees 
elected by assemblies of representatives from local governments.
However, this structure created jurisdictional conf licts between the 
different levels of authority. Responsibility was not clearly divided and health 
care was not planned consistently at the national and regional levels. Above 
all, regional governments considered the resources they received from the 
central government to be insufficient to satisfy the health-care needs of their 
populations. As a result, regional public deficits mounted and the central 
government had to cover the accumulated debts. The separation between central 
financing responsibilities and regional and local spending powers was seen as 
the main cause of constantly rising health-care expenditure. Moreover, health 
care was markedly different in the north and the south of the country, causing 
concern about the capacity of the health-care system to guarantee equal rights 
to citizens across the country. In addition, health-care management suffered 
from excessive politicization, as political party representatives managed USLs 
according to their electoral strength. 
Faced with these problems, the government set out new reforms to the health-
care system with Decrees 502/1992 and 517/1993, that combined universal 
coverage with new financing mechanisms. Incentives and competition among 
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providers would improve efficiency and responsiveness to consumers at the 
micro level, while containing costs and ensuring equity at the macro level. The 
1992 reform introduced managerial principles into the SSN and began concerted 
efforts to devolve health-care powers to the regions. USLs and major hospitals 
were transformed into autonomous bodies and made more independent of 
political influence. The USLs were thus transformed into public entities, the 
ASLs; major hospitals became semi-independent public enterprises – ‘public 
hospital enterprises’ (aziende ospedaliere, AOs); and both ASLs and AOs were 
made directly accountable to the regions. 
In 1998, dissatisfaction with the effects of the 1992–1993 reforms prompted 
the government to reorganize the SSN. Changes involved the relationship 
between levels of responsibility and management, the roles of actors such as 
managers, doctors and local institutions, and the balance between economic 
constraints and the principles of universalism and equity of access. The resulting 
reform was launched by Decree No. 229/1999, which extended regionalization 
and strengthened the role of municipalities, distributing responsibilities more 
clearly between levels of government. This reform also softened the previous 
shift to quasi-market and internal competition, promoting cooperation among 
health-care providers and partnerships with local authorities for health 
promotion and community care. To tackle the previously unresolved issue 
of the relationship between health care and social services, it created a more 
integrated framework for delivering health care to disadvantaged people such 
as the elderly, the poor and those with reduced autonomy.
As a step towards decentralizing fiscal powers so as to give more financial 
responsibilities and powers to each region, a Decree in 2000 (No. 56/2000) 
set out a timetable to eventually abolish the National Health Fund, which was 
used to collect and distribute central resources to regional health-care systems.3 
Various regional taxes became the sources of health care funding. Regions 
unable to provide the basic package of health services with their own resources 
would receive additional funding from a newly created National Solidarity Fund. 
Money from this fund is allocated annually based on criteria recommended 
by the government and the Standing Conference on the Relations between 
the State, the Regions and the Autonomous Provinces (or the State-Regions 
Conference, for short). Table 2.1 summarizes the main historical landmarks in 
the development of Italy’s health-care system.
3 However, due to continuing stalemates between the central government and the regions over resource allocation 
criteria, the National Health Fund is still in operation. See Chapter 3.
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Table 2.1
Historical background and recent reforms in Italy’s health-care system 
1861–1920 Autonomous mutual aid associations are established for artisans and workers; the Catholic Church 
and charitable institutions establish several health-care providers; provincial and municipal networks 
provide social assistance to the needy and disabled.
1898 Insurance for occupational accidents becomes compulsory for the first time.
1904, 1917 Insurance becomes compulsory in industry and agriculture, respectively.
1923 The right-to-hospital care for the needy, indigent population is guaranteed for the first time.
1925 A national body in charge of insurance for the employees of local authorities is created (INADEL).
1926 A small number of centres for cancer diagnostic testing are created.
1927 Provincial authorities for tuberculosis treatment are created, and tuberculosis insurance becomes 
compulsory.
1926–1929 Health-care provisions for workers become mandatory for the government to approve collective 
labour force agreements.
1942 A national body is created to guarantee social insurance and health care for public employees 
(ENPAS).
1943 A national body for private employees’ health care insurance is created (INAM).
1958 An independent Ministry of Health is created.
1968 Public institutions providing hospital care are established as autonomous entities (Law 132/1968).
1974–1975 Responsibility for hospital management is transferred to the regions (Laws 386/1974 and 382/1975).
1978 A national health service (SSN) is established by Law 833. Health insurance funds are abolished 
(First reform of Italian health care).
1992–1993 Second reform of the SSN (Legislative Decrees 502/1992 and 517/1993). Devolution of health care to 
regions begins; managerial autonomy granted to local health authorities (ASLs) and hospitals (AOs); 
elements of an internal market are introduced.
1994 First National Health Plan (1994–1996). The plan defines national health targets and establishes 
that a uniform core benefit package (‘essential levels of assistance’ – LEAs) should be guaranteed 
to all citizens.
1997 Further steps towards federalism: Law 51/1997 devolves some key political powers to the regions; 
Law 446/1997 initiates the process of fiscal federalism.
1998 Second National Health Plan (1998–2000).
1999 Third reform of the SSN (Decree 229/1999). Further development of devolution; strengthening of 
cooperation and regulation to partially reorient the internal market; establishment of tools to define 
the core benefit package; regulation of the introduction of clinical guidelines for quality in health care.
2000 Decree 56/2000 replaces (in theory) the National Health Fund with a National Solidarity Fund; 
plan for fiscal federalism to be operative in 2013.
2001 Constitutional Law No. 3 modifies the second part of the Italian Constitution (Title V), giving 
regions with more powers. Law 405/2001 introduces new regional governance tools and stronger 
responsibility in the control of health-care expenditure.
2003 Third National Health Plan (2003–2005).
2005 Memorandum of understanding between the state and the regions reforms the health-care financing 
system and introduces new mandatory financial rules.
2006 Fourth National Health Plan (2006–2008). In June the newly formed Centre-left government outlines 
the policy programme, A New Deal for Health. National Budget Law 2007 introduces financial 
turnaround (recovery) for regions with deficits
2009 Law 42/2009 provides the framework for fiscal federalism. In the following years, a series of 
decrees defines the distribution of local taxes to the tiers of government and the criteria for central 
equalization and redistribution of funds.
2012 A spending review of the national budget includes cuts to health spending and a reduction of hospital 
beds per inhabitant.
2012 Decree 158 (‘Balduzzi Law’) modernizes the SSN on several levels: continuity of care; selection 
by merit of general directors and head physicians; simplifications for homeopathic and innovative 
pharmaceuticals; rationalized pharmaceutical and capital spending.
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2.3 Organizational overview
2.3.1 National level
The national Government, through the Ministry of Health, takes the lead in 
health-care planning, including the definition of the benefit package (LEAs, see 
section 2.4) and the setting of long-term goals; financing, with the distribution 
of available funds to the regional health systems; monitoring of the SSN; and the 
general governance of the National Institutes for Scientific Research (IRCCS).
The ministry is currently organized into three independent and specialized 
departments, each comprising several directorates:
1) Department of Public Health and Innovation. 
 • Prevention
 • Health and biomedical research
 • European and international relationships
 • Communication and institutional relations.
2) Department of Planning and Organization of the SSN. 
 • Health-care planning
 • Health statistics and information system
 • Health professions and SSN human resources
 • Medical devices, pharmaceutical service and safety of care.
3) Department of Veterinary Care, Food Safety and Collegial Organs for 
Health Protection. 
 • Veterinary care and pharmaceuticals
 • Food and nutrition safety
 • Collegial organs for Health Protection.
The Ministry is supported in its functions by several permanent government 
agencies: 
• The National Institute of Health (ISS) carries out scientific research, 
surveillance and promotion of public health, and dissemination of 
knowledge. It has an advisory role to the ministry with a significant 
degree of independence, including its own research facilities.
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• AGENAS (National Agency for Regional Health Services) works at the 
interface between the Ministry of Health and the regional authorities, 
helping them ensure organizational quality, efficiency and efficacy in 
the delivery of care. It carries out monitoring activities in these areas 
and supports both the ministry and single regional health-care systems 
in planning and implementing organizational reforms. 
• CCM (National Centre for Disease Prevention and Control) was 
established to liaise between the Ministry of Health and regional 
governments in surveillance, prevention and health emergency response. 
Over the years its role has expanded to include designing evidence-based 
national strategies for disease prevention, health promotion and equity 
in access to care. It provides assistance to the regional technical working 
groups in public health programmes, and maintains relationships with 
large international epidemiology and public health networks. 
• AIFA, the national authority for pharmaceutical regulation (see 
section 2.8.4).
• IRCCSs (National Institutes for Scientific Research), tertiary care and 
research centres; and the IZSs (Experimental Zooprophylactic Institutes), 
which regulate and control animal livestock and food of animal origin. 
The single most important technical and consultative body to the Ministry 
of Health is the National Health Council (CSS). It consists of 50 members 
and a president, and it brings together representatives of the national 
government agencies listed above as well as scientists, physicians and other 
recognized experts. 
The State-Regions Conference was established in 1983 to provide a 
permanent interface for consultation and communication between the state 
and the regions in the domains of public policy where their mandates overlap. 
2.3.2 Regional level
The 19 Regions and 2 Autonomous Provinces share planning and financing 
responsibilities with the central government in the State-Regions Conference, 
and are exclusively responsible for delivering public health and health-care 
services through their regional health-care systems.
Each region, through its elected Regional Council, carries out legislative 
activity, which was enlarged in scope by the 1999 SSN reform and 
currently includes:
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• general principles and organization of the regional health-care system, 
including the general rules about the roles of the regional authority, 
ASLs and AOs (public providers) and private providers;
• criteria for financing public and private health-care providers;
• technical and management guidelines for service provision and planning, 
including assessment of the need for new hospitals.
The executive functions of the regional government in health care, mainly 
carried out through the regional Department of Health, include drafting the 
three-year Regional Health Plan; defining the criteria for authorizing and 
accrediting public and private health-care providers and monitoring the quality 
of their care; coordinating health and social care through a Standing Conference 
for Regional Health and Social Care Planning; and managing ASLs and AOs 
by defining their geographical boundaries, allocating resources to them, and 
appointing their directors.
Eleven regions, mainly northern ones, currently have a regional agency for 
health responsible for both supporting the regional health department itself in 
its executive functions and providing technical and scientific support to the 
ASLs and hospitals. 
2.3.3 Local level
Within each region, responsibility for the organization and delivery of services 
rests on geographically and population-defined institutions, the ASLs. These 
Local Health Authorities directly depend on the government of their region, 
which funds them according to financing schemes that vary from region to 
region (see Chapter 3). They provide preventive medicine and public health 
services, primary care – including family medicine and community services – 
and secondary care. The territory of each ASL is further divided into Districts, 
the institutional level that directly controls the provision of public health 
and primary care services. Each district is statutorily set to have a coverage 
population of approximately 60 000 inhabitants. As of 2012, there were 
143 ASLs and 826 Districts in the SSN.
The providers of all health and social care services have different 
relationships with ASLs, ranging from direct dependency (in-house provision 
of services) to commissioning: 
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• Preventive medicine and public health services are delivered by the 
Department of Prevention, present in every ASL. ASLs of different sizes 
may have several additional departments that may take on more public 
health services.
• A network of general practitioners (GPs) provides family medicine 
services and acts as a gatekeeper to higher levels of care. They work 
for the regional health system and coordinate with the activities of the 
Districts. However they are not salaried employees of ASLs as the 
terms of their work are set out in a national agreement between the 
State-Regions Conference and (since 2001) the association of health 
professionals with a contract with the SSN, SISAC (Società Interregionale 
Sanitari Convenzionati). 
• Community services include primary medical and nursing care, home and 
residential care for the elderly and the disabled, and hospice care. 
• Secondary care can be either delivered directly by the ASLs through the 
hospitals they own or by public hospital enterprises, the AOs (Aziende 
Ospedaliere). In the latter case, the ASLs work as purchasers of services 
in a quasi-market system. It is up to the individual regions to choose 
whether to opt for purchaser–provider separation. 
• Accredited private hospitals and specialists. 
• Social care and social welfare services are delivered by municipal 
authorities, with varying degrees of integration and coordination with ASLs.
2.4 Centralization and decentralization
The national level has exclusive authority in determining the core benefit 
package (Livelli Essenziali di Assistenza – LEA), that must be guaranteed 
throughout the country free or with cost sharing, using the resources collected 
through general taxation. The delivery of LEA is organized into three levels: 
public health; community health medicine and primary care; and hospital care. 
A specific National Commission for the definition and updating of the LEA is 
requested to follow three criteria: efficacy, appropriateness and consistency 
with the functions and goals of the SSN.
Regions have exclusive authority in execution-level planning and delivery 
of health care, as well as health protection and health-related disciplines such 
as labour safety, organization of professions, food safety and scientific research. 
Since 2001, agreements between the national level and the regions have become 
Health systems in transition  Italy24
the main instrument for planning and organization of public health care in 
Italy. In fact, different regions have made different choices on how to use 
their increasing autonomy. For instance, Tuscany decided to keep the system 
heavily centralized, with most hospitals remaining under ASL control and 
only a handful becoming AOs. At the other extreme, Lombardy opted in 1998 
for a fully fledged experiment in which all hospital and specialist services 
are delivered by AOs or private providers. The region’s main hospitals were 
converted to AOs, free to negotiate financing terms with ASLs – although 
controlled on the quality of services provided – and citizens were given full 
freedom of choice between ASLs, hospitals and even social care services. While 
a part of these features was repealed in subsequent years, the basic configuration 
is still the same. Since 2006, ‘financial recovery plans’ (Piani di Rientro) have 
further affected the level of decentralization of policies (see section 3.3.3).
Because of these regional differences in policies and financing, a large 
vertical fragmentation exists in the extent and the quality of such strategies 
between regions or ASLs of excellence, which are mainly found in the 
northern part of the country, and areas where self-directed initiatives are scant. 
In addition, horizontal fragmentation undermines the continuity of care for 
chronic diseases, as integration between actors of social care (municipalities) 
and health care (ASLs) varies across the country and is mostly incomplete.
The process of decentralization was set to end with the full implementation 
of fiscal federalism, set in motion in 2009 (Law 42/2009). However, this reform 
has stalled. The uncontrolled increase of regional health-care spending since 
2001 and the international financial and economic crisis that began in 2008 
have led policy-makers to reconsider full fiscal decentralization. 
2.5 Planning
2.5.1 National level planning
The main instrument for national level health-care planning is the National 
Health Plan (NHP). Drafted by the Ministry of Health following consultations 
with the regions, it is then approved by the government in agreement with 
the State-Regions Conference, and covers three years. The first NHP was 
released in 1994. Within a flexible structure, such plans set the fundamental 
principles and values of the health system, the general goals of the SSN and 
the strategic directions for quality improvement, evaluation of the system’s 
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efficiency and efficacy, and for scientific research. The single most important 
part of the NHP is the LEA, the main instrument for planning, priority setting 
and assuring equity.
The NHP for 2011–2013 defines at all levels (prevention, diagnosis, care, 
rehabilitation):
• the LEA;
• criteria for ensuring that the financing of regional health care is adequate 
to guarantee the LEA (see Chapter 3);
• criteria for resource allocation of regional funds across the individual ASLs;
• economic sustainability;
• criteria for adapting national goals with the epidemiological features and 
health needs of regional populations.
The NHP also compares the predicted annual number of new graduates in 
the health professions and the estimated number of health professionals that will 
be needed, also considering the average age of the workforce. It discusses the 
potential impact and the administrative effects of newly introduced provisions, 
including fine-tuning of education and training policies; and specifies the 
provisions included in the yearly National Financial Laws that are relevant to 
health and health care.
2.5.2 Regional level planning
The main health-care planning instrument at the regional level is the Regional 
Health Plan (RHP). Every region adopts one within 150 days of the introduction 
of the NHP and forwards it to the Ministry of Health to receive feedback on its 
consistency with the national plan. The RHP is generally more detailed than the 
NHP. It includes details such as the distribution of beds in secondary, emergency 
and long-term care, size and location of hospitals, measures to ensure balance 
between primary and secondary care, integration between health and social 
care, and continuous improvement. Approaches to regional planning widely 
vary: some regions regularly issue plans while other have rarely used formal 
planning to steer the system. 
2.5.3 Local level planning
Although there are great intra- and inter-regional variations, every ASL 
generally plans on three levels: Managing Board, Department Directors and 
single professionals.
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The Managing Board performs long-term strategic planning and monitoring, 
which includes the following stages:
• definition of long-term institutional goals;
• analysis of the external environment (needs and demands, indications 
from regional and national planning, features of other organizations with 
a similar mandate) and the internal environment (SWOT analysis at the 
organizational and the technological level);
• definition of critical success factors;
• formulation of strategy with specific goals;
• implementation plans;
• definition of strategic control functions, consisting of monitoring and 
correcting actions.
The Department Directors draft the budget for the medium term, which 
includes:
• budgeting, which defines specific and concrete sub-goals leading to the 
attainment of the general goals defined through strategic planning, and 
accountabilities; and assigns sufficient resources to each goal;
• reporting, which sets up a periodic comparison between set goals and 
actual achievements.
Health-care professionals at the management level carry out short-term 
operational planning and monitoring.
2.6 Intersectorality
Compared to similar institutions in other countries, the Italian Ministry of 
Health has much wider ‘horizontal’ administrative competences. In addition to 
health financing and planning, its mandate includes protecting citizens’ health 
through the preventive control of industrial production (e.g. biotechnologies 
and health and safety at work) and agriculture (e.g. veterinary public health and 
food safety), the exchange of several goods (e.g. manufacturing and marketing 
of medicines, medical devices and cosmetics), and human international mobility. 
Moreover, enforcement of certain environmental health standards (e.g. air and 
water quality) also fall within the remit of the ministry, as does the control of 
their implementation through the structures of the SSN.
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The Ministry of Health links closely to the Ministry of Economy and 
Finance, especially with regard to the definition of the health-care budget, 
and the Ministry of Welfare and Social Affairs, in the coordination of social 
services with SSN infrastructures. Table 2.2 lists the main actors responsible 
for health-related issues in several public policy domains.
Table 2.2
Main actors responsible for health-related issues in public policies 
Domain Responsible authority Activities
Agriculture and 
food safety control
Ministry of Agriculture, Regions, 
ASLs (Veterinary Division, Food 
and Nutrition Hygiene Division) 
Customs offices and port bureaus 
of the Ministry of Health 
Enforcement of EU regulations (1997 European 
Commission Green Paper on the General Principles of 
Legislation in the field of Food, 2000 White Paper on 
Food Safety, 2002 General Food Law, 2006 Hygiene Pack 
with Regulations 852, 853, 854, 882/2004 and Directive 
2002/99. Biochemical and microbiological controls on 
food production, labelling, distribution, import and export, 
yearly reports.
Workplace safety, 
occupational 
hazards
Ministry of Health, Directorate-
General of Preventiona
Municipal fire brigades
Municipal police
Specialized doctors in Labour Medicine are authorized 
by the ministry to prevent and diagnose work-associated 
health hazards and diseases. Employers must comply with 
workplace safety standards set by law and monitored by 
local fire brigades and police officers. Employees must 
follow safety training and are entitled to care by Labour 
Medicine doctors. 
Road Safety Ministry of Public Works
Ministry of Transport and Navigation
Ministry of Economic Development
ISS
Enforcement of relevant legislation: the 1999 National Plan 
for Road Safety (Piano Nazionale Sicurezza Stradale) and its 
three implementation programmes (2002, 2003, 2007), the 
latter still ongoing. The ISS runs a permanent observatory 
on road safety. 
Emergency 
response
Prime Minister’s Office, Department 
of Civil Protection, ASLs
The Civil Protection Department is responsible for 
responding to seismic, volcanic, hydrogeological, fire, 
nuclear, environmental, industrial, and terrorism-related 
large-scale risks. It has its own workforce and equipment. 
Environment Ministry of Environment, Regional 
Environmental Authorities (ARPA) 
Municipal fire brigades
Safety of industrial sites handling dangerous substances. 
Water, air Ministry of Environment, ASLs, 
Regional Environmental Authorities 
(ARPA)
Quality control of drinking water and bathing water.
Veterinary Health Ministry of Agriculture, ASLs, 
Veterinary Health Service, IZS 
(Experimental Zooprophylactic 
Institutes)
Controls on industrial and non-industrial farming. 
Smoking, alcohol 
and drugs
Ministry of Health, Ministry of 
Economic Development, ASLs, 
Municipal social care services, 
Provinces
Health promotion campaigns, addiction treatment and 
rehabilitation.
Note : aIn 2010, following an institutional reorganization, the National Institute for Prevention and Safety at Work (Istituto Superiore per la 
Prevenzione e la Sicurezza del Lavoro, ISPESL) was disbanded and its roles assigned to existing government agencies.
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In 2007, the CCM (see Section 2.3.1) adopted the evaluation tool in the 
WHO’s Health in all Policies strategy. The evaluation involved the fields of 
mobility and transport, work, identification of social and environmental health 
determinants, poverty and health, and urbanization and health. However, 
the Health in all Policies principles were not systematically applied by the 
Ministry of Health or regional governments. In 2011, the Health Committee of 
the State-Regions Conference created a National Working Group to act upon 
the European Commission’s Communication (of October 2009) ‘Solidarity in 
health: reducing health inequalities in the EU’. In 2012, the Group submitted 
to the Conference the draft of a White Paper on health inequalities in Italy that 
is currently being discussed by citizens’ and patients’ associations and other 
relevant stakeholders. 
2.7 Health information management
2.7.1 Information systems
Collection, processing and dissemination of data relevant to the statutory 
health-care system and to citizens’ health status fall within the mandate of the 
Ministry of Health’s General Directorate of Health-care Statistics (Statistics 
Office). ASLs collect data and send them to regions, which in turn, forward 
them to the Office.
Specific data f lows originate locally, from GPs and ASL departments. 
The surveillance data f low for infectious diseases, the SIMI (Sistema 
Informativo Malattie Infettive), collects notifications filed by doctors on cases 
of 47 infectious diseases. Each ASL forwards them to the Regional Public 
Health Agency, which warns the Ministry of Health and the National Health 
Council; these can notify international organizations (EU, WHO). An annual 
Epidemiological Bulletin collects the data by month and by location. A similar 
data flow exists for occupational hazards and work-related accidents. 
One of the most important databases is the national database on 
hospitalizations (Sistema Informativo Ospedaliero – SIO). This database is 
based on the Hospital Discharge Form (Scheda di Dimissione Ospedaliera – 
SDO), introduced in 1991, that reports all details of each hospitalization in 
secondary care structures, classifying diseases based on the most recent 
revision of the International Classification of Diseases and listing the services 
provided to patients. Other notable data flows are the information system on 
accidents and emergencies (Sistema Informativo Emergenza Sanitaria – SIES); 
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the Register of Delivery Certificates (Certificato di Assistenza al Parto – 
CeDAP), which collects details on every birth in all regions (since 2008); and 
the data on organ donations and transplants collected by the National Centre 
for Transplants. 
General demographic statistics with relevance to health, such as general 
mortality, child mortality and mortality of live births, are produced by the 
National Institute of Statistics (Istituto nazionale di Statistica – ISTAT), 
which supports all ministries and central government agencies. Financial 
and organizational data are also collected and analysed by the State General 
Accountant (Ragioneria Generale dello Stato). 
Over the last few decades, several steps have been taken to coordinate 
local, regional and national information systems. The Health-care Information 
System (Sistema Informativo Sanitario – SIS) was established in 1984 within 
the Ministry of Health to coordinate and manage SSN data flows. Since 2001, 
a centralized national information system for storage and management of health 
and health-care-related data, the New Health Care Information System (Nuovo 
Sistema Informativo Sanitario – NSIS), has been under development. Common 
and interoperable languages have already been developed for its subcomponents 
(pharmaceutical distribution database; monitoring of care networks; information 
system on mental health; observatory of public investments in health care; 
national information system on addictions; traceability of pharmaceuticals; 
emergency and urgency; home care; residential and semi-residential care; 
hospital drug consumption; information system for the monitoring of health 
care errors).
2.7.2 Health Technology Assessment (HTA)
The first evaluations of medical technologies were carried out by clinical 
engineers at the ISS in the 1980s, and they spread to teaching hospitals at the 
beginning of the 1990s. After the 1993 meeting of the International Society 
of Technology in Health Care (ISTAHC), held in Italy, interest grew in public 
regional institutions, especially with regard to opportunities for price control. 
HTA units were set up in several teaching hospitals and through regional health 
care agencies; Emilia-Romagna was the first region to produce HTA reports. 
With the publication of the first research grants in HTA by the Ministry of 
Health, the Italian Network of Health Technology Assessment was formed in 
2003, and the Italian Society of HTA (SIHTA) in 2006. In the same year, the 
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regions of Emilia-Romagna and Veneto, and the Catholic University of Rome, 
entered the EUnetHTA project, aimed at building a European HTA network 
(Favaretti et al., 2009). 
The first official mention of HTA at the institutional level was in the 
2006–2008 National Health Plan, which described the recognition of its tools 
as a priority. Following this statement, the State-Regions Conference assigned 
AGENAS (see section 2.3.1) the task of supporting the regions to develop HTA 
activities. Through an ad hoc working group, AGENAS started to publish 
reports for the General Directorate of Medical Devices. 
So far, Italy has not established a national HTA governmental agency; HTA 
activity by central agencies has been conducted by AGENAS in the field of 
medical devices and by AIFA for pharmaceuticals. However, five regions out 
of 21 have taken action to structurally include HTA in their health-care decision-
making processes: Veneto (the forerunners), Emilia-Romagna, Lombardy, 
Piedmont and Tuscany (CSA, 2012). Their experience is quite heterogeneous. 
The involvement of industry only occurs in Emilia-Romagna, and involvement 
of patients only in Piedmont; the other three regions do not provide a role 
for either. The degree of centralization is low in Veneto, where many bodies 
share responsibilities and play a role in the decision-making process, while it is 
high in the remaining four regions. On the other hand, research and decision-
making are assigned to different bodies only in Emilia-Romagna. Inter-regional 
differences also exist in the application of HTA: in 2012, of the 18 regions 
that reported conducting some HTA activity, 14 applied it to both medical 
devices and pharmaceuticals, and 4 – concentrated in central-southern Italy – 
exclusively on medical devices.
2.8 Regulation
2.8.1 Regulation and governance of third-party payers
Until 1992, only the central government could raise taxes and allocate funds 
to the regions, while the regions funded the ASLs and their hospitals. Funding 
was based on past spending, and the ASLs had no incentives to contain costs. 
Therefore, most ASLs overspent their budgets, and the central government 
funded their deficits. In the 1990s, a series of reforms was introduced, 
underpinned by the principles of managerialism, regionalization and managed 
competition. Managerialism gave ASLs greater independence but required 
them to improve their performance and encouraged them to adopt governance 
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techniques similar to those of private companies (Cantú, Ferré & Sicilia, 2010). 
It also made it possible for hospitals to become independent from ASLs by 
taking on the legal form of a Hospital Enterprise (Azienda Ospedaliera – AO), 
with their own managing board. Reimbursements to providers are based on 
activity-related funding: diagnosis-related groups (DRGs) for hospitals and 
a capitation (partially combined with fee-for-service) for GPs and outpatient 
specialist services (see Chapter 3). 
Regionalization has progressively transferred full jurisdiction on health care 
to the regions. They carry out goal-setting and planning; fund their spending 
with regional taxes and user charges (even though a national equalization 
fund still compensates for cross-regional differences in fiscal capacity); and 
are free to decide whether to keep the purchasing role for themselves or 
transfer it to the ASLs. As a result, since the 1990s different regions have been 
experimenting with different organizational and funding models, thus resulting 
in great diversity:
• Most regions use an ‘ASL-centred template’, with each ASL acting as 
both provider and (to a limited extent) as purchaser of services from a 
limited number of AOs. This template partly resembles a quasi-market, 
as ASLs are financially penalized if residents seek care from providers 
other than theirs, as they have to pay them. 
• A few smaller regions in northern and central Italy adopt a ‘region-centred 
template’, where most purchasing concentrates at the regional level, while 
ASLs act mostly as providers. These regions directly control most public 
providers and they accredit only a limited number of private providers. 
• Lombardy is the only region that has carried out a complete purchaser–
provider split. Most hospitals have been taken out of ASL control and 
established as AOs. ASLs purchase services from public and private 
providers, while the region has a regulatory role. The incentive for ASLs 
to ensure financial control by limiting provision balances the incentive 
for providers to increase volumes by attracting patients who have full 
freedom of choice. However, inadequate governance of demand makes 
ASLs act more often as third-party payers than purchasers, and volume-
driven profits have led hospitals to increase demand artificially. Though a 
significant part of the reform that introduced the model was withdrawn in 
the early 2000s, Lombardy remains the region with the greatest emphasis 
on freedom of choice and a tendency towards a purchaser–provider split. 
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2.8.2 Regulation and governance of providers
Health-care providers can be either public or private. Public health-care 
providers are either under direct control of their ASL or are independent 
organizations (AOs, University Hospitals and Public Research Institutes – 
IRCCSs), though under a regional planning, financial and control scheme. 
On the other hand, private providers, both for-profit or non-profit, cooperate 
with public ASLs and regional authorities in ensuring the supply of services. 
However, several provisions exist to ensure they meet minimum structural, 
organizational and operational standards; the main ones are: authorizations, 
institutional accreditation and contracts. 
Authorization procedures concern the minimum structural, technological 
and organizational criteria required under Italian law to operate in the health-
care sector and concerns individual professionals and facilities. Authorization 
applies to any subject operating in Italy, even if its activities are completely 
outside those of the SSN.
SSN accreditation is a form of public licensing necessary for providing health 
care on behalf of the SSN, which is quite different from voluntary accreditations 
issued by organizations such as the Joint Commission International or the 
International Organization for Standardization. SSN accreditation hinges on 
more extensive quality criteria than authorization. It encompasses management 
of human and technical resources, as well as consistency of the provider’s activity 
with regional health planning, and evaluation of the activities already conducted 
and the results achieved. The standards for the accreditation procedure were 
first set in 1997 by the National Accreditation Act. The Constitutional reform 
of 2001 gave regions the freedom to set their own accreditation criteria and 
procedures, as long as the LEA is guaranteed. At present, significant variability 
exists in regional accreditation policies. 
Lastly, contracts between private providers and regional authorities 
(on behalf of the SSN) specify the financing conditions that will apply to that 
provider. Contracts qualify them as ‘SSN providers’, thus allowing them to 
begin to operate on behalf of the SSN, as authorization and accreditation alone 
are not enough for that purpose. Regional health authorities, in cooperation 
with ASLs, define the details of the contract agreements. Contracts also specify 
the operational and financial information the provider must supply to the ASL 
and region, the terms for supervision and monitoring, the maximum yearly 
volume or mix of care, and the financial and administrative sanctions if the 
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provider exceeds or does not reach the targeted volume (Cantú, Ferré & Sicilia, 
2010). These contracts for private providers are the equivalent of the formal 
agreements ASLs establish with public providers.
2.8.3 Registration and planning of human resources
Every region determines its annual requirements for medical specialists by 
means of an ad hoc algorithm. The algorithm combines, per specialty, the 
overall turnover rate of SSN doctors according to the latest annual state budget 
with the variation of the number of specialists that each region needs for that 
year. These data express regional needs for the three categories of medical 
specialties, surgical specialties and medical services specialities.
Every three years, the State-Regions Conference determines the number of 
medical residencies allotted to each region. The annual requirement for medical 
specialists turned in by each region is matched with financial resources made 
available by the Ministry of Finance. If these resources are not enough to 
finance all the residencies needed, the regions can fund the remaining ones 
through regional or private funds. 
2.8.4 Pharmaceuticals
Governance of pharmaceuticals rests with the AIFA, the Italian Agency for 
Pharmaceuticals. AIFA approves the pharmaceuticals that can be produced, 
used and marketed in Italy, and authorizes clinical trials.
Pharmaceuticals are divided into three categories, with different 
reimbursement regimes. Class A (Classe A) includes pharmaceuticals that are 
reimbursed by the SSN with or without co-payment and distributed either by 
pharmacies or by hospitals. Regions are free to impose a share of co-payment 
on their price, mainly used for cost-containment purposes or as a disincentive 
against inappropriate drug use. These shares can be dependent on parameters 
such as the patient’s health status, income, age or employment status, and the 
number of regions introducing them has been on the increase over the last 
decade (see section 5.6). Class H (Classe H) includes pharmaceuticals that 
are fully reimbursed by the SSN, but can only be distributed by hospitals. 
Class C (Classe C) includes drugs that are entirely paid for by patients, except 
when regional health departments include specific drugs in reimbursement 
schemes. Class C pharmaceuticals are divided, in turn, into medicines with 
compulsory medical prescription and medicines not requiring a compulsory 
medical prescription. The latter are over-the-counter (OTC) pharmaceuticals 
against minor, mild or intrinsically transient conditions or symptoms, suitable 
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for self-medication. Off-label use of a pharmaceutical – defined as the use in 
clinical practice of a registered pharmaceutical with a therapeutic indication or 
administration forms different from what the AIFA registration specifies – is 
strictly regulated. In principle, it is only allowed when no alternative exists and 
enough scientific evidence for its efficacy is available. 
Until 1992, the Ministry of Health had a statutory power to decide which 
pharmaceuticals were publicly reimbursed and to determine their prices. After 
a series of corruption scandals, the role of reimbursement and marketing 
regulation was taken up by several different independent committees, until 
AIFA was established in 2003. The prices of Class A and H drugs are determined 
by a negotiation process between AIFA and the producer. The producer must 
file an application, including evidence proving a positive cost–effectiveness 
ratio or otherwise show that the pharmaceutical is of interest to the SSN. The 
prices of all Class C drugs are determined by the producer but with some 
constraints. The price must be the same across the country; it can only be 
increased every two years; and the increase cannot be higher than expected 
inflation. AIFA monitors the market to check that these conditions are met. The 
prices of OTC drugs are freely determined by the producer. 
Italian law distinguishes, for patent purposes, between branded 
pharmaceuticals and generic or equivalent pharmaceuticals. Branded drugs 
are pharmaceuticals sold with specific names and packages, either within 
patent or after the patent has expired. Generic or equivalent pharmaceuticals 
are not covered by patent but have the same composition, pharmaceutical 
form and dosing. Generic drugs are usually identified by the International 
Non-Proprietary Name (INN). They can be produced and sold following an 
authorization to enter the market (Autorizzazione all’Immissione in Commercio – 
AIC) by the Ministry of Health. However, their price must be at least 20% lower 
than the price of the matching branded pharmaceutical previously covered by 
patent. Reimbursement of pharmaceuticals not covered by patent – that is, either 
with an expired patent or a generic – is regulated by national provisions that 
specify a minimum reduction in price and even leave single regions free to 
set their reimbursement price as the price of the cheapest matching generic 
pharmaceutical available under regional distribution. 
An incentive exists for generic substitution: pharmacists have to ask patients 
whether they would like to replace a patented pharmaceutical with the cheapest 
equivalent drug. If the doctor explicitly states that the prescribed pharmaceutical 
cannot be replaced or the patient refuses the replacement, the patient must 
pay the difference between the price of the prescribed pharmaceutical and the 
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price of the matching generic. Over the last few years, more cost-containment 
measures have been introduced. Since 2011, AIFA has set a maximum 
reimbursement price for equivalent Class A drugs. This reimbursement cap is 
based on a survey of current prices in other European Union countries, and must 
be enough to determine a predetermined yearly saving for regions. The first 
deliberation (March 2011) used Germany, UK, France and Spain as reference 
countries and determined a maximum reimbursement of 40%. 
2.8.5 Regulation of medical devices and aids
Regulation of medical devices and aids falls within the remit of the Ministry 
of Health’s General Directorate for Medical Devices, Pharmaceutical Services 
and Care Safety. Its duties include surveillance of the production of medical 
devices, their commerce and their use within the SSN, in line with Italian and 
the European regulations. It oversees surveillance, provides the forms and the 
contacts for notifications of malfunctions or accidents connected to medical 
devices, and checks the requirements for correct notifications. With AGENAS 
and AIFA, it coordinates HTA activities (see section 2.7.2). Since 2010, an 
information system has been active to monitor medical devices bought or used 
by all public health providers. This information system is connected to the 
NSIS (see section 2.7.1). In 2012, the directorate began a reorganization, which 
is ongoing. 
2.8.6 Regulation of capital investment
The first investment plan for buildings and technologies was introduced in 
1988. In 1998, the investment framework for public resources was changed and 
since then health-care infrastructure is no longer regulated through the same 
administrative pathways that regulate other public spending. Instead, single 
ministries are responsible – mostly the Ministry of Health. For this purpose 
the ministry created the Centre for Evaluation and Verification of Public 
Investments. The regions also obtained the main responsibilities for planning. 
The centre consists of professionals drawn from the ministry, regions and ASLs, 
and its composition is changed every three years. It advises on all proposed 
investments, deliberates on the use of European Funds in health care, monitors 
annual data on infrastructure planning and implementation sent by the regions 
to the ministry, and supports projects that come across difficulties. The centre 
also cooperates with the European Health Property Network (EUPHN). The 
Inter-ministerial Committee for Economic Planning (CIPE) is a public agency 
that supervises all public capital investments, ensures financing and prevents 
illicit use of investments.
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2.9 Patient empowerment
There is no single law or code on patient empowerment or patient rights in Italy. 
Patient rights and the participation of patients in the statutory health system or 
in their own care are enshrined in a broad diversity of legislation, conventions 
and case law. Despite the lack of systematic programmes or initiatives, the SSN 
reforms of the last 20 years have progressively recognized these principles and 
provided a number of tools for their implementation at several levels.
2.9.1 Patient information
The Health Services Charter that all health-care providers have been required to 
adopt since 1995 gives citizens the right to consult health planning documents 
at all levels. In 2010 the Ministry of Health produced a set of guidelines to 
improve online communication by health-care providers, within the framework 
of health promotion. However, no system is in place to monitor compliance 
with the guidelines, nor is any institution charged with overseeing their 
implementation. A 2012 study analysing all 245 websites of the country’s AOs 
found that compliance with the guidelines was low. The most critical area was 
availability of health information (Vanzetta et. al., 2012). 
Since 2009, the National Health Outcomes Programme has evaluated 
hospitals’ care outcomes; today, it represents an official tool to assess the SSN. 
The data include post-intervention mortality at 30 days from hospitalization 
or intervention for ischaemic heart disease, heart failure, stroke, COPD, 
upper gastrointestinal haemorrhage, cholecystectomy, major cancer surgical 
interventions and femur fracture. In addition, inappropriate hospitalizations 
are reported per ASL, in an attempt to evaluate quality of local primary care 
and community care services in chronic disease management. These indicators 
included hospitalizations for acute complications of chronic diseases such as 
diabetes or COPD, or for conditions such as influenza, childhood gastroenteritis 
or childhood asthma. In addition to outcome indicators, the last edition of 
the programme (2013) includes a set of volume indicators for the conditions 
with available evidence of an association between volume and outcome. Data 
from the National Health Outcomes Programme are not publicly accessible 
(PNE, 2013). However, in late 2013 a research-driven initiative to publicly 
report health outcomes data was started (see: http://www.doveecomemicuro.
it/index.php).
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2.9.2 Patient choice
Within the SSN, patients are free to seek health care from any public health-care 
provider (even outside their ASL or region) and any private provider accredited 
to offer care on behalf of the SSN. Providers must describe their equipment and 
tariffs for the most relevant services (Law 502/1992, art. 14). Patients are free 
to choose their GP and paediatrician for children under 14 from among those 
working in their ASL. People cannot switch GPs for at least 12 months, and their 
current registration is automatically extended if there is no explicit withdrawal. 
However, GPs and paediatricians must accept all patients and can only refuse 
a patient or remove them from their list due to exceptional and proven reasons 
of incompatibility. Patients are also free to choose providers of specialized and 
secondary health care among the available SSN-accredited public or private 
providers, in any Italian region. As with the choice available for GP services, 
this choice is also limited by capacity constraints. Patients are free to choose 
any accredited hospital but do not have the right to choose hospital specialists. 
To promote freedom of choice, the 1992 reform placed a statutory duty on the 
Ministry of Health to publish and regularly update the list of all public and 
accredited providers of specialized care.
2.9.3 Patient rights
Personal rights are one of the mainstays of the Italian Constitution. The 
fundamental right to self-determination, the liberty to dispose of one’s body 
and the right to health are the subject of explicit references and underpin 
diffuse legislation. 
The principles and the strategies proposed by international consensus 
documents such as the WHO 1994 Declaration on the Promotion of Patients’ 
Rights in Europe and the 2000 Charter of Fundamental Rights of the European 
Union were not implemented through a systematic strategy in Italy. In 2002, 
the European Charter of Patients’ Rights was drafted under the auspices of the 
Active Citizenship Network, the international department of the Italian NGO 
Cittadinanzattiva (‘Active Citizenship’). The charter directly stemmed from the 
2000 Charter of Fundamental Rights, and 16 European consumer associations 
adhered to it. It identifies and describes 14 patient rights: the right to preventive 
medicine, access, information, consent, free choice, privacy and confidentiality, 
respect of patients’ time, observance of quality standards, safety, innovation, 
avoidance of unnecessary suffering and pain, personalized treatment, complaint 
and compensation (see Active Citizenship Network, 2007). 
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Legislation on privacy and protection of personal data has been collected in 
the Code on the protection of personal data. The Code specifies the criteria for 
informed consent and the conditions for use of data on personal health status, 
including genetic data. It gives a mandate to the Authority for Protection of 
Personal Data (Garante per la protezione dei dati personali) to monitor its 
implementation and also decide on specific cases.
2.9.4 Complaints procedures
In Italy, there are three main ways that a patient can seek redress for malpractice 
or service failure: administrative complaint procedures; judicial procedures; 
and professional responsibility. 
Patients, their relatives, and/or regionally accredited volunteer and consumer 
associations can lodge comments, concerns, and complaints at the Public 
Liaison Office (Ufficio Relazioni con il Pubblico – URP) of every AO and ASL 
within 15 days of the event or of realizing there is a valid reason to complain. 
This administrative procedure brings the case to the attention of the General 
Director of the ASL and AO, who has a duty to react within a further 15 days, 
after consulting the Medical Director. 
A judicial procedure can be pursued through recourse to the ordinary public 
judicial system. The Italian legal system is based on civil or continental law, 
in which criminal law and civil law have markedly different features. Medical 
malpractice cases follow the general rules of contractual liability, part of civil 
law, as health-care relationships originate from a contract (Nuti et al., 2007; 
Traina, 2009). However, a medical malpractice case may also be pursued with a 
criminal law procedure in cases of proved ‘negligence injury’, described by the 
Italian criminal law code as ‘an event that, even if it occurred without intention, 
occurred due to negligence, imprudence, lack of skill or failure to comply with 
laws, regulations, orders and disciplines’ (art. 43, Italian Penal Code). In this 
case, the accused are prosecuted by a public attorney and punishments are 
more severe, including prison. A civil procedure and a criminal procedure may 
co-exist. In a 2010 Eurobarometer survey (European Commission, 2010), Italy 
was shown to be the European country with the highest share of its citizens 
believing that legal action taken against the responsible health-care facility was 
a possible form of redress in their country in cases of harm received during 
the provision of health care, while other forms of redress such as financial 
compensation or an investigation into the case were less known in Italy than 
the EU average. Over the last few years, measures have been taken to tackle 
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excessive recourse to legal action against doctors and to prevent defensive 
medicine practices. In 2010, the instrument of conciliation was introduced in 
an attempt to reduce the number of cases reaching the judicial level. 
In 1980, Cittadinanzattiva, one of the largest Italian citizens’ associations, 
created the Tribunal for Patient Rights (Tribunale per i diritti del malato) 
whereby a network of around 10 000 citizens and professionals are organized 
in 300 local sections. The association collects complaints from users of health-
care services, publishes reports and undertakes action to ensure patient 
participation in health-care policy. In 2001, Cittadinanzattiva established 
the Active Citizenship Network (ACN) along with 70 citizens’ associations 
of 30 EU or EU-candidate countries, to compare experiences and strengthen 
cooperation with national and European institutions (see Tribunale per i diritti 
del malato, 2013). 
Professional responsibility falls within the mandate of the Orders and 
Colleges of Health Professions. They can carry out their own investigations, 
even in cases not deemed relevant by public courts, and take disciplinary action 
against their members. This action can take the form of a reprimand, a fine, 
temporary suspension from the register, partial restriction of the professional’s 
licence to practise or permanent removal from the register. 
2.9.5 Public participation
The founding law of the SSN included statements of principles on patient 
participation in health care but their implementation has been unsystematic 
and is still far from complete. The predecessors of the ASLs – the USLs – 
were managed by local health authority management committees (Comitati di 
Gestione delle USL) that included municipal representatives. They were the 
only legitimate channel for citizens’ involvement. 
The law enforcing the 1992 reform devoted a whole article to citizens’ rights 
(Law 502/1992, art. 14). It placed a statutory duty on local SSN bodies to take 
measures for the collective involvement of patients through volunteers and 
community group representatives, and the use of patient satisfaction surveys. 
At the national level, it specified that the Ministry of Health, together with 
patients’ and citizens’ associations, would establish a set of indicators for this 
purpose. In addition, both the 1992 and the 1999 reforms required regions and 
ASLs to develop formal channels for consultation with volunteers’ and patients’ 
associations in health policy planning and evaluation. An example of such tools 
is the Conference of Health Services, a conference open to the public where 
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the administrators of the statutory health-care services, health-care workers 
and citizens´ organizations meet to evaluate the relationship between ASLs 
and citizens.
Regions have shown different degrees of commitment in the implementation 
of these statutory and non-statutory instruments. Emilia-Romagna and Tuscany, 
in particular, have emphasized the role of standing committees, which include 
members from citizens’ associations, while the Veneto Region has focused on 
systematic patient satisfaction surveys. 
2.9.6 Patients and cross-border health care
Italy has converted into national law EU Directive 24/11 on the application of 
patients’ rights in cross-border health care. The SSN’s system of international 
mobility primarily ensures health-care coverage to both Italian citizens who 
move within the borders of the EU, Switzerland and the European Economic 
Area (EU countries plus Norway, Iceland and Lichtenstein) and those who 
are in other countries with which Italy has active cross-border health-care 
agreements. At present, before going abroad for health care Italian patients 
ought to contact their relevant health services provider to obtain information 
about the following: the required procedures to obtain coverage of the expenses 
that they will incur, whether prior authorization is required and how to ask for 
it, if the cost of care will be paid directly by the regional health-care system 
or if the patient will need to first pay in full and then be reimbursed, and if 
so, what proportion will be refunded. To receive health care in these other 
countries, Italian residents must make available the documents issued by their 
ASL of residence. They will receive the same care as local citizens. In the case 
of third-party payment arrangements, the Italian Ministry of Health will pay 
the foreign providers, charging the patient’s ASL of residency in Italy. The 
balance between international debts and credits for each ASL is considered 
when assigning resources to the regions.
3. Financing
The National Health Service is largely funded through national and regional taxes, supplemented by co-payments for pharmaceuticals and outpatient care. In 2012, total health expenditure accounted for 9.2% of 
GDP (slightly below the EU average of 9.6%). While this reflects a process of 
upward convergence towards the EU average over the last couple of decades, 
part of this apparent increase is also due to relatively weak GDP growth for 
Italy over that period. 
Public sources made up 78.2% of total health-care spending, with private 
spending, mainly in the form of OOP payments (17.8%), accounting for the 
remainder – these OOP payments are mainly for diagnostic procedures 
(laboratory tests and imaging), pharmaceuticals, specialist visits and for 
unjustified (non-urgent) interventions provided in hospital emergency 
departments. Only about 1% of total health-care expenditure is funded 
by private health insurance. The production, distribution and pricing of 
pharmaceuticals are strictly regulated by a national agency, and provisions are 
made progressively more complex by repeated attempts at cost containment of 
pharmaceutical expenditure.
Since the early 2000s the health-care system has been undergoing a process 
of fiscal devolution from the central government to the regions. Within Italy 
there are substantial differences in funding between regions, with per capita 
expenditure ranging from 10.2% below the national average to 17.7% above. 
Although most funding is pooled at national level and redistributed to regions, 
there is scope for significant regional variation in tax rates (in particular 
through taxing corporations and a regional surcharge on income tax). The 
resulting financing system has an unevenly distributed tax base, smaller room 
for manoeuvre for poorer regions and a need for poorer regions to increase 
tax rates more than high-income regions, with consequent disincentives for 
business location, for example.
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In recent years there have been attempts to place stricter controls over 
regions’ health spending after a few incurred considerable deficits (mainly in 
the central and southern parts of the country). Moreover, in light of the global 
economic and financial crisis, tighter cost containment measures on public 
health expenditure have been proposed and are being slowly implemented 
(e.g. caps on specific spending areas). At the same time, higher co-payments 
for outpatient/ambulatory care, diagnostics and drugs have been introduced, 
adding to private spending on health.
Health care is delivered mainly by public providers, with some private or 
private-public entities. Although reforms in 1992 aimed to introduce a quasi-
market system with patients free to choose any provider, in practice these 
arrangements vary across regions and, in some regions, are barely present. Only 
in the regions of Lazio, Campania, Molise and Lombardy is there a relatively 
high level of private care, with around 30% of total hospitalization supplied by 
private providers. 
In general, doctors employed by the National Health Service are salaried 
and have civil servant status, although general practitioners and paediatricians 
are independent professionals, paid via a combination of capitation and fee-for-
services for some interventions. All salaried doctors are allowed to practise 
privately and thus can earn additional income on a fee-for-service basis; they 
are encouraged to do so within National Health Service facilities and then pay 
a proportion of their income to that facility. 
Payment rates for hospital and outpatient care are determined by each 
region, with national rates (determined by the Ministry of Health) as a reference. 
Payment for hospital care (ordinary and day hospital treatments) is based 
on DRG tariffs, although it is generally complemented with other payment 
methods (lump sum or global budget) while outpatient care is reimbursed using 
a tariff per unit of care. There are considerable inter-regional variations in the 
prospective payment system adopted by each region, such as how the fees are set, 
which services are included and the tools employed to influence patterns of care.
3.1 Health expenditure
In Italy, as in most OECD countries, health expenditure has steadily increased 
over time, making its containment a major issue for governments. However, it 
is noteworthy that public health-care expenditure remained virtually unchanged 
between 2010 and 2012 (with a +1.1% average yearly change). The recent history 
of health-care expenditure is marked by attempts to place stricter control over 
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regions’ health spending after a few regions incurred considerable deficits. To 
address this financial failure, the government introduced a special regime for 
overspending regions that requires the adoption and implementation of formal 
regional ‘financial recovery plans’ (Piani di Rientro). Since 2007, ten4 out of 
the twenty-one regional health systems have adopted these plans, which include 
actions to address the structural determinants of costs. All subsequent dynamics 
of public spending for health care must be seen in light of these provisions. 
The overall effect of this regime has been a decrease in the yearly level of 
overspending. In 2012, the total deficit of the public health-care sector was 
€1.04 billion, declining by 77% since 2006 (€4.48 billion) (Armeni & Ferré, 2013).
Total health expenditure (public and private) exceeded €140 billion in 2012 
(9.2% of GDP) (Table 3.1), growing at a yearly average5 of 4.7% from 2000 to 2009 
and by only 0.9% from 2009 to 2012. Since 2000, total health-care expenditure 
has increased by 1.3 percentage points of GDP (from 7.7% in 2000 to 9% in 
2010), mainly because the public component has experienced rates of increase 
that are substantially higher than GDP. Only in the last three years (2010–2012) 
has the increase in public health-care expenditure been radically contained; 
thus, the ratio of total health-care expenditure to GDP has been stabilized.
Table 3.1
Trends in health expenditure in Italy (1990, 1995, 2000, 2005, 2009–2012)
 1990 1995 2000 2005 2009 2010 2011 2012
Total expenditure on health per 
capita (PPP International $)a
– 1 494.08 2 028.6 2 478.8 3 037.0 3 025.7 3 016.8 3 040.1
Total health expenditure in € 
(millions)
50 173 66 051 92 813 121 793 136 944 138 580 140 669 140 770
Total health expenditure as % 
of GDP
5.6 7.6 7.7 8.5 9.0 8.9 8.9 9.2
Mean annual real growth rate 
in GDP (%)
– -2.9 5.7 2.8 -3.5 2.1 1.7 -0.8
Public expenditure on health as 
% of total expenditure on health
82.6 73.8 75.6 79.5 80.5 80.3 80.2 80.8
Private expenditure on health as 
% of total expenditure on health
17.4 26.2 24.4 20.5 19.5 19.7 19.8 19.2
Government health spending as 
% of GDP
4.6 5.6 5.9 6.7 7.3 7.2 7.1 7.3
OOP payments as % of total 
expenditure on health
– – 23.10 19.00 17.69 17.52 18.00 17.84
VHI as % of total expenditure 
on health
– – 0.9 0.9 1.0 1.0 1.0 0.9
Sources : Armeni & Ferré, 2013, using Ministry of Health and Finance data; aWHO Health For All, 2014.
Notes : GDP: gross domestic product; 2011 and 2012 public health expenditures include depreciation expenses.
4 Piedmont, Liguria, Abruzzo, Molise, Lazio, Campania, Puglia, Calabria, Sicily and Sardinia.
5 In this chapter yearly or annual average growth rates are calculated as CAGR (compounded annual growth rate).
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Using WHO Health for All data, Fig. 3.1 shows Italy’s position with regard to 
health-care expenditure as a percentage of GDP compared with other countries 
in the WHO European Region. In 2012, the country’s health spending (9.2%) 
was almost on a par with the EU average (9.6%). Fig. 3.2 shows this trend 
more concisely by comparing Italy’s total health expenditure and that of a 
selection of Western European countries from 1990 to 2012. For much of this 
period, Italy was one of the lowest spenders, along with Spain and the United 
Kingdom but since 2009, most of the countries in the group have seen a decline 
in expenditure and have converged around the EU average. It is important to 
highlight that since the early 1990s Italian GDP has grown substantially less 
compared to the rest of Europe. Consequently, important increases in the share 
of GDP for health care were driven by moderate increases in absolute spending. 
Per capita health expenditure among countries in the WHO European Region is 
shown in Fig. 3.3 where Italy positioned itself at $US 3040 PPP in 2012, below 
the EU average of $US 3346 PPP. 
In 2012, €112.6 billion in public funding was made available for health 
care. Overall public expenditure on health was €113.6 billion, with a modest 
growth rate of 0.8% compared to the previous year, and confirming the marked 
deceleration since 2005 (Armeni & Ferré, 2013). From 2006 to 2012, the 
average annual public health-care expenditure growth rate was 2.2%, compared 
to 6.6% during 2000–2005. Although volatile, private health-care expenditure 
also appears to be stable in the long term with an annual average increase of 
2% between 2000 and 2005 but with a lower growth rate in the last six years 
(+0.8%). In 2010 and 2011 the level of private expenditure rose more than that 
of public expenditure (1% and 1.3% in public expenditure vs 1.9% and 2.2% in 
private expenditure). These changes may reflect two contrasting forces: on the 
one hand, the economic crisis has reduced households’ disposable income and, 
thus, demand for private health care; on the other, because of cost-containment 
policies in the public sector, patients may be forced to pay higher co-payments 
or to go fully private due to longer waiting times or other forms of implicit 
and explicit rationing. In this respect, it is interesting to note the emergence 
of low-cost initiatives in the private sector (e.g. for dental and eye care), which 
are mainly provided in the form of discounted services (Del Vecchio & 
Rappini, 2011). 
During 2007–2009, the central government had increased its efforts to 
contain costs, especially through policies aimed at increasing the efficiency of 
public spending. The main strategy was to make regions more accountable in 
their provision of the benefit package by keeping within financial constraints. 
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Fig. 3.1 
Health expenditure as a share (%) of GDP in the WHO European Region, latest 
available year, 2012 
Source: WHO Health For All, 2014. 
Notes: CIS: Commonwealth of Independent States; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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Fig. 3.2
Trends in health expenditure as a share (%) of GDP in Italy and selected countries, 
1990 to latest available year (2012)
Source : WHO Health For All, 2014.
More recently, more stringent cost-containment measures have been introduced, 
including the requirement to reduce the number of hospital beds (to 3.7 beds 
per 1000 population versus 4 previously), promoting lower hospital admissions 
(by increasing the use of appropriateness criteria to avoid unnecessary 
admissions) and also reducing the average length of stay. In addition, in 
response to the financial crisis and the stricter public budget imperatives 
of the European Commission and the European Central Bank, the national 
government cut central transfers to regions and local governments for disability, 
childhood, migrants and other welfare policies. 
The 2012 ‘Spending Review’ (Decree Law n. 95/2012), the ‘Stability Law’ 
(Legge di Stabilità, Law n. 228/2012) and the ‘Decreto Salva Italia’ (Decree 
Law n. 201/2011) reduced total public health financing by €900 million in 
2012, €1.8 billion in 2013 and a further €2 billion in 2014. This reduction in 
central funding was compensated for primarily by higher co-payments (see 
section 3.4) and cost-saving measures to reduce pharmaceutical expenditures. 
Cost-containment measures also targeted the expenditure side: the government 
decreased outsourcing expenditures to accredited private providers by 0.5% in 
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Fig. 3.3 
Health Expenditure in $PPP per capita in the WHO European Region, 2012 
Source: WHO Health For All, 2014. 
Notes: CIS: Commonwealth of Independent States; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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2012, 1% in 2013 and 2% in 2014 (compared to the 2011 level). The budget 
for regions’ pharmaceutical spending, introduced in the late 1990s to force 
regions to implement effective cost-containment initiatives was also revised, 
reducing the budget cap that is in place by 0.2% from 13.3% in 2011 to 
13.1% in 2012 and 11.35% in 2013 on drugs used in non-hospital settings 
(patient co-payments are excluded from the budget cap). A budget cap for 
medical devices expenditure was also introduced: 4.8% of regional budgets 
in 2013 and 4.4% in 2014. Moreover, for 2012 the government imposed a 5% 
reduction in the value of purchasing contracts for medical goods and services 
signed by public health organizations (including medical devices but excluding 
pharmaceuticals). The measure places great emphasis on homogenizing the 
prices of medical goods and services across the country, allowing public ASLs 
and AOs to roll over or withdraw contracts if large price differences exist for 
the same good/service (difference >20% of the reference price) among regional 
health systems.
Finally, a main feature of the health-care system is regional variation in 
the distribution of health-care expenditure and in the supply and utilization 
of services. Table 3.2 shows the evolution of per capita regional health-care 
expenditure for selected years. While per capita public health expenditure 
varied widely in 1990 between Calabria (€586) and Emilia Romagna (€856), 
by 2012 regional differences had narrowed to between -10.2% and +17.7% 
of the national average. In general, regions in the centre and north were 
above the national average, and southern regions were below. Part of the 
differences in regional public expenditure are related to the different 
age structure of the population, with some regions having a larger share of 
elderly citizens than others. Such differences are also taken into account 
as the main adjustment to per capita funding in the allocation formula 
to calculate the fair amount of resources that each region should have to 
provide the LEA. Public health-care expenditure tends to be lower in less 
affluent and less economically developed regions, and in Italy such regional 
differences have persisted despite allocation formulas aimed at equalizing 
the distribution of financial resources. Nevertheless, these differences are 
getting smaller. 
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Table 3.2
Per capita health-care expenditure (in €) in Italy’s regions, selected years
 1990 1995 2000 2005 2009 2010 2011 2012
North
Piedmont 688 828 1 300 1 661 1 883 1 903 1 897 1 914
Valle d’Aosta 756 875 1 392 1 829 2 076 2 170 2 236 2 224
Lombardy 709 868 1 185 1 573 1 766 1 813 1 872 1 870
A.P. Bolzano 722 995 1 589 2 059 2 134 2 183 2 234 2 259
A.P. Trento 731 907 1 318 1 722 2 044 2 088 2 209 2 229
Veneto 746 861 1 249 1 609 1 769 1 788 1 782 1 823
Friuli Venezia Giulia 730 868 1 234 1 650 1 958 1 979 2 076 2 095
Liguria 841 957 1 342 1 837 2 026 2 006 2 043 1 983
Emilia R 856 975 1 282 1 699 1 906 1 920 1 926 1 983
Centre
Tuscany 788 891 1 240 1 647 1 919 1 899 1 914 1 945
Umbria 766 865 1 251 1 629 1 807 1 806 1 841 1 850
Marche 834 886 1 237 1 544 1 744 1 795 1 793 1 800
Lazio 788 891 1 283 1 919 2 011 1 971 1 965 1 950
South
Abruzzo 724 761 1 281 1 729 1 757 1 743 1 751 1 773
Molise 678 776 1 145 2 033 2 072 2 070 2 037 2 035
Campania 692 743 1 150 1 670 1 747 1 719 1 710 1 692
Puglia 671 783 1 109 1 515 1 751 1 772 1 731 1 730
Basilicata 603 707 1 071 1 505 1 753 1 796 1 818 1 816
Calabria 586 721 1 130 1 423 1 741 1 719 1 697 1 686
Sicily 700 747 1 054 1 559 1 666 1 688 1 717 1 727
Sardinia 695 860 1 163 1 632 1 826 1 874 1 932 1 951
ITALY 730 840 1 208 1 648 1 825 1 836 1 850 1 859
Coefficient of variation (%) 9.5 9.8 10.0 10.1 7.7 8.1 9.3 9.3
Source : Armeni & Ferré, 2013, using Ministry of Health and Finance data.
3.2 Sources of revenue and financial flow
In Italy, public financing accounted for 78.2% of total health spending in 
2012, while 21.8% was privately financed, through OOP payments (17.8%), 
especially for pharmaceuticals, outpatient care and dental services, voluntary 
health insurance coverage (0.9%) and non-profit institutions serving households 
(3.1%) (Table 3.3). 
Fig. 3.4 highlights that the majority of funding among EU countries comes 
from public sources (on average 76%). Based on this WHO data, in 2012 Italy 
ranked just higher than the EU average (with 78.8%) in terms of the share of 
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public funding devoted to total health-care expenditure. Data from the OECD 
shows a slight increase in this public share of health funding by 0.9 percentage 
points in 2012 compared with 2011 (see Table 3.3). According to national, OECD 
and WHO data the share of private expenditure as a percentage of total health-
care expenditure decreased between 2000 and 2009, before increasing again 
– especially the OOP share – at the onset of the economic crisis. Conversely, 
the public share of total health-care expenditure, which was 74.2% in 2000, 
kept rising until 2009 when it reached 78.9% and then fell between 2010 and 
2012 by an average of 0.2 percentage points. This decrease can be partially 
explained by the recent series of cost-containment policies adopted by the 
national government, aimed at containing public health-care expenditure, 
reducing overcapacity and improving efficiency. 
Fig. 2.1 (in Chapter 2) provides a snapshot of the financial and service flows 
within the Italian health-care system, more details of which are given below.
The public health-care system is financed primarily through (Table 3.4):
• An earmarked corporate tax (IRAP) on the value added of companies 
and on the salaries paid to public sector employees. The tax is pooled 
nationally and allocated back to the regions. The tax base rate is set at 
3.9% of value-added produced by a company (i.e. the difference between 
operating revenues and costs before interest income and expenses) and 
regions have the flexibility to raise the level by 0.92% depending on 
the industry, thus leading to inter-regional differences in the corporate 
tax base.
• A regional surcharge on the national income tax (addizionale IRPEF). 
The tax base rate is set at 1.23% (increased in 2012 from 0.99%) and 
regions have the flexibility to raise the level by an additional 0.50%. 
The tax is either applied by regions on a regressive (flat rate) or 
progressive basis (adjusted for income brackets).
• A fixed proportion of national value-added tax (VAT) revenue collected 
by the central government to be used the national equalization fund. It is 
used to provide resources to regions unable to raise sufficient resources 
to provide the core health benefit package (LEA). Currently, 38.5% of 
VAT is used to fund health care.
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Fig. 3.4 
Health expenditure from public sources as a percentage of total health expenditure in 
the WHO European Region, latest available year, 2012 
Source: WHO Health For All, 2014.
Notes: CIS: Commonwealth of Independent States; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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Table 3.4
Distribution of main sources of health financing, 2012
Sources of financing  % of total financing 
IRAP and additional IRPEF 35
VAT and other excise taxes (Decree Law n. 56/2000) 47
Other transfers from public and private organizations 9
Health organizations’ revenue and other income 3
National Health Fund and Restricted National Funds 4
Other 2
Total 100
Source : Armeni & Ferré, 2013, using Ministry of Health and Finance data.
IRAP and IRPEF rate levels can be further increased by regions that are 
facing health-care budget deficits since regions are financially responsible for 
covering with their own resources any deficits incurred (see section 3.3.3). An 
additional 0.15% on IRAP and 0.30% on the IRPEF maximum rate can be 
applied by overspending regions that do not achieve health-care planning and 
expenditure goals expressed in their financial recovery plans. For instance, the 
regions of Molise, Campania and Calabria apply the highest IRAP rate 4.97% 
(3.9%+0.92%+0.15%) and also have the highest IRPEF tax rate.
Currently, the financing system appears to have an unevenly distributed tax 
base, smaller room for manoeuvre for poorer regions and the need for poorer 
regions to increase tax rates more than high-income regions, with subsequent 
negative incentives for business location. Moreover, every region is allowed to 
generate its own additional revenue, leading to further inter-regional financing 
differences (e.g. revenues from motor vehicle tax and other taxes6). Other 
sources of financing include other unrestricted resources generated by public 
and private organizations within regional health systems, health organizations’ 
revenue and restricted national health funds. 
3.3 Overview of the statutory financing system
3.3.1 Coverage
The SSN covers all citizens and ordinarily resident foreign nationals. Coverage 
is automatic and universal. Since 1998, undocumented immigrants have been 
granted access to basic services. Temporary visitors from countries outside the 
6 From 2010 petrol excise is no longer a source of funding for health care (Legislative Decree 6/10/2010).
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European Union can receive health services by paying for the costs of treatment, 
while since October 2013 European Union citizens have been able to obtain 
free cross-border health-care provision7 (EU Directive 24/2011). Modelled after 
the British National Health Service, the SSN replaced a Bismarckian system of 
health insurance funds from 1978. Complementary and supplementary private 
health insurance are also available (see section 3.5).
Health-care services provided within the SSN (i.e. the LEA) are identified 
by positive and negative lists using criteria related to medical necessity, 
effectiveness, human dignity, appropriateness and efficiency in delivery 
(Lo Scalzo et al., 2009). Positive lists exist for community care services 
(primary care, emergency care, pharmaceuticals, specialist outpatient care, 
integrated care, prosthesis care, ambulatory and home care, residential and 
semi-residential care and thermal therapy), hospital services and public health 
and occupational health services (Torbica & Fattore, 2005). For the latter, there 
is a list of general community and individual levels of preventive services that 
are covered, including hygiene and public health, immunization and early 
diagnosis tools. Dental care – specifically orthodontics and dental prostheses – 
is generally not covered8 and is paid for out of pocket (see section 3.4). Negative 
lists include ineffective services; services that are covered only on a case-by-
case basis, such as orthodontics and laser eye surgery; and inpatient services 
for which ordinary hospital admissions are likely to be potentially inappropriate 
(e.g. cataract surgery and carpal tunnel release). For the latter category, regions 
should provide substitute treatment at other levels of the health-care delivery 
system, such as day hospital and ambulatory care. 
Currently, the Ministry of Economics and Finance and the State-Regions 
Conference are discussing an update of the health benefit package. Despite 
heavy cuts to health-care spending (Spending Review), the proposed revision 
promotes the inclusion of 110 rare diseases and five major chronic conditions 
(bronchopneumopathy, chronic osteomyelitis, chronic renal diseases, polycystic 
kidney disease and sarcoidosis) in the positive list of treatments covered by 
the SSN.
Regions can choose to offer non-LEA services, but must finance these 
themselves. The health benefit package does not include a specific list of 
mental health services. Rather, national legislation creates an organizational 
framework for these services, and local health authorities are obliged to define 
the diagnostic, curative and rehabilitative services available at each level of 
7 Long-term care services and vaccination programmes are excluded.
8 Some limited care is available to special groups of patients defined according to age and specific clinical conditions.
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care. Nor does the health benefit package explicitly define rehabilitative and 
long-term care services that are covered by the SSN. Instead, they are broadly 
referred to as services to be delivered as part of a standard, inpatient curative 
care program (Donatini, 2012).
3.3.2 Collection
The main source of finance for the Italian SSN is a mix of taxes applied at 
both regional and national level (see section 3.2). Thus, collection is performed 
partially at national and partially at regional level, although pooling of funds 
is managed at national level.
3.3.3 Pooling of funds
Historically the allocation of resources for the SSN has been a source of 
contention between the central government and individual regions and among 
regions themselves, resulting in delays in the assignment of regional shares for 
health care. Substantial difficulty arises in the allocation of funds due to the 
large geographical differences in levels of economic development, size and age 
of populations and long-term patterns in the availability of services. To address 
these issues, in 1997, the government implemented a weighted capitation 
system that took into consideration the current demand for health services, 
age,9 geographical distribution, social deprivation and health condition of the 
population based on the mortality rate. 
The capitation rate should, theoretically, represent the resources needed to 
finance services included in the LEA and represents on average 97% of total 
health-care resources available to regions. The remaining 3% of resources are 
integrated by the regional systems with additional own sources of funding; this 
is often the case of the five regions granted greater autonomy (home rule) (see 
section 1.1). It is also the responsibility of the Ministry of Health to propose 
the allocation of resources to each region: the proposal is then discussed 
by the State-Regions Conference, which must approve or reformulate it. 
Under Ministry of Health specifications, annual health-care funding should 
be allocated to three different health-care categories as follows:
• community health care (district-level, which includes primary care 
services) (50%);
9 On average, the percentage of the population aged over 65 exceeds 20%, with the highest level registered in Liguria 
(27.3%) and the lowest in Campania (16.6%) (ISTAT, 2012b).
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• hospital health care (45%);
• public health services and preventive medicine (5%).
According to these categories, individual regions are then free to reallocate 
the funds received within different programmes and assign spending duties 
to local health authorities.10 Thus, the percentages fixed by the Ministry of 
Health can be modulated at the regional level in accordance with regional 
planning targets (Lo Scalzo et al., 2009). In fact, while the central government 
regulates the health benefit package for citizens and controls the distribution 
of tax revenue, each region is individually responsible for the organization and 
delivery of services within its jurisdiction. 
The aims of the devolution reform of 2001 have been two fold: to increase 
microeconomic efficiency and to increase regions’ financial responsibility. 
From this perspective, however, there is still a notable trend for the national 
government to assume an increasing steering role and oversight of regional 
financial performance. This is illustrated by two recent developments. The first 
is the establishment of financial recovery plans. In 2006 it emerged that several 
regions suffered from severe financial deficits (Fig. 3.5) because of their health-
care spending (annual deficits above 7% of total funding). Negotiated financial 
recovery plans were instigated to restore financial stability and to address 
the structural determinants of the organizational failures and cost over-runs. 
Additional regional resources to cover deficits are then tied to the achievement of 
health-care planning and expenditure goals expressed in the financial recovery 
plan. Thus, this process sets out a new collaborative agenda between national 
government and the respective regions, with disciplinary consequences for 
non-compliance. It has also enabled increased central government interference 
in regions’ autonomy to fund and plan health-care services.
A second development is emerging but is not yet implemented11 and involves 
significant innovation with respect to the current resource allocation formula 
for the regions. The basic idea is to adjust the age-weighted per capita formula 
with criteria that would fund hospital and community services according to 
‘standard costs’ identified as the lowest cost registered by regions (Pamolli & 
Salerno, 2010; Caruso & Dirindin, 2012; Citoni & Solipaca, 2013). How to 
combine these two criteria has not yet been clarified. Moreover, the scheme is 
highly controversial because many feel that is not feasible and does not respect 
regional powers in the internal allocation of resources. In addition, the use of 
10 Local health authorities are funded mainly through capitated budgets.
11 Legislative Decree n. 68/2011, implementing Law n. 42/2009 on fiscal federalism.
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Fig. 3.5
Per capita health care deficits (in €) by region, 2001–2012
Source : Armeni & Ferré, 2013, using Ministry of Health and Finance data.
efficiency criteria to allocate funds is seen as risking – at least in the short 
term – the re-allocation of resources in favour of the northern regions and thus 
of increasing the existing resource gap between the south and the north. 
3.3.4 Purchasing and purchaser–provider relations
Legislation approved in 1992 and 1993 (Legislative Decree n. 502/1992 and 
subsequent modifications) introduced a quasi-market system where both public 
and private providers were expected to be paid according to DRGs (for hospital 
care) and fee-for service (for specialist outpatient care) and could compete for 
patients who are free to choose any provider. However, the legislation did not 
make clear reference to purchasing per se. Subsequently, Legislative Decree 
n. 229/1999 (Bindi reform) introduced measures aimed at regulating and 
promoting purchasing. In general, regions may either directly purchase services 
or delegate the function to ASLs. Thus, depending on regional arrangements 
and local purchasing strategies, services can be purchased from public, private 
or private–public entities, potentially in competition with each other, and thus 
producing incentives for specialization.
On the basis of the 1992 reform, regions have to set accreditation criteria 
to identify providers (public and private) that respect minimum quality 
criteria/rules of compliance (accreditation). Private accredited providers sign 
a contractual agreement stating the volume, price and quality of the services 
to be delivered (usually renegotiated every year). The initial assumption of 
the purchaser–provider relationship was that regions would simply set the 
fundamental rules of compliance, with market incentives guiding the behaviour 
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of public and private providers. Since the beginning of 1997, regions have 
gradually reinforced ‘hierarchies’ and ‘institutions’ to supplement and correct 
market incentives (Anessi Pessina, Cantu & Jommi, 2004). Since 2008 there 
has been a good deal of concern over the balance between public and private 
provision and regional turnaround plans have been introduced. For example, 
regions are now playing a more stringent role in differentiating fees across 
classes of providers (i.e. between public and private providers or between 
teaching and non-teaching hospitals) and introducing provider-specific 
funding ceilings to contain expenditure and limit incentives for volume 
increases for specific sets of services. Regional health systems have gradually 
included planning and control systems – as supplementary managerial tools to 
contacting – to predefine the volumes, mix, prices and possibly other features, 
such as waiting times and quality, to be offered by each provider. Over time, 
these systems have become increasingly top-down, with a more stringent 
regulatory framework, and focused on the financial dimension of performance 
due to budget constraints. 
Quasi-market arrangements vary across regions and in some regions are 
barely present. Regions appear to be predominantly public-service based with 
the introduction of some internal markets mechanisms, i.e. separating the 
responsibility of buying health care from the provision of services within the 
regional health service itself. Among the 21 regional health systems, only Lazio, 
Campania, Molise and Lombardy present a rather high level of private acute 
care, with 30% of total hospitalization supplied by private providers (Ministero 
della Salute, 2010a). Moreover, mixed networks of public–private partnerships 
are developing as alternative arrangements to financing and delivering public 
health-care services.
3.4 Out-of-pocket payments
Out-of-pocket (OOP) payments play a significant role in Italy: between 17% 
and 19% of total health expenditure between 2005 and 2012 (Table 3.3), which 
is in line with the OECD average. In 2012, a total of more than US$32 million 
PPP was paid by patients for health-care services in the form of cost-sharing 
for services covered by the SSN or direct payments outside the SSN (Fig. 3.6).
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Fig. 3.6
OOP expenditure (US$ millions) in Italy, 2000–2012
Source : OECD, 2013. 
3.4.1 Cost-sharing (user charges)
Cost-sharing mainly refers to co-payments for diagnostic procedures (laboratory 
tests and imaging), pharmaceuticals, specialist visits and for unjustified 
(non-urgent) interventions provided in hospital emergency departments. Primary 
and inpatient care are totally free at the point of use for everyone. Co-payments 
for pharmaceuticals were first introduced in 1978 and are regulated at both 
national and regional level; co-payments for specialist visits and other outpatient 
services were established in 1982 and are regulated by national legislation with 
some regional variations. Since their introduction both have undergone several 
extensive changes (Lo Scalzo et al., 2009). Co-payments on medicines are 
applied in 15 of the regions as a flat rate or percentage of the price (pursuant to 
Legislative Decree n. 98/2011) (Osservatorio Farmaci, 2013). 
Turning to prescriptions for diagnostic procedures and specialist visits, the 
co-payments structure varies among regions and has a rather long history. Since 
1993, patients have paid for the total cost per visit up to a ceiling determined by 
law. The ceiling currently stands at €36.15 per prescription. Therefore, a patient 
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who receives two separate prescriptions (e.g. a magnetic resonance imaging scan 
and a laboratory test) after a visit has to pay the first €36.15 on each prescription. 
To address the public finance crisis, in July 2011 (Legislative Decree n. 98/2011) 
the government introduced an additional €10 co-payment for each ‘prescription’. 
Co-payments have also been introduced for the ‘unwarranted’ use of hospital 
emergency services – that is, instances deemed to be noncritical and non-urgent 
(although some regions have not enforced this co-payment). Public providers, 
and private providers under a contractual agreement with the SSN, are not 
allowed to charge above the scheduled fees. Notwithstanding the centralized 
nature of these interventions, the national government allowed regions to decide 
whether to apply the co-payment in full or to enact regional rules that allow for 
varying co-payments according to gross family income or service tariffs. As a 
result, co-payments differ among the regions.
Total exemptions from cost-sharing are applied to people aged 65 and over; 
children aged 6 and under; the unemployed; patients who live in households 
with a gross income below a certain threshold (approximately €8263 for single 
and €11 362 for larger households); people with severe disabilities; and prisoners. 
People with chronic or rare diseases, people who are HIV-positive, and pregnant 
women are exempt from cost-sharing for treatments related to their condition. 
Most screening services are provided free of charge.
The introduction and increase in co-payments/user charges are emerging 
health policy responses to the economic and financial crisis in Europe 
(Mladovsky et al., 2012). However, there is a general concern about their 
efficiency (e.g. shifting and increasing spending in other areas of care), 
effectiveness (e.g. reducing the use of needed care services and thus worsening 
health outcomes) and increased inequity in access.
3.4.2 Direct payments
Direct payments refer to payments by users to purchase health-care services and 
OTC medicines that are not covered by the SSN. These services may be offered 
either by public or private facilities. Most private accredited hospitals also offer 
services to patients who directly pay for them or are covered by voluntary 
health insurance (VHI). A few private hospitals in Italy are not accredited 
by the SSN and thus work only with private patients. Services outside SSN 
coverage can be offered by SSN facilities within the intra-moenia framework 
i.e. where SSN professionals, mainly specialists, can also offer their services to 
privately paying patients within SSN facilities as part of their (part-time) private 
practice (see also section 3.7.2 and footnote 17). Private health-care services 
refer mostly to dental services, OTC medicines, diagnostic services (if not 
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during a hospital admission) and specialist visits. The most recent estimate 
using the national ISTAT survey reports that 56.8% of total specialist visits in 
2005 were paid fully by patients, 27.8% applied a co-payment and the remaining 
15% were free of charge (Cislaghi & Giuliani, 2008). Dentist12 and gynaecology 
outpatient visits are the most common privately paid visits outside the SSN. 
In Italy there is a common perception that in order to ensure faster access 
and/or enhance consumer choice of providers, people are encouraged to opt 
for privately paid services. This is especially true for diagnostic and laboratory 
examinations (PiT Salute, 2012). Moreover, as an incentive to increase private-
sector utilization, and to help families bear the burden of co-payments, private 
health expenditure is eligible for a tax credit: 19% of medical expenses (no caps 
on OOP spending) can be deducted from individual taxable income (there is a 
deductible of €129) (see section 3.5.3).
3.5 Voluntary health insurance 
3.5.1 Market role and size
Spending on voluntary health insurance (VHI) accounted for 0.9 % of total 
health expenditure in 2012, with no significant change since 2000. Premiums 
are mainly paid by employers as fringe benefits to their employees or are 
requested by individuals for being affiliated to professional groups. In nominal 
terms, it steadily increased from 2000 to 2009 and then declined with the outset 
of the economic crisis (Fig. 3.7). 
The VHI market plays a double role: (1) a complementary role,13 covering 
user charges and co-payments required within the SSN, expenditures associated 
with hospital stays (per diems for private rooms or rehabilitation) or services 
excluded from the public system or partially covered such as dental care, 
home care,14 cosmetic treatments, thermal therapy and alternative medicine; 
(2) a supplementary15 role to ensure faster access and/or enhance consumer 
12 Dental care is generally not covered by the SSN and is paid for out of pocket.
13 Complementary insurance refers to services not covered by the statutory system, co-payments required or other 
forms of payments related to the disease episode (e.g. for a day of hospitalization).
14 Residential long-term care is still rarely covered.
15 Supplementary insurance refers to coverage of services covered by the SSN but for which the patients decides to 
go privately due to perceived better quality in the private sector, freedom of choice of the specialist and shorter 
waiting time.
Health systems in transition  Italy62
Fig. 3.7
VHI expenditure (US$ millions) in Italy, 2000–2012
Source : OECD, 2014b. 
choice of providers (i.e. intra-moenia services16) (De Pietro & Cavazza, 2011, 
2012). Full substitutive VHI does not exist as it is not possible to opt out of the 
public system. There are two types of VHI plans: group plans purchased by 
companies to cover their employees and sometimes also their families; and 
individual plans purchased by individuals for themselves or for their families. 
Policies differ in the degree that they are complementary and/or supplementary 
to the public system. Survey data suggest that people mainly buy VHI to jump 
waiting lists for treatment (Thomson & Mossialos, 2009) and in some cases 
to obtain better quality of care. The availability of, and waiting times for, 
public and accredited health services vary across regions and areas of care. 
For example, the average waiting time for some diagnostic tests and specialist 
consultations17 is over 7.5 months (Fattore, Mariotti & Rebba, 2013).
16 Since 1999, doctors working in the public sector have been required to choose between public and private practice 
but with the possibility of working privately within a public hospital (‘intra-moenia’) both in the area of inpatient 
and outpatient specialist care. Most physicians have chosen to remain in the public sector and opted for intra-
moenia practice.
17 The longest waiting times are reported for major imaging tests such as OCM-Osseous Computerized 
Mineralography (15 months), mammograms (12 months), echography (8.5 months), MRI, PET and CT scans 
(10 months on average). Regarding specialist consultations, longer waiting times are reported for urology, 
ophthalmology and cardiology consultations.
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In 2010 around 5.5% of the population had VHI coverage (1.33 million 
families), a 0.5% increase compared to 2008. Insurance take-up is concentrated 
in higher socio-economic groups (16.3% of the families in the highest quintile 
vs 1.4% in the lowest quintiles) and among middle-aged groups compared to 
younger and older age groups (Bank of Italy, 2012). There is also a geographical 
variation in the diffusion of VHI: families in the north and centre of the country 
are more inclined to have VHI (7.6% and 7.2% respectively) compared to those 
living in the south (1.3%). Education is another determinant of VHI take-up, with 
people with higher education being more likely to be insured (Bank of Italy, 2012). 
3.5.2 Market structure
VHI plans are sold by collective complementary private insurance funds (called 
Integrated Health Funds or Fondi integrativi del SSN) and private insurance 
companies. Integrated Health Funds are for-profit or not for-profit private 
health insurance funds that are, after the SSN (first pillar), considered to be 
the second pillar of health insurance. Integrated Health Funds may provide both 
complementary and supplementary cover. They are allowed to reimburse user 
charges, services provided privately within public facilities and expenditures 
for services that are complementary with respect to ‘SSN essential services’, 
i.e. not included in the SSN benefit package and supplied only by accredited 
private structures integrated with the SSN or by SSN providers themselves. 
Table 3.5 outlines the different kinds of VHI providers. 
Table 3.5
Types of VHI providers in Italy
VHI provider Profit 
status
Types of plans 
offered
Details Number of 
providers 
(2010)a
Fondi Aziendali Not-for-
profit
Corporate 
(firm-specific 
insurance funds)
Employer-specific insurance funds; provided by companies 
such as FIAT, ENI and Luxottica; can be managed internally 
by the companies themselves or by commercial insurance 
companies on their behalf; people over 75 are usually not 
eligible for such schemes but they cover retired people 
provided that they were enrolled for a minimum time span 
before retiring.
n.a.
Fondi di 
categoria
Not-for-
profit
Collective Insurance funds managed by organizations of categories 
of professional workers; they cover retired people provided 
that they were enrolled for a minimum period before retiring.
n.a.
Società di 
mutuo soccorso
Not-for-
profit
Individual or 
collective policies
Insurance funds organized in the form of mutual aid 
societies
3
Commercial 
insurance 
companies
For-profit Corporate and 
individual
Non-life health insurance companies; the biggest eight 
account for 50% of the commercial health insurance market 
(ANIA, 2012)
65
Sources : authors compilation and aISTAT, 2012b. 
Note : n.a., data not available.
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The Private Insurance Supervisory Authority (ISVAP) (primarily) and the 
Ministry of Health are the bodies responsible for regulating and monitoring the 
VHI market. In addition, commercial insurance companies are regulated by the 
Code for Private Insurance established in 2005. 
3.5.3 Market conduct
Historically, there have been differences between the for-profit and not-for-
profit VHI sectors. For instance, for-profit insurers apply individual risk rating 
for both individual and group policies, while in the non-profit sector the biggest 
funds use community rating (Giannoni, 2009). In addition, tax treatment varies 
depending on the type of insurer. VHI has been subsidized through various 
forms of tax incentives. Currently, 19% of medical expenses can be deducted 
from individual taxable income, even if part or all of these expenses are covered 
by a VHI policy (there is a deductible of €129). For workers’ associations, 
Integrated Health Funds and mutual organizations VHI contributions are 
deductible up to a limit of €3615.2 per worker per year.
Private insurers are not vertically integrated with providers. People with VHI 
coverage can usually seek treatment by private and public providers within the 
intra-moenia framework. Several insurers, both profit and non-profit, operate 
selective contracting and incentivize patients to use closed lists of providers. 
3.5.4 Public policy
Traditionally, VHI was seen as a marginal sector for a small and affluent 
segment of the population and received little attention from the government. 
However, since 1992 VHI, and especially the Integrated Health Funds, were 
introduced and promoted in order to manage the growth of private health-care 
expenditure, without forgoing the key features of solidarity and universality 
of the SNN system. Since 2010 the government has required insurance 
companies that provide complementary policies to be listed in the national 
register of Integrated Health Funds (complementary insurers/Fondi Integrative 
Sanitari) and to allocate at least 20% of premiums to dental care and social care 
(i.e. mainly long-term care) for subscribers who are not self-sufficient (in terms 
of age and physical impairment) in order to gain fiscal benefits. In the future, 
such complementary SSN insurance funds could gain greater relevance to 
secure financial sustainability of the SSN and to promote integration between 
health and social care.
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3.6 Other financing
Other sources of financing are not relevant in the Italian context as almost 
all financing comes from public funds (78.8% of total expenditures), direct 
payments from patients (OOP 17.8%) or forms of complementary private 
insurance (0.9%). For instance, there is no parallel health system providing 
services for certain categories of employees and public officials as is the case for 
some European countries such as Portugal. In June 2008, penitentiary health care 
was transferred to the responsibility of the SSN. The only exception is a parallel 
health-care system for active military personnel funded by the Department 
of Defence. Minimal external funding comes from bilateral/multilateral 
organizations or donations, mainly for providing services to undocumented 
immigrants. Italian regions can apply for European Structural Funds for capital 
investments, human development and cross-border cooperation within the 
health-care sector. Moreover, Italy attracts some (competitive) international 
grants from the European Commission for specific health research projects.
Social care services for the elderly and people with disabilities 
(e.g. community home care) are not the responsibility of the Ministry of Health 
but are dealt with by local authorities (mainly municipalities) and volunteer 
associations or non-profit social service cooperatives. Unlike residential and 
semi-residential care (see section 5.8), community home care is not designed 
to provide physical or mental care services, but rather to enhance a patient’s 
autonomy by providing additional assistance throughout a course of treatment 
or therapy. 
3.7 Payment mechanisms
3.7.1 Paying for health services
Payment rates for hospital and outpatient care are determined by each region, 
with national rates (determined by the Ministry of Health) as a reference. More 
specifically, payment for hospital care (ordinary and day hospital treatments) 
is based on DRG tariffs, although this method is generally complemented with 
other forms of payments (see below) and is not applied to hospitals run directly 
by local health authorities. National tariffs are used to set inter-regional hospital 
patient mobility rates. DRG tariffs are set at the national level, presumably 
based on average production costs, and then regions can modify the tariffs 
implemented in their own health systems. Consequently, there is considerable 
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inter-regional variation in the prospective payment system, the frequency of 
fee schedule updates, their value, how to deal with innovation and the tools 
employed to monitor providers and patterns of care. Since 2009 regions have 
adopted the ICD-9-CM (International Classification of Diseases, 9th revision, 
Clinical Modification) classification and DGR version 24. In addition, in all 
regions, a portion of funding is administered outside the prospective payment 
system (e.g. funding of specific functions such as emergency departments, 
teaching programmes, organ transplants, blood and tissue banks). All regions 
have mechanisms for cutting tariffs once a spending threshold for the hospital 
sector or even each provider is reached, in order to contain costs and offset 
incentives to increase admissions (Fattore & Torbica, 2006). The only two 
forms of hospital treatment for which a bed-day rate still applies are for 
rehabilitation and long-term care. These two types of hospital care have a 
progressive rate reduction scheme to prevent the unnecessary lengthening of a 
hospital stay. A length-of-stay longer than a set limit (usually 60 days) triggers 
a 40% reduction in the bed-day rate (psychiatric care does not follow this rule). 
Moreover, budgets for specific care services (e.g. emergency services, oncology 
treatments, hospital-teaching activities) are not based on DRG tariffs but are 
paid on the basis of global budgets.
Reimbursement for outpatient specialist care, diagnostic services and 
imaging is based on tariffs defined by unit of service. Specialist/ambulatory 
care is generally provided by local health authorities or by public and private 
accredited hospitals under contractual agreement with a local health authority. 
Once referred, patients are given free choice of any public or private accredited 
hospital. Across regions there is great variation in nomenclature (coding and 
classification systems) used to list outpatient services. In addition, there are 
inter-regional differences on the tariffs adopted since regions are allowed to set 
their own reimbursement rates (using national rates as maximum). In general, 
cost assessment to define tariff levels are not conducted regularly and based on 
a gross costing approach in which the total costs for ambulatory care services 
is first allocated to different specialty areas and then to specific services; there 
are very few cases of cost assessment using a micro-costing approach (Fattore 
& Torbica, 2006).
Primary/ambulatory care is managed by GPs and is paid via a combination 
of capitation and fee-for-service, sometimes related to performance, and is 
regulated under national and regional contracts. Capitation is adjusted for age. 
The majority of GPs operate in solo practices, although the state and most 
regions have offered economic incentives to encourage group practice, to foster 
greater integration between GPs and social care and to promote home care and 
Health systems in transition  Italy 67
health education (see section 5.3). Moreover, regional health-care systems are 
developing integrated services for non-acute care involving GP groups as the 
principal agents to respond to post-acute and chronic care needs. An innovative 
example in delivering and paying for chronic care is found in Lombardy 
(CReG – chronic related group) where, for a few conditions, the region sets a 
predetermined amount of resources needed for each pathology – similar to the 
DRG mechanism for acute care reimbursement – and defines an annual amount 
of resources available for each chronic patient according to the severity of the 
condition. The prospective payment system covers all ambulatory, prosthesis, 
pharmaceutical and home care expenses that are needed for the appropriate 
clinical and organizational management of patients’ chronic conditions. CReG 
tariffs are applied to accredited providers (public and private health-care 
providers and physician groups) that deliver services in coordination with 
ASLs. Overall, Lombardy is redesigning the medical practice of chronic care 
with expected improvement in the quality of life of chronic patients through 
enhanced access to primary care, and long-term savings resulting from fewer 
hospital admissions, visits to hospital emergency departments and specialist 
physician consultations.
Paying for long-term care and residential or semi-residential services 
where health care and rehabilitation are provided (see section 5.8) is based 
on cost-sharing between the patient and his/her municipality with important 
variations across regions and even municipalities. The level of cost-sharing is 
generally determined by patient income. 
Mental health care is provided by the SSN in a variety of community-
based, publicly funded settings, including community mental health centres, 
community psychiatric diagnostic centres, general hospital inpatient wards 
and residential facilities (see section 5.11). New admissions to mental health 
hospitals were banned by legislation enacted in 1978 (Law 180/1978) and 
currently no such specialized hospital is operating in Italy. Flat co-payments 
apply to diagnostic procedures, pharmaceuticals and specialist visits. In relation 
to pharmaceutical care, payment is differentiated according to product classes 
(A, H and C class):
• Class A includes essential products and those intended for chronic 
diseases and are fully reimbursed by the SSN. 
• Class H includes products that are only fully reimbursed in hospital.
• Class C includes other products that do not have the characteristics of 
Class A and are not reimbursed.
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3.7.2 Paying health workers
In general, doctors employed by the SSN are salaried and have civil servant 
status (including physicians or specialists providing mental health services), 
with the exception of GPs and paediatricians who are independent professionals 
with a special contract with the SSN. GPs and paediatricians delivering primary 
care and preventive medicine are paid via a combination of capitation (with a 
ceiling for the number of patients18) and fee-for-services for some interventions. 
All the doctors employed by ASLs and AOs work and are compensated 
according to national contracts that generally define monthly salaries and 
performance-related payments administered at local level.
More specifically, GPs and paediatricians are paid via a combination of 
capitated payments adjusted for patient characteristics (e.g. age and chronic 
conditions in some regions), and fee-for-service, sometimes related to 
performance. Delivery and payment of primary care workers are regulated 
under national, regional and ASL-based contracts. A national contract (Accordo 
Collettivo Nazionale) is usually negotiated every two to three years between 
the government and union representatives (the more prominent are FIMG, 
SNAMI and SMI) and determines the tasks and functions of primary care 
physicians as defined by the benefit package and the capitation rate. The last 
national collective bargaining agreement was signed in July 2010. Regional 
agreements (Accordo Integrativo Regionale) adjust the national contract 
to the regional context. Finally, ASL-based contracts (Accordo Attuativo 
Aziendale) detail projects and activities required in each local setting for the 
implementation of national and regional contracts and provide further scope for 
local initiatives.
The majority of GPs run solo practices, although national contracts and 
regional agreements encourage group practices by offering supplements 
to capitation, extra resources for the practice, including nursing and staff 
support. A share of GP income comes from extra payments for participation 
in special programmes (such as the development of electronic patient records) 
or achievement of specific policy targets (such as improving prescription 
appropriateness). Financial rewards exist for providing additional services such 
as home care, care for the aged in residential homes and vaccination of special 
groups, such as flu shots for the elderly. A few services are paid on a fee-for-
service basis, including certificates of good health, disability statements and 
services provided during night or non-working hours. Physicians providing 
18 1500 patients maximum for GPs and 800 for paediatricians.
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primary care at night and during weekends when GPs and paediatricians are not 
on duty and other specific categories of physicians working on specific projects/
activities receive an hourly rate determined at national level.
Hospital-based physicians are salaried employees and their level of payment 
is contracted at national level with a separate contract subject to review every 
3–5 years. Salary is a function of grade and performance, related to locally 
defined annual targets. Since 2007, freezing doctors’ salaries and periodic 
across-the-board hiring freezes have been commonly implemented policy tools 
in the public health-care sector.
All salaried doctors are allowed to practise privately and thus can 
earn additional income on a fee-for-service basis. A 1999 reform (Decree 
Law 229/1999) created attractive incentives for private practice within SSN 
facilities (intra-moenia) versus activities carried out in private settings (extra-
moenia). Employment contracts set forth a scheme of incentives and bonuses, 
including up to a 20% increase in salary and career promotion for those who 
chose intra-moenia practice. Doctors had to choose one or the other scheme, 
and a survey conducted in early 2000 recorded that most doctors (91.6%) 
and other SSN professionals chose the intra-moenia option (France, Taroni 
& Donatini, 2005). In 2004, a change in legislation (Decree Law 81/2004) 
allowed public-hospital physicians to decide – on an annual basis – between 
an exclusive employment relationship and independent practice outside the SSN 
and abolished the career advantages tied to choosing the first option. Doctors 
choosing independent practice must register with the relevant ASL, indicating 
the place and hours of their private service. All public physicians choosing to 
conduct private care within public hospitals pay a proportion of their extra 
income to the hospital. Recent legislation (Law 189/2012) promotes the creation 
of ad hoc facilities within public hospitals to practise intra-moenia activities. 
Dentists working within the SSN come under the category of specialists 
and are paid a salary. In addition, pharmacists employed by the SSN managing 
pharmaceutical care within public facilities are paid with a monthly salary.19 As 
with other public health workers, nurses and other staff are paid according to 
national collective agreements negotiated every three years by representatives 
of the trade unions and government.
19 Pharmaceuticals are distributed to the public via a network of pharmacies, on average, one for every 
3293 inhabitants. The bulk of pharmacies are private (16 425), with a small number of public pharmacies (1614) 
owned and operated mainly by local authorities (Federfarma, 2012). The regions are responsible for licensing 
and regulating pharmacies, which are remunerated with a nationally negotiated percentage margin of SSN drug 
retail prices.
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4. Physical and human resources
Over the last five years, Italy has decreased investment in expensive infrastructure and has even halted some projects due to cost-cutting measures, although in 2013 the government announced 162 new 
capital investment plans totalling nearly €1.5 billion. In addition, in a period of 
increasing decentralization and recent national-level cost-containment measures, 
the regions have sought additional sources of funding for health infrastructure. 
Sources include ad hoc regional funds, European funds, self-financing by 
local health service organizations, and traditional and non-traditional forms of 
financing such as mortgages or project financing.
In terms of hospital sector infrastructure, in 2012 Italy had 3.4 hospital beds 
per 1000 people; 80% of which are dedicated to acute care (higher than the 
EU average of 69%).
The importance of medical technology has generally grown over time. The 
number of MRI units, CT scanners and PET units is constantly rising, at least 
doubling over the last 10 years to become one of the highest per capita in the EU, 
albeit with great regional variability. E-health initiatives are promoted by the 
government and current development is focused on increasing online services, 
electronic health records (EHRs) and the digitalization of medical prescriptions 
and certificates.
With 3.7 practising doctors per 1000 people, Italy is slightly above the 
EU average of 3.4 – though the number of nurses is relatively low, at 6.3 per 
1000 people, and the ratio of nurses to doctors (roughly 1:1) is among the lowest 
in the EU – the average is 2.5 nurses to every doctor. This is despite an increase 
in the number of health-care professionals over the last 25 years, especially 
practising nurses and midwives, with the former becoming more active in the 
management of patients with chronic conditions. In terms of health worker 
mobility, Italy is predominantly a destination country, with higher levels of 
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inflows for certain categories of health professionals such as nurses and care 
assistants (both legal and illegal), largely due to chronic nursing shortages, 
which have shifted attention to recruitment from abroad. In contrast, emigration 
mostly affects medical doctors. 
4.1 Physical resources
4.1.1 Capital stock and investments
Until 1988, a proportion of the National Health Fund was earmarked for 
capital investment in the health sector (including new buildings, renovations, 
purchasing of technologies), with a central committee approving which projects 
to fund. This funding stream provided a stable flow of resources and procedural 
stability that allowed regional planners to implement projects in the medium 
to long term. The programme was renewed in 1998 with the approval of new 
investment plans (€17.5 billion) to improve health-care infrastructure. During 
this second term, this source of funding was replenished with ad hoc funding 
allocated by the central government. For example, in 2000 a lump sum was 
allotted to the promotion and modernization of radiotherapy facilities; and 
again in 2001 for the expansion of structures reserved for physicians working 
intra-moenia (see section 3.7.1). Again, in 2008 the Financial Law renewed 
the investment plan, raising the funds to nearly €20 billion. To coordinate the 
capital investment plan and monitor its implementation across the country, 
the government set up an independent assessment body to evaluate the 
implementation of publicly funded facilities’ investment (Nucleo valutazione 
e verifica investimenti pubblici).
Given the increased autonomy and responsibility of regions, they also 
activated additional sources of funding for health infrastructure. Several 
sources have been explored, including ad hoc regional funds, European Union 
funds, self-financing by ASLs and AOs (such as mortgages, budget advances 
and the sale of assets) and non-traditional forms of financing (such as project 
financing). Over the last five years, Italy has decreased investment in expensive 
infrastructure and has even halted some projects due to cost-cutting measures. 
In 2012, the central government approved a €1 billion reduction in hospital 
building and technology investments. Some commentators consider this 
measure to be a high risk one in relation to health workers’ and patients’ safety, 
given that the mean age of Italian hospitals is 70 years (De Belvis et al., 2012). 
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4.1.2 Infrastructure
In 2012, Italy had a total of 202 676 hospital beds (including general hospital, 
mental health and other specialized hospital beds) (OECD, 2014b) of which 
80% were dedicated to acute care and the remaining to rehabilitation and 
long-term care activities. On average, 68.4% of hospital beds are public while 
the remaining are in private facilities accredited by the SSN, with a high 
concentration of private accredited beds in the regions of Lazio, Campania 
and Lombardy (OECD, 2014b).
Fig. 4.1 shows the declining trend in the overall number of beds from 1990 
to 2012, totalling 3.4 beds per 1000 people in 2012. In particular, the number 
of acute hospital beds per 1000 population decreased from 6.16 in 1990 to 2.73 
in 2012. This figure does not include day-care or non-acute care beds (see also 
section 5.4.3). The current legislative targets are 3.7 beds per 1000 population 
of which 0.7 should be for non-acute care beds. However, interregional 
variability exists. 
Fig. 4.1
Mix of beds in acute care hospitals, psychiatric hospitals and long-term care 
institutions, 1990–2012
Source : OECD, 2014. 
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Fig. 4.2 clearly shows that the trend over time for acute care hospital beds per 
100 000 population in Italy is comparable to the overall trend of other European 
countries. In Italy there was a sharp decrease in bed supply particularly between 
1996 and 2000, from 577 beds per 100 000 to 407 beds per 100 000. In addition, 
the bed occupancy rate has been increasing steadily since 2003 (Fig. 4.3); it is 
higher than that of the other countries, except for Germany and the United 
Kingdom, and is higher than the EU average. The average length of stay in Italy 
has been falling steadily since 1990, comparable to the EU-15 average, along 
with Spain and the United Kingdom; it is considerably lower than in Germany 
(Fig. 4.4). 
Fig. 4.2
Beds in acute hospitals per 100 000 population in selected countries, 1990 to latest 
available year 
Source : WHO Health For All, 2014. 
In Italy, the change in bed utilization over time is an expected result of the 
policies aimed at controlling health expenditure, increasing hospital efficiency 
and reducing waste. Therefore, on the one hand, there has been a consistent 
reduction in bed numbers, in compliance with national guidelines, including 
the target of 160 hospitalizations per 1000 inhabitants of which 25% should 
be provided in day-hospital settings (Decree Law 95/2012); on the other hand, 
there has been a reduction in the number of health-care facilities particularly via 
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Fig. 4.3
Bed occupancy rate (%) in acute care hospitals only, in Italy and selected countries, 
1990, latest available year
Source : WHO Health For All, 2014. 
Fig. 4.4
Average length of stay (days), in acute care hospitals only, in Italy and selected 
countries, 1990, latest available year 
Source : WHO Health For All, 2014. 
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the closure of small hospitals or the transformation of acute care facilities into 
other types of services to meet changing needs (for example, to provide care 
for those with chronic diseases or care for the frail and elderly). 
Nowadays, many hospitals are no longer organized along the lines of clinical 
specialties or departments; instead, the use of space and beds is determined by 
managers, while multidisciplinary teams of clinicians treat patients according 
to the level of care required. Adoption of lean management techniques is 
also developing in Italy, where hospitals are encourage to think in terms of 
systems and process management (Carbone et al., 2013). An example of this 
is the Careggi Hospital in Florence, where clinical activities are performed in 
10 clinical departments created on the basis of health needs (Rechel et al., 2009). 
The new health-care environment has resulted in other innovative approaches 
to capital assets and working practices. For example, some hospitals are now 
open only Monday to Friday (‘week hospital’) for elective surgery and other 
planned treatments so patients are discharged before the weekend. Evaluation 
of this experimental model is ongoing and is part of a planned network of care 
in a few regions (Piedmont and Tuscany). These are some of the regions that 
have moved away from a hospital-centred form of regional planning towards 
one that integrates primary and community health services and encompasses 
the whole spectrum of health-care services.
4.1.3 Medical equipment
The importance of medical technology has generally grown over time. The 
number of MRI units, CT scanners and PET units is constantly rising, doubling 
between 2000 and 2011 in the case of CT scanners and more than tripling in 
the case of MRI units (Table 4.1). In 2011 there were 30.4 CT scanners per 
million population and almost 20 MRI units per million population available 
in hospital (including public, private accredited and non-accredited providers) 
and ambulatory settings (public and private accredited providers) (OECD, 
2014b). However, the diffusion of medical technology is not evenly distributed 
across the country. Some regions, such as Liguria, the central regions, as well 
as Molise, Basilicata and Sardinia have high levels (higher than the national 
average) of technologies available in public facilities while others in the south 
have constantly lower levels (Campania, Puglia, Calabria and Sicily). 
Table 4.2 highlights this uneven distribution with the number of total MRI 
units ranging from 7.2 units per million population (Campania) to 31.2 (Molise) 
and CT scanners ranging between 20.2 (Friuli-Venezia Giulia) and 43.8 (Molise). 
PET units are available only in high density regions, with the highest available 
number in Friuli-Venezia Giulia.
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Table 4.1
Number of MRI units, CT scanners, PET per million population, 1990–2011
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
MRI units 4.11 5.82 6.25 7.76 9.07 10.83 11.84 13.98 14.84 16.73 18.48 19.72
CT scanners 14.80 18.01 18.99 21.13 23.01 24.00 23.80 26.01 27.52 28.89 30.06 30.44
PET n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 1.77 2.01
Source : OECD, 2014.
Note : OECD data includes equipment in public as well as private SSN-accredited and non-accredited facilities; n.a., not available.
Table 4.2
Number of MRI units, CT scanners, PET per million population in public and private-
accredited hospitals and ambulatory settings, Italy 2011
Public Private accredited
MRI CT PET MRI CT PET
North
Piedmont 10.1 19.3 – 4.3 3.4 –
Valle d'Aosta 23.4 31.2 –  – – –
Lombardy 11.2 17.5 0.2 5.3 5.0 0.1
A.P. Bolzano 9.8 15.8 – 3.9 3.9 –
A.P. Trento 7.6 20.8 – 5.7 5.7 –
Veneto 12.4 17.0 0.2 2.0 1.4 –
Friuli Venezia Giulia 8.1 17.8 1.6 4.0 2.4 –
Liguria 19.2 22.3 – – – –
Emilia R 9.5 19.0 0.2 6.8 3.6 0.2
Centre
Tuscany 13.3 20.5 0.8 1.6 2.7 –
Umbria 12.1 23.2 – 1.1 2.2 –
Marche 14.7 21.7 – 4.5 3.8 –
Lazio 18.2 21.5 – 5.6 6.8 –
South
Abruzzo 8.9 17.9 – 8.9 7.4 –
Molise 28.1 34.4 – 3.1 9.4 –
Campania 3.6 13.7 0.3 3.6 8.7 0.2
Puglia 7.6 17.1 0.5 2.9 5.1 –
Basilicata 11.9 23.8 – 1.7 1.7 –
Calabria 6.5 18.9 – 5.0 9.4 –
Sicily 6.9 19.4 0.2 4.6 9.7 0.2
Sardinia 9.5 17.9 0.6 3.0 4.2  –
ITALY 10.6 18.6 0.2 4.2 5.2 0.1
Source : Ministero della Salute, 2013a. 
Note : The difference in the total numbers of medical imaging technologies between Table 4.1 and Table 4.2 is due to differences in data 
collection. In Table 4.1, the OECD source includes public facilities as well as private-accredited and private non-accredited providers in 
the national total. In Table 4.2 data by the Ministry of Health includes public facilities and only private-accredited facilities. 
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Purchasing of medical technology differs between type of technology 
(e.g. drugs, prosthesis or diagnostic devices). In general, medical technologies 
are purchased through open public tender procedures. Negotiations take place 
at the local level between health providers and manufacturers/wholesalers even 
though there is a tendency to centralize purchasing as a way to strengthen 
market power and reduce hospitals’ administrative costs (Cappellaro, Fattore 
& Torbica, 2009). For instance, various types of voluntary and compulsory 
consortia to centralize technical and administrative activities between health 
providers have been established (called centrali d’acquisto).
4.1.4 Information technology
The use of information and communication technologies in the health-care 
sector is increasing in Italy as in other European countries. E-health initiatives 
are promoted by the government and current development is focused on the 
overall plan to implement the New Health Care Information System (NSIS, 
Nuovo Sistema Informativo Sanitario), which is an information system and 
governance tool to assist, monitor and oversee all primary levels of health-
care services (see section 2.7.1). Another relevant initiative is included in the 
E-Government Plan 2012, which aims to encourage government innovation 
within the entire public sector, including health care, where the focus is 
on increasing online services, developing EHRs and digitalizing medical 
prescriptions and certificates. 
In 2010 approximately 86% of Italian GP practices used a computer. Overall, 
71% of Italian GP practices are connected to the Internet and broadband 
connections can be found in almost half the practices (49%) (Tamburini 
et al., 2010). With regard to the use of eHealth applications (e.g. EHR or 
digitalization of medical prescriptions), the best results are achieved for the 
storage of administrative data (patient summary) and the use of computers for 
consultation purposes. However, the exchange of electronic patient data is not 
yet well established: only 3% of GPs exchange administrative data with other 
care providers and just about 1% of GP practices use electronic exchange of 
prescriptions (e-prescription) (Tamburini et al., 2010). 
At regional level, many patient summary pilots are running and are highly 
developed; some regions, such as Lombardy and Emilia Romagna, have 
already fully deployed a patient summary that includes administrative data and 
medical history (Tamburini et al., 2010). Italy is also involved in the European 
epSOS (European patients Smart Open Services) project where the Italian 
initiative – IPSE – focuses on the transregional transfer of medical data and the 
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establishment of a patient summary as well as e-prescription. Regional pilots for 
e-prescription have run in Italy since 2002. In the region of Emilia Romagna, 
‘SOLE – Online Healthcare’ programme20 aims to develop an integrated 
(inter-operational) telematic network of hospitals and health-care professionals, 
including the electronic management of prescriptions.
Italy’s background in telemedicine includes the €50 million (TELEMED) 
initiative in 1991 that for 10 years represented a focal point for several 
applications. Many telemedicine pilots and projects are currently ongoing, 
including the ‘Renewing Health’ European funded project,21 which started at 
the beginning of 2010, coordinated by the Veneto Region. This project aims 
to promote the adoption of remote patient monitoring and treatment for those 
suffering from chronic conditions.
4.2 Human resources
4.2.1 Health workforce trends
In 2010 the SSN employed a total of 646 236 health-care personnel, of which 
70.2% are health staff, 18.1% technical staff and 11.7% administrative staff. 
Among health staff, 23.7% are physicians and dentists, 58.3% are nurses and 
the remaining 18% include other health professionals (pharmacists, biologists, 
physiologists and veterinarians22) (Ministero della Salute, 2013b). Almost 
64% of SSN employees are women, with a marked concentration in nursing, 
rehabilitation and administrative (Ministero della Salute, 2013). Overall, the 
number of health-care professionals increased from 1990 to 2011, especially 
with regard to practising nurses and midwives. In the last ten years an increase 
of 18% in the number of nurses and midwives has been registered (Table 4.3).
The number of active physicians grew during the 1990s and early 2000s, 
declining to the minimum of 3.65 physicians for every 1000 population in 
2006. The trend is now stable at around 4 active physicians per 1000 population. 
Over the same period, dentists also increased with a peak in 2006 (0.63 per 
1000 population). The number of active pharmacists is available from 2004 
only and here too there is an increase up to 2008 followed by a small decline.
20 Also known as Emilia Romagna Digitale.
21 See http://ec.europa.eu/information_society/apps/projects/factsheet/index.cfm?project_ref=250487.
22 In Italy, veterinarians working in local health authorities are counted as health professionals. The veterinary 
activities of local health authorities are divided into two functional areas: one dealing with animal health and 
hygiene of animal farming and production, the other with production and trade of food of animal origins.
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By way of comparison Fig. 4.5 shows OECD data on the number of active 
physicians per 1000 population in Italy and selected European countries 
in 2012 or the latest available year. The rate in Italy (4.1) is on a par with 
that of Sweden and Germany and higher than the rates in France, Spain and 
the United Kingdom. (Other OECD data on practising physicians shows 
3.7 practising doctors per 1000 people in Italy, which is slightly above the EU 
average of 3.4).
Fig. 4.5
Number of physicians per 1000 population in Italy and selected European countries, 
2011 or latest available year 
Source : OECD, 2014b.
Notes : aData refer to professionally active physicians, which include practising physicians plus other physicians working in the health 
sector as managers, educators, researchers, etc. (adding another 5–10% of doctors); bdata refer to practising physicians, which are 
defined as those providing care directly to patients.
Conversely, compared to these countries the number of nurses (not 
including midwives) per 1000 population is considerably lower in Italy, with 
the exception of Spain (Fig. 4.6). Interestingly, the nursing profession in Italy is 
currently experiencing an enhancement of its role, especially with regard to the 
management of patients with chronic conditions with the introduction of formal 
or informal nurse-led professional groups in primary settings (see Chapter 5). In 
terms of the combined number of physicians and nurses per 100 000 population, 
WHO data show that Italy is roughly in line with the European Union average 
with around 1092 of these health-care professionals compared with an average 
of 1182 (Fig. 4.7). 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
United KingdombSwedenbSpainbItalybGermanybFrancea
Ph
ys
ic
ia
ns
 p
er
 1
 0
00
 p
op
ul
at
io
n
Health systems in transition  Italy82
Fig. 4.6
Number of nurses per 1000 population in Italy and selected European countries, 2011 
or latest available year 
Source : OECD, 2014b.
Notes : aData refer to professionally active nurses, which include practising nurses plus other nurses working in the health sector as 
managers, educators, researchers, etc. (adding another 5–10% of nurses); bdata refer to practising nurses, which are defined as those 
providing care directly to patients.
Fig. 4.8 shows in greater detail the trend in the number of dentists per 
100 000 population over the last 20 years or so in a selection of countries. 
Europe registers a steady increase in the available number of dentists over time, 
with the exception of France and Sweden. In Italy the trend is rather unstable 
with peaks (1999 and 2006) and declines (1995, 2003 and 2008). 
Fig. 4.9 provides a snapshot of the trend in number of pharmacists per 
100 000 population across Europe. On average, for EU-15 countries, the 
number has increased but the trend is not steady for all the countries featured, 
particularly Spain and Italy. The few data available for Italy indicate a sharp 
reduction in 2006 (-12 professionals available per 100 000 population in one 
year) followed by a significant increase in 2008 (+25 professionals available 
per 100 000 population in two years), and then a decline again before a 
new rise. These fluctuations are the outcome of intermittent employment 
freezes on public pharmacists imposed by national and regional level 
cost-containment measures and possibly of poor quality of available data 
(see Chapter 3).
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Fig. 4.7 
Number of physicians and nurses per 1000 population in the WHO European Region, 
2012 or latest available year 
Source: WHO Health For All, 2014. 
Notes: CIS: Commonwealth of Independent States; TFYR Macedonia: The former Yugoslav Republic of Macedonia.
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Fig. 4.8
Number of dentists per 100 000 population in selected countries, 1990 to latest 
available year 
Source : WHO Health For All, 2014. 
Fig. 4.9
Number of pharmacists per 100 000 population in selected countries, 1990 to latest 
available year 
Source : WHO Health For All, 2014. 
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4.2.2 Professional mobility of health workers
Few data at national level map the mobility (outflows and inflows) of health 
workers in Italy, especially with regard to personnel working outside hospital 
settings (e.g. informal care workers). Since 2007 the National Federation 
of Nurses (Federazione Nazionale Collegi Infermieri – IPASVI) has been 
monitoring the f low of nurses and reporting on the composition of the 
workforce; there are no reliable national data on the mobility of medical doctors 
or care workers.
Estimates report that Italy has a relatively low reliance on foreign medical 
doctors – less than 5%, when compared to UK, Ireland and Switzerland where 
such rates range between 22.5% and 36.8% (Wismar et al., 2011). Currently, 
the country is facing a freeze on medical doctor turnover as well as health 
care-professionals turnover in general. In addition, it is difficult for both 
foreign-trained and domestically trained foreign medical doctors to find stable 
employment. Consequently, medical doctors tend to leave, rather than enter, 
the country. On the other hand, nursing shortages have led to high inflows 
of foreign nurses. In fact, one in ten nurses is of foreign origin. The largest 
groups are from the European free-movement area, including Romania 
(25%), Poland (10.7%), Switzerland (7%), Germany (5.6%), France and Spain 
(around 3.5% each), and a significant number are from South America (Peru 
5.3%) (Wismar et al., 2011). The majority of foreign nurses have migrated to 
central and northern Italy. In addition, the elderly care and home-care sectors 
rely heavily on foreign carers, who nevertheless are mainly undocumented 
workers working in the grey economy. The demand for informal care workers 
(badanti) is estimated to be three times higher than the demand for nurses 
(Chaloff, 2008). The increasing demand for assistance for elderly people is 
the main driver influencing international health professional mobility. Recent 
legislation has sought to regularize the immigration status of care workers 
and partly reflects the needs of the health and long-term care systems; entry 
requirements for nurses also have been eased. However, health professionals 
from non-EU countries cannot hold permanent public sector positions and are 
thus disproportionally affected by less favourable working conditions. 
To encourage health workforce mobility and strengthen education and 
capacity building within the health professions, bilateral agreements have 
been developed at regional and local level. Regions and health-care units 
have primarily agreed bilateral programmes with foreign nursing institutes, 
especially with Eastern European partners, to guarantee the recruitment of 
qualified professionals (e.g. through distance learning programmes). 
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4.2.3 Training of health workers
The educational pathway to achieving and maintaining professional status for 
doctors includes basic medical training, which occurs primarily at a public 
university (5–6 years). The initial years are dedicated to pre-clinical/basic 
science and later years to clinical rotation (university based). Before entering 
postgraduate specialization, medical graduates take a state examination in order 
to be listed in the national register and be granted the authorization to practise 
as physicians. Postgraduate education consists of a minimum two years of 
residency depending on speciality and is often much longer. Physicians wishing 
to become GPs must be registered on a national list. Ranking on the list depends 
not only on the number of educational and academic qualifications achieved 
but also, as of 1 January 1995, on successful participation in a two-year GP 
training course. Legislative Decree No. 256/1991, which implemented the EU 
directive on GP training, made participation in this two-year course compulsory 
to practise family medicine.23 There are lifelong continuing medical education 
(CME) requirements for public and private sector employees. 
Since 1999, to limit the number of training positions available in the medical 
field, enrolment in university medical education programmes (medicine and 
surgery, veterinary science and dentistry) has been based on a competitive 
assessment exam. For the 2013–2014 cycle, there are 9897 slots available for 
medicine and surgery training, 825 slots for veterinary science and 984 slots 
for dentistry. There are also restrictions on advancement to postgraduate levels. 
However, it is worth noting that despite these efforts to control the national 
supply of medical doctors, there is still an over-supply in the country, resulting 
in an outflow to other EU countries, especially the UK and Germany, where 
they find more stable employment conditions (Wismar et al., 2011).
In 2001 the training programmes for qualified nurses changed to encourage 
more qualified personnel to enter the health-care workforce. Currently, nursing 
training occurs at university level (3 years) and includes foundation courses and 
clinical rotation at the end of which candidates are required to take a national 
examination. This is in line with EU Directive 85/595/ECC on the upgrading of 
the nursing profession. Some nurses continue with specialization programmes 
in fields such as public health, paediatrics, mental health and psychiatry, and 
geriatrics, taking a first or second level Masters degree or a two-year graduate 
degree. Doctoral programmes also are available.
23 In accordance with Legislative Decrees Nos. 256/1991 and 368/1999, certificates issued by other EU Member 
States to practise as a GP are equivalent to those issued in Italy and therefore are valid for practising in Italy 
(Lo Scalzo et al., 2009).
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Both doctors (GPs and specialists) and qualified nurses are registered in 
their national registries (Albo Porfessionale) that are available by specialities. 
Moreover, there is mutual recognition of medical qualifications gained in other 
EU Member States, Switzerland, Norway, Iceland and Lichtenstein for the 
purpose of practising in Italy. 
In general, CME is recommended for continuing certification and career 
development for all health professionals. The National Programme on 
Continuing Education in Medicine (NPCEM) was established by the Ministry 
of Health in 2002 and from 2008 its coordinating body is the National 
Agency for Regional Health Services – AGENAS (see Chapter 2). All health 
professionals are currently required to earn 150 CME credits every three years 
(minimum 25 and maximum 75 credits per year), including comprehensive 
knowledge upgrades in management and leadership skills. Regardless of the 
profession or training level, in order to offer CME credits, institutions typically 
require accreditation by central or regional governments as part of quality 
assurance requirements. 
Ancillary staff, such as laboratory technicians or nurses’ aids, are often 
trained through some specialized courses not associated with a university. 

5. Provision of services 
The Ministry of Health is the main institution responsible for public health at the national level. Immunization and screening programmes are considered to be priorities. In addition to the mandatory and voluntary 
routine immunization programmes, pap tests, mammography and colorectal 
screening are offered free of charge to target populations nationally. 
Primary care services are delivered by health districts, the operative 
branches of local health authorities. Over the last 15 years, there have been 
attempts to reorganize the delivery of primary care, with the objective of moving 
from the traditional model of GPs and other health professionals working in 
single practices to an integrated care model that connects different health-care 
professionals and bridges the gap between frontline staff and patients, though 
change has been slow.
Inpatient care is provided through a network of accredited public and 
private hospitals, with general practitioners and paediatricians (who usually 
treat children up to the age of 6 or if parents so wish, up to the ages of 14–16) 
playing a gatekeeping role. In recent years there has been a progressive increase 
in Accident and Emergency Department admissions, some of which are due to 
inappropriate use by patients (e.g. for minor illnesses or prevention interventions 
that could have been treated by primary care physicians) for which co-payments 
of €25 are imposed (see above). 
Medicines are grouped into three main classes: Class A are essential 
medicines that are reimbursable (but require a co-payment, that varies by 
region) and include those indicated for the treatment of severe, chronic or 
acute illnesses. Class C includes non-reimbursable pharmaceutical products 
(though some regions opt to offer some reimbursement). Class H includes 
pharmaceutical products delivered only within hospitals. To contain 
pharmaceutical expenditure, the 2012 Spending Review reduced the budget for 
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drugs used in non-hospital settings from 13.3% of total health-care expenditure 
to 11.35% in 2013. However, in the last decade, the cost of pharmaceuticals 
delivered by hospitals has significantly increased due to new expensive products 
and the delivery by hospital pharmacies of products that are then used outside 
hospital settings. 
With regard to mental health care, the 1978 Basaglia Law marked the switch 
from institutional care to community mental health services. Subsequently, 
specific departments of mental health have been established within local 
health authorities. A priority remains closing the gap between the northern 
and southern regions with regard to the provision and quality of services, which 
remains a major challenge.
Health-care delivery to vulnerable or excluded groups has undergone 
a recent change in policy. After several years without specific regulations, 
legislation has now been defined to guarantee that immigrants (both legal and 
temporarily undocumented) are eligible to receive the same public health-care 
services that are available to Italian citizens. 
The central issue with health service delivery is the heterogeneity of regional 
arrangements. In general, northern and central regions appear to keep pace 
with institutional, organizational and professional developments aligned with 
best international practices and in line with central government orientations, 
while southern regions appear to lag behind. The gaps between northern and 
southern regions mainly reflect socioeconomic and cultural factors that are far 
beyond the health-care system. However, it is also likely that decentralization 
policies introduced in the last two decades have not favoured the homogeneity 
of regional systems as they have provided opportunities for improvement to the 
best institutionally equipped regions while leaving southern regions with less 
central support to cope with more difficult social contexts.
5.1 Public health 
The main institution responsible for public health at the national level is the 
Ministry of Health, which undertakes a stewardship role and sets the general 
policies targeting health improvement and prevention. Public health policies are 
implemented by the regions through their Departments of Health and ASLs, the 
remits of which include protection of the population’s health, health promotion, 
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preventing diseases and disability, and improving quality of life. The main 
areas of activity are: public hygiene, occupational health, food and nutrition 
and veterinary health care.
5.1.1 Communicable diseases control programmes: vaccinations
The reduction or elimination of the burden of vaccine-preventable diseases is 
considered a priority of the public health service. The routine immunization 
programme includes diphtheria, tetanus (DT) and poliovirus (oral poliovirus 
vaccine – OPV) vaccinations, which have been mandatory by law since the early 
1960s for all newborns under 24 months. The hepatitis B vaccine was added in 
1991, introducing universal vaccination of infants and children (up to 12 years 
of age). Vaccinations against pertussis, measles, mumps, rubella, Haemophilus 
influenzae type b (Hib), meningococcal C and pneumococcal meningitis, 
chickenpox and HPV are non-mandatory vaccinations but are recommended 
by the Ministry of Health. Compulsory and recommended vaccinations are 
included in the benefit package and are provided free of charge for all Italian 
and foreign children living in the country. 
Regions are in charge of organizing and implementing their own vaccination 
strategy, based on the National Vaccination Plan (NVP). In 2012 a new NVP – 
NVP 2012–2014 – was released, which emphasizes the right to vaccination, 
defines the specific objectives to be reached for the population and certain risk 
groups and sets the standards for vaccination coverage (Ministero della Salute, 
2012b). ASLs and the Ministry of Health are responsible for implementing the 
activities outlined in the plan. Childhood vaccinations are routinely provided 
through a well-established and organized network of public facilities and are 
usually administered by specific departments within ASLs. Moreover, primary 
care paediatricians are the key contacts for counselling and information; 
they verify that children have received vaccinations and can administer 
vaccines themselves. 
To evaluate the efficacy of vaccination programmes, national and sentinel 
surveillance systems are used to collect data and provide information on the 
incidence of infectious diseases and vaccination coverage. SIMI (Computerized 
Infectious Disease System) is the statutory notification system, administered 
by the National Institute of Health, in collaboration with the Ministry of Health. 
Remarkable progress has been achieved in terms of coverage rates for the 
compulsory vaccinations, reaching an average of 96% and meeting the target 
of 95% set by the National Vaccination Plan, in accordance with World Health 
Organization guidelines. With regard to the recommended vaccinations for 
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measles, mumps and rubella, coverage (89.9%) has increased significantly over 
the last 10 years, even if further efforts are needed to meet the target of 95% 
and a certain degree of heterogeneity still persists, at both the regional and local 
level (Table 5.1). 
Table 5.1
Mandatory and some recommended vaccination coverage per 100 newborns under 
24 months, 2011
Regions POL3 DTP3 DT-DTP3 EpB3 MPR1-
MPRV 
M-MPR1-
MPRV 
Hib3 
Piedmont 95.9 95.9 96.0 95.9 92.2 92.2 95.4
Valle d'Aosta 95.6 95.2 95.3 94.8 86.2 86.4 94.9
Lombardy 97.0 96.9 97.1 96.2 93.9 94.6 95.9
Bolzano-Bozen 89.0 89.9 89.9 89.6 72.4 72.4 90.5
Trento 95.9 95.7 95.8 95.5 89.0 89.1 95.1
Veneto 95.3 95.3 95.3 95.1 92.3 92.5 94.7
Friuli Venezia Giulia 96.0 96.2 96.7 95.4 91.6 91.6 95.0
Liguria 96.7 96.7 96.7 96.7 85.6 85.7 96.3
Emilia Romagna 96.5 96.2 96.6 96.3 92.8 92.9 95.4
Tuscany 96.2 95.8 98.6 95.9 92.1 92.2 95.2
Umbria 97.8 97.8 97.8 97.4 94.7 94.7 97.5
Marche 97.2 97.1 97.1 97.1 92.3 92.4 97.1
Lazio 96.6 96.5 96.5 99.9 90.0 90.0 96.8
Abruzzo 99.1 99.1 99.1 99.1 91.9 91.9 99.1
Molise 99.0 99.0 99.0 99.0 89.7 89.7 99.0
Campania 91.9 91.9 93.5 90.2 86.5 86.5 88.1
Puglia 96.9 96.9 96.9 96.9 92.7 92.7 97.2
Basilicata 98.6 98.6 98.6 98.6 92.4 92.4 98.6
Calabria 95.9 95.9 95.9 95.9 85.8 85.8 95.9
Sicily 94.8 94.8 94.8 94.8 90.1 90.1 94.8
Sardinia 96.1 91.4 96.0 96.0 92.7 95.8 96.0
Italy 96.1 95.8 96.3 96.0 89.9 90.1 95.6
Source : Ministero della Salute, 2012c. 
Notes : POL3, three doses of polio vaccine; DTP3, three doses of diphtheria–tetanus vaccine; DT-DTP3, three doses of diphtheria–
tetanus–pertussis vaccine; EpB3, three doses of hepatitis B vaccine; MPR1-MPRV, measles, rubella, mumps and chickenpox; 
M-MPR1-MPRV, measles, rubella, mumps and chickenpox; Hib3, three doses of Haemophilus influenzae type b vaccine.
5.1.2 Occupational health
Driven by EC Directives, the occupational health sector has made significant 
progress in recent years. The Italian Occupational Health and Safety Act 
(Legislative Decree 81/2008) provides the legal framework, setting out the rights 
and duties of all parties in the workplace and harmonizing previous legislation. 
Due to spending cuts, in 2010 the National Institute for Occupational Safety and 
Prevention (ISPESL) was absorbed within the Italian Workers’ Compensation 
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Authority (INAIL). This organization is responsible for the administration of 
the compulsory insurance scheme related to work/industrial accidents and 
occupational illnesses. Public funds are the main source of funding and are 
set through the National Health Fund, along with additional finance that can 
be provided by the regions and the European Commission. In all workplaces 
where workers can be exposed to specific risks an occupational health specialist 
must be appointed by law for medical check-ups of employees and education 
information activities.
5.1.3 Screening programmes
Since 2001, the government has adopted a series of measures to promote the 
widespread and uniform adoption of screening policies and guiding principles 
at the national level. Secondary cancer prevention has been included in the 
benefit package. To improve screening coverage and following the EU’s 
recommendation on cancer screening (December 2003), several plans have been 
developed with the aim of strengthening the diffusion of active programmes: 
National Health Plan (2003–2005), National Screening Plans (2004–2006 
and 2007–2009) and National Prevention Plan (2005–2007). Moreover, 
Law 138/2004 contains a commitment to reduce the gap between the target 
and the screened population, allocating €50 million.
Important progress in the extension of screening programmes has been made 
in recent years (for example, see Fig. 5.1) Cervical Pap tests, mammography and 
colorectal screening are offered free of charge to target populations nationally. 
For cervical cancer the Pap test is offered every three years to women 
aged 25–64, in accordance with European Union guidelines. Mammography 
screening is offered every two years to women aged 50–69. As for colorectal 
screening, current guidelines recommend two screening tests: the majority of 
programmes use the faecal occult blood test (FOB) in subjects aged 50–69/74, 
while others (mainly those in the Piemonte and Veneto regions) have adopted 
flexible sigmoidoscopy (FS) once in a lifetime (or with a frequency of at least 
10  years) in patients aged 58 or 60. The screening programmes are regulated 
and organized at the regional level through the ASLs, which actively invite 
the target population to have preventive tests (mammography, Pap test, FOB) 
free of charge. Participation in screening programmes is voluntary and several 
indicators are calculated to monitor screening invitations and uptake, which 
impacts on the efficacy of programmes in reducing cancer mortality. The 
National Centre for Screening Monitoring (Osservatorio Nazionale Screening) 
was created in 2002 and was charged by the Ministry of Health with monitoring 
and promoting screening programmes nationwide. 
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Fig. 5.1
Nominal extension of breast cancer screening, 2000–2010 
Source : Osservatorio Nazionale Screening, 2012. 
5.1.4 Smoking bans
It is worth mentioning that, as a major national public health measure to reduce 
the prevalence of tobacco usage, the introduction of a general ban of smoking in 
all public and working places was implemented in 2012. This ban, approved by 
parliament after a long history of attempts, was implemented rapidly (Mele & 
Compagni, 2010).
5.2 Patient pathway
Fig. 5.2 represents a typical patient pathway for non-emergency health care. The 
different levels consist of GPs, ambulatory care, hospital care and primary care 
follow-up after discharge. In practice, a patient’s first contact with the health-
care system occurs when their health problems are explicitly manifest. In these 
cases, the severity and type of the health problem drives the patient towards 
the main points of access to care. Most of the time, GPs play a gate-keeping 
role and represent the first point of contact for patients. Every patient has 
access to free visits and freedom of choice in terms of registering with a GP. 
Generally speaking, when GPs provide a referral, they can recommend a certain 
organization, taking into account the patients’ special needs in terms of urgency 
of care, proximity to where they live and quality of services. 
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Fig. 5.2
Typical patient pathway 
Source : Based on Ministero della Salute, Direzione Generale del Sistema Informativo e Statistico Sanitario, 2012. 
For specialist care, patients can choose both public and private providers, 
according to their willingness to pay and to wait. After preliminary contact 
with a GP, patients can enter ambulatory care through public facilities located 
either in a hospital or in ASLs. The required intervention can be requested via 
a central booking point (Centro Unico di Prenotazione – CUP), in most cases 
by calling a special telephone number. CUP operators can suggest providers 
where the service would be available sooner, thus reducing waiting times. 
Such information about waiting lists covers both public and private accredited 
hospitals that provide reimbursable services. Services provided in public or 
private-accredited facilities require a referral and are covered by the SSN 
(apart from any co-payments due for outpatient services). For those who want 
to skip waiting lists or choose an individual specialist, and are ready to pay, 
care is also available outside statutory coverage through private providers or 
SSN specialists operating intra-moenia (who also have their own information 
systems for bookings and waiting lists). In such cases (private visits), patients 
have direct access to the facility without a referral from a GP and pay the total 
cost without any reimbursement from the SSN. 
If further care is needed, the next step in the care pathway may involve an 
inpatient (acute) hospital admission. In the case of surgical interventions, one-day 
pre-admissions for patient preparation are increasingly common in order to 
reduce the length of stay; day hospital and day surgery rates are also growing 
(see section 5.4). Once treated in the acute setting, a patient pathway is expected 
to move into integrated home care (Assistenza Domiciliare Integrata – ADI) 
if the patient needs post-acute care. Usually the discharging hospital will refer 
the patient to a specific provider for rehabilitative care or if appropriate, to local 
residential care (Residenza Sanitaria Assistenziale – RSA) for long-term care.
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In the case of out-of-hours emergency care, or where a consultation with 
a GP is not possible, care is provided by ‘continuous care physicians’ (Medici 
di Continuità Assistenziale – MCA – formerly called emergency doctors). 
Continuous care, designed according to effective integrated models, has 
been reformed at national and regional level over the last 20 years in order 
to guarantee 24 hour coverage, 7 days a week.24 Where the situation requires 
urgent attention, a free ambulance service to the closest hospital is provided 
by calling the Emergency System number 118 or patients can go directly to the 
nearest hospital emergency department to obtain necessary treatment. Charges 
can be applied if patients use emergency services inappropriately. Further 
details on emergency care pathways are provided in section 5.5. 
5.3 Primary/ambulatory care
According to the National Health Plan (2011–2013), primary care represents 
the ‘hub’ for delivering general practice at the first point of contact with the 
SSN and is responsible for providing continuity of care through appropriate 
coordination. Thus, the primary care network promotes the maintenance of 
health, health education, diagnosis and treatment of acute and chronic disease 
in different settings, from ambulatory care to home care (Damiani & Ricciardi, 
2010). This section focuses on ambulatory care provided outside hospital by 
GPs and specialists.
GPs and paediatricians (who usually treat children up to the age of 6 or if 
parents so wish, up to the ages of 14–16) have a gatekeeping role. They are 
responsible for prescribing medication and, after diagnosing a health problem, 
referring patients to specialist consultations or further levels of care if needed. 
GPs are self-employed and independent doctors, paid on the basis of a capitation 
fee on the number of registered patients (up to 1500; see Chapter 3) augmented 
by a fee-for-service component for specific activities (e.g. home visits) and 
additional payments according to specific performance indicators (typically 
managed at regional and local level). In order to practise, GPs must complete 
specialist training consisting of a three-year professional training course in 
general medicine. Recent legislation has promoted a revision of the criteria 
governing fitness to practise for both GPs and paediatricians (Law 189/2012), as 
negotiated during the National Labour Contract for General Practice (Accordo 
Collettivo Nazionale – ACN) (see also section 3.7.2). The profile of paediatricians 
is quite unusual as they are both specialist independent doctors and physicians 
24 Legislative Decree 502/92; National Health Plan 2010–2012; Legislative Decree 158/2012.
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who are fully integrated within the SSN and responsible for guaranteeing 
the first level of care for children aged up to age 14–16. Alternatively, if no 
paediatrician is available or when a child reaches 6 years of age, parents can 
choose to register him or her with a GP. Paediatricians can have a maximum 
of 800 registered patients in their lists (up to 880 with a special dispensation). 
Organizationally, both GPs and paediatricians are included within Health 
Districts, the operative branches of ASLs that are responsible for guaranteeing 
the provision of primary care services. Each Health District is expected to plan 
and deliver health and social care based on population needs. Multidisciplinary 
teams of professionals (GPs and paediatricians, specialists, nurses, social 
assistants, social care staff and other technical and administrative staff) work 
within Health Districts to provide different types of services to meet community 
needs (e.g. GP and specialized ambulatory care, maternal–infant care, frail care, 
mental health care, etc.). 
Over the last 15 years, there have been attempts to re-organize the delivery 
of primary care, with the objective of moving from the traditional model of 
GPs and other health professionals working in single practices to an integrated 
care model that connects different health-care professionals and bridges 
the gap between front-line staff and patients. In 2000, the National Labour 
Contract for GPs represented a milestone for primary care reorganization, 
introducing economic incentives for group practice and integration between 
primary care physicians and Health District services (e.g. social and home care, 
environmental health, etc.). In particular, three different models were introduced 
with increasing degrees of integration: ‘base-group practice’, ‘network group 
practice’ and ‘advanced group practice’ (see Longo, 2007; Fattore et al. 2009; 
Lo Scalzo et al., 2009; Armeni, Compagni & Longo, 2014 for details about 
organizational developments in primary care). Further developments for group 
practice occurred in 2005, with the introduction of Primary Care Territorial 
Units (Unità Territoriali per l’Assistenza Primaria – UTAP) and in the 2009 
National Labour Contract for GPs, which established an additional compulsory 
framework known as a Complex Primary Care Unit. More recently, in 2012, 
the Balduzzi Decree Law n. 189/2012 has promoted the voluntary formation 
of group practice in primary care, particularly to foster continuity of care and 
greater integration of care. In particular, given that GPs play an important 
‘liaison’ role in the management of chronic care patient pathways they make a 
key contribution in defining the best care programme and delivery setting for 
a patient. Currently, GPs, paediatricians, continuous care physicians (MCAs) 
and ambulatory specialists are urged to supply 24-hour continuous care, 7 days 
a week by organizing their group practice according to the organizational 
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models mentioned above. In terms of implementation, different models have 
been adopted in different districts and regions but with an observed decline 
nationally in single and base-group practice and a slow evolution towards more 
complex aggregative working models (Osservasalute, 2012). Table 5.2 provides 
a summary of the different types of group practice models currently available, 
even though in practice solo practice still dominates.
Table 5.2
GP group practice models
Simple models Complex models
Functional Structural Functional Structural
Base group practice
(Medicina in associazione)
Advanced group practice
(Medicina di gruppo)
Functional territorial 
collective practice
(ATF – Aggregazioni 
funzionali territoriali)
Complex Primary Care Unit 
(UCCP – Unità Complesse 
di Cure Primarie)
Network group practice
 (Medicina in rete)
Primary care territorial unit 
(UTAP) formally introduced 
by ACN in 2005
Source : Damiani & Ricciardi, 2010.
Notwithstanding these efforts to encourage multi-professional group 
practice, it remains the case that comprehensive management in primary care 
settings still requires a stronger integration between health services and social 
care, which in Italy are still split into two sectors: all social care services are the 
responsibility of municipalities while all health-related services are covered by 
the ASLs. Only a few regions (e.g. Veneto, Emilia Romagna, Tuscany, Marche) 
have really implemented effective governance tools to integrate these two areas 
in terms of merged management and financing. 
5.4 Specialized ambulatory care/inpatient care 
5.4.1 Specialized ambulatory care
Ambulatory activities consist of complex specialist services, such as visits, 
diagnosis, laboratory services, curative therapy and rehabilitation care for 
patients who do not require hospitalization (Ministero della Salute, 2012d). 
In particular, they include specialized care services within the SSN that are 
accessible only with a GP’s referral, except for dental care, obstetric and 
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gynaecological services and paediatric care, which are services that can be 
directly accessed. Direct access is also guaranteed for private (intra-moenia) 
specialist services.
Specialized ambulatory medical services, including diagnostic imaging and 
laboratory tests, are coordinated by the ASLs, which can either provide them 
directly through health district clinics and hospital (outpatient) ambulatories 
and diagnostic laboratories or purchase these services through accredited public 
and private suppliers. Specialized ambulatory care experiences long waiting 
lists – a common phenomenon in Italy that is often related to unsatisfactory 
quality of care. A few regions, such as the Veneto region, have experimented 
with a proactive waiting list management system, dedicated to patients 
expected to wait more than three months for ambulatory visits, resulting in 
a significant reduction in patients voluntarily ‘dropping out’ of the waiting 
list for publicly provided services (de Belvis et al., 2013). Overall, however, 
given the existence of such waiting lists, people often seek care within 
the private sector and significant inter-regional mobility of patients takes 
place, especially from southern to northern regions in order to access care 
faster. Currently, a new National Plan for the Governance of Waiting Lists 
(2014–2016) has been produced with key support from the National Agency for 
Regional Healthcare (Agenas), which plays an essential role in promoting and 
implementing a framework to monitor ambulatory care waiting lists at regional 
and national level.
5.4.2 Inpatient/secondary care
Inpatient hospital care is delivered through a network of hospitals, which can be 
either public or private institutions. These structures can provide both outpatient 
care and inpatient care and are formally categorized (by legislation) into:
• Aziende Ospedaliere (AOs) (Hospital Trusts): these are quasi-independent 
public agencies that are accountable to the regions and provide tertiary 
care with a high level of specialization;
• Aziende Ospedaliere Universitarie (Teaching Hospital Trusts) and 
Policlinici Universitari (Academic University Hospitals); 
• Istituti di ricovero e cura a carattere scientifico (IRCCS) (National 
Hospitals for Scientific Research);
• Presidi Ospedalieri (District General Hospitals), which are directly 
managed by ASLs;
• Single-specialty hospitals, such as for maternity services or orthopaedics;
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• Religious hospitals (so called Ospedali classificati);
• Residenza Sanitaria Assistenziale (residential facility with long-term 
care beds).
More generally, Italy’s hospital network has been organized according to the 
level of specialization and capacity to treat emergency cases. Thus, hospitals 
can be categorized according the following functional levels: 
• Basic hospitals: cover a catchment area of between 80 000 and 
150 000 inhabitants and have emergency services with a set of 
limited specialties, with a network of emergency care on call.
• Level I hospitals: have a catchment area of between 150 000 and 
300 000 inhabitants and host a first-level Accident and Emergency 
Department. These structures provide a large number of specialty 
medical services available on call. Radiology services with CAT and 
ultrasound, laboratory service and immune transfusion services have 
to be available 24 hours a day, either in situ or connected through 
web-based applications. 
• Level II hospitals: have a catchment area of between 600 000 and 
1.2 million inhabitants.25 They are equipped with facilities corresponding 
to Level II Accident and Emergency Departments and mainly comprise 
Hospitals Trusts, University Hospitals and IRCCS. They share the 
same characteristics as Level I hospitals but in addition are equipped 
with departments and facilities that are able to deal with more complex 
health conditions. 
Since the 1990s, the reorganization of the country’s hospital network has 
focused on promoting the clinical and organizational appropriateness of hospital 
care and has aimed, first and foremost, to reduce the number of beds and 
hospital admissions. The standardized number of beds per acute care facility 
(both public and private accredited) was originally defined by Law 405/2001 and 
revised by the 2010–2012 Healthcare Pact. The latter set the regional standard 
for the average number of beds at 4 beds per 1000 inhabitants, including 0.7 beds 
(per 1000) for rehabilitation and long-term care. These interventions basically 
aimed to promote the shift from ordinary admissions to day hospital and from 
day hospital to ambulatory care, as well as to favour home and domiciliary care 
for the elderly requiring long-term care. At national level the average number 
25 In regions with fewer than 600 000 inhabitants, access to Level II hospitals can be obtained via an interregional 
agreement with neighbouring regions.
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of all beds in acute wards fell from 3.5 beds per 1000 inhabitants in 2010 to 
3.3 beds per 1000 inhabitants in 2011, with a national average of 324 beds per 
institution in 2011 (a slight increase over the 2009 figure of 315). 
The overall distribution of acute beds by region in 2011 is described in 
Table 5.3. Further changes have been brought about by the Spending Review 
Decree issued in 2012 (Decree 95/2012) that set a target to reduce the number 
of hospital beds by 7389 units nationally. 
Table 5.3
Distribution of acute beds in public structures and private-accredited hospitals wards 
in 2011 and Spending Review impact on the number of acute-care beds
Regions Number of beds in 
acute care wards, 2011
Expected effect of Spending Review 
on the number of acute-care beds 
Public Private 
accreditated
Total 1 January 
2012
After Spending 
Review
Variation
Piedmont 12 733 1 392 14 125 13 706 14 155 449
Valle d'Aosta 445 0 445 450 363 -87
Lombardy 28 925 492 33 845 31 938 30 512 -1 426
PA Bolzano 1 722 62 1 784 1 795 1 436 -359
PA Trento 1 652 110 1 762 1 751 1 533 -218
Veneto 15 612 794 16 406 16 125 14 900 -1 225
Friuli Venezia Giulia 4 471 500 4 971 4 679 3 989 -690
Liguria 5 963 79 6 042 5 677 5 442 -235
Emilia Romagna 13 835 2 791 16 626 16 673 14 666 -2 007
Tuscany 11 265 1 364 12 629 12 301 12 195 -106
Umbria 2 597 239 2 836 2 827 2 921 94
Marche 4 938 502 5 440 5 293 4 867 -426
Lazio 16 759 2 546 19 305 18 734 17 090 -1 644
Abruzzo 3 759 604 4 363 4 234 4 026 -208
Molise 1 097 104 1 201 1 146 1 047 -99
Campania 12 854 4 816 17 670 16 963 15 253 -1 710
Puglia 1 134 1 815 13 155 12 326 11 436 -890
Basilicata 1 745 56 1 801 1 804 1 697 -107
Calabria 5 023 1 572 6 595 6 327 5 387 -940
Sicily 1 185 361 1 546 15 036 14 118 -918
Sardinia 521 1 065 6 275 6 137 4 846 -1 291
Italy 173 795 28 941 202 736 195 922 181 879 -14 043
Source : Authors’ elaboration on data from Ministero della Salute, Direzione Generale del Sistema Informativo e Statistico Sanitario, 2012. 
Note : Acute-care wards do not include the following disciplines: residual asylum, spinal unit, recovery and functional rehabilitation, 
long-term care, neurorehabilitation, palliative care/ hospice.
Law 135/2012 (which converted the Spending Review Decree into law) set 
a new target for an overall national average of 3.7 beds per 1000 inhabitants, 
of which 0.7 must be dedicated to rehabilitation and long-term care and 3.0 for 
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acute patients. As of 1 January 2012, there were 231 707 hospital beds, including 
day-care and non-acute beds (3.82 per 1000 inhabitants), of which 195 922 
were in acute care (3.23 per 1000 inhabitants) and 35 785 were dedicated to 
post-acute care (0.59).
At national level, the standardized hospitalization rate (considering only 
acute admissions and excluding day hospital and non-acute admissions) 
decreased from 120 discharges per 1000 residents in 2009 to 108 in 2011. 
Regions such as Calabria, Friuli Venezia Giulia, Apulia and Campania showed 
an even more pronounced reduction. In particular, the hospitalization rate in 
2011 was the lowest in Friuli Venezia Giulia (74 per 1000) while the rates 
for Veneto and Calabria were under 100 (92 and 94 per 1000 respectively) 
(Ministero della Salute, 2012e).26 By international comparison and using OECD 
data, Italy’s hospital discharge rate for the period 2009–2011 is lower than 
the EU-24 average, and in 2011 stood at the very end of the ranking, with 
13 544 discharges per 100 000 population (OECD, 2014b). 
5.4.3 Day care
Day care services are considered to be activities provided to acute patients 
during the day, without an overnight stay. They were introduced for the first 
time in 1985 (Law No. 595) with the term Day Hospital as an alternative to 
traditional hospitalization. In fact, Day Hospital refers to hospitalizations 
and access to hospital services during one part of the day, preferably during 
daytime hours, for the delivery of a variety of health care, multi-professional 
and specialist services, including diagnostic, therapeutic and rehabilitation 
activities (e.g. chemotherapy, radiotherapy, physiotherapy). 
Subsequent measures have further regulated the operating model and 
encouraged the development of other forms of hospital care specific to surgical 
activities, such as day surgery, one day surgery and week hospitals. Day 
surgery refers to surgical diagnostic procedures and/or invasive/semi-invasive 
procedures performed during daytime hours and delivered by public or private 
hospitals. It does not normally involve an overnight stay (e.g. cataract surgery, 
vein ligation and stripping) but exceptionally, according to regional guidelines, 
it can refer to day care that includes an overnight stay. All day care services 
consist of hospital admissions (one or a set of admissions) that are accessible 
through hospital clinicians and ambulatory specialists (both public and private) 
or through a GP’s referral. The most frequent day care procedures are medical 
26 These data reflect the hospitalization rates of residents, including admissions in hospitals in regions other than 
those of a person’s residence.
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(the average number of day hospital admissions at national level equals 3.79), 
while surgical services have a lower average admissions rate (1.60). Finally, 
the week hospital has been implemented in some acute structures as a new 
organizational model which, circumventing the logic of clinical departments, 
develops elective surgical intensive care in homogeneous areas within the 
working week (from Monday to Friday).
According to Ministry of Health data, the overall trend for day hospital 
admissions from 2001 to 2010 is decreasing, thus suggesting more appropriate 
delivery of services is provided in ambulatory/outpatient settings. In particular, 
in 2010, day hospital for acute care fell by 5% (that is, by 160 000 admissions 
compared to 2009), with a parallel reduction in ordinary admissions (-2.8%); on 
the other hand, day hospital for rehabilitation fell by -2.8% with a contrasting 
growth in ordinary admissions for rehabilitation (+1%) (Ministero della 
Salute, 2013c). 
5.5 Emergency care
The SSN has exclusive responsibility to provide the emergency care system 
and to guarantee uniform delivery of services throughout the country 
(Presidential Decree, 27 May 1992). In accordance with the Guidelines for 
the Health Emergency System (1996), which set organizational and functional 
requirements, the emergency care system is composed of: 
• an emergency number (118) system that citizens can call in case of health 
emergencies and accidents. The system operates throughout the country 
and is organized at the regional level. Coordination of interventions/
responses is carried out by the Central Operations Centre;
• a system of rescue vehicles: ambulances, mobile intensive care units and 
helicopters;
• first-aid care, known as the pronto soccorso, where the health emergency 
is solved or the patient is stabilized before being transferred to more 
specialized facilities; 
• Accident and Emergency Departments (AEDs), which are open 24 hours 
a day, 7 days a week, in hospitals to provide immediate care and treatment 
for patients presenting with life-threatening medical conditions, trauma 
or accidents. Depending on their complexity and type of operative units, 
these departments can be classified into two groups; Level I AEDs 
include first-aid care, a reanimation unit, brief length-of-stay, observation 
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unit, general medicine diagnostic–therapeutic interventions, general 
surgery, orthopaedics, stroke units and laboratory tests. Level II AEDs 
provide the same services as Level I AEDs as well as highly specialized 
functions such as cardiac and vascular surgery, treatment for acute 
coronary syndrome, trauma and paediatric, gynecological and obstetric 
emergencies, along with technologically advanced diagnostic services.
When arriving at the AED, the patient’s level of urgency will be evaluated 
and a Triage code will be given to establish the priority of access to treatment 
(the color codes are red, yellow, green and white in decreasing order of severity).
Emergency care is provided free of charge to everyone. In recent years there 
has been a progressive increase in AED admissions, many of which are due 
to inappropriate use by patients, i.e. for minor illnesses and primary care that 
do not require emergency treatment, and has contributed to driving up costs 
and increasing inefficiencies, such as longer waiting times. To cope with this 
issue, patients who are assigned white or green codes are required to make a 
co-payment of €25 (Law n. 296/2006) and, depending on regional regulations, 
a further €25 should specialized care be required. 
5.6 Pharmaceutical care
5.6.1 Pharmaceutical provision and reimbursement
The SSN is responsible for providing pharmaceutical care and accounts for 
the majority of total pharmaceutical spending. Drugs are dispensed through 
two channels: community and hospital pharmacies. Community pharmacies 
can be either publicly or privately owned and deliver prescriptions and OTC 
drugs to citizens living in the community. Hospital pharmacies are in charge of 
purchasing, stocking and delivering drugs to hospitalized patients. According 
to the Italian legislation, hospital pharmacies have a discount on the nominal 
price of pharmaceuticals of at least 50%. This discount and the desire to 
closely monitor the delivery and administration of certain categories of drugs 
(e.g. anti-retroviral drugs for HIV and AIDS patients) motivated legislation that 
makes it possible for hospital pharmacies to deliver certain categories of drugs 
to patients that then use them in the community. More recently, agreement 
between the SSN and pharmacies has made it possible that community 
pharmacies deliver drugs to patients ‘on behalf of the SSN’, which means that 
these drugs are purchased by the SSN (with the relative discount) but delivered 
by community pharmacies. 
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Class A medicines
As illustrated earlier (see sections 2.8.4 and 3.7.1), Class A includes essential 
medicines for the treatment of severe, chronic or acute illness. They are 
partially reimbursed by the SSN and involve a modest co-payment that varies 
across regions. These reimbursable medicines are listed in the National 
Pharmaceutical Formulary (Prontuario Farmaceutico Nazionale – PFN), 
which is administered nationally by the Italian Medicines Agency (Agenzia 
Italiana del Farmaco – AIFA) and updated every year, or every six months if 
community public pharmaceutical expenditure as a percentage of total public 
health-care expenditure exceeds a 13% ceiling. Three main criteria determine 
inclusion in this class: clinical efficacy that must be proven by an evidence-
based literature review, relevance of the disease and cost. AIFA’s Technical 
Scientific Committee is responsible for assessing new drugs for inclusion 
in the PFN. For each medicine the PFN provides detailed information on 
commercial name, active ingredients, dosage instructions, price, manufacturer, 
etc. Drugs in Class A are available only through a medical prescription. 
They can be prescribed by a GP or a paediatrician, an on-call doctor, A&E 
doctor, ambulatory specialist or hospital physician working within the SSN. 
Some medicines in this class have prescription limitations (known as ‘AIFA 
notes’) that make them eligible for reimbursement only for patients with 
specific conditions.
Class C medicines
Class C includes non-reimbursable pharmaceutical products acquired either 
with or without prescription. The latter group include ‘without prescription’ 
medicines (‘farmaci senza prescrizione’ – SP) and OTC drugs (known in Italy 
as Class C-bis drugs). SP medicines do not require a prescription and cannot 
be advertised, while OTC drugs also do not require a prescription but can be 
advertised. This group of pharmaceuticals is not reimbursed by the SSN but 
at national level, where the physician recognizes the therapeutic benefit for 
the patient (Law n. 203/2000); those receiving war pensions are exempt from 
payment. In addition, regions are free to decide whether to fund with their 
own resources the partial reimbursement of Class C drugs, thus resulting in 
variations in access at regional level.
Class H medicines
Class H includes pharmaceutical products delivered only within hospitals under 
specialist supervision and they cannot be purchased in pharmacies. The PFN 
lists these medicines as it may also determine that only certain categories of 
centre can administered these drugs.
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Every month AIFA publishes a ‘transparency list’ of off-patent drugs that 
are available on the Italian market, listing both the original medicine and its 
equivalent substitute (generic), with equal composition in active ingredients, 
same pharmaceutical form, method of administration, number of units and 
dosage unit. According to the reference price system introduced in 2001, the 
SSN reimburses the lowest price among the off-patent pharmaceuticals. For 
prescription drugs the pharmacist is required to deliver the product with 
the lowest price and can substitute the original branded medicine unless 
the physician specifies ‘no substitution’ and if the patient agrees. In cases 
where the doctor or the patient wants a product with a higher price, the 
patient pays the difference between the price of the selected product and the 
reference price. 
Off-label use
Where no alternative therapy is available, patients may have access to treatments 
(under Law No. 648/1996) in the following cases:
• innovative medicines already authorized in other countries, but not yet 
in Italy;
• drugs under clinical investigation, but with recognized benefits;
• off-label use. 
For inclusion in these special cases an application must be submitted to 
AIFA’s Technical Scientific Committee, supported by a scientific dossier. 
Medicines approved under Law No. 648/1996 are reimbursable and funded by 
the ‘AIFA Fund’, which has been in operation since 2005.
5.6.2 Price setting
Price setting applies only to medicines that are reimbursed by the SSN 
and is administered at the central level by AIFA through its Pricing and 
Reimbursement Committee. In 2004, the regulatory scheme for determining 
pricing and reimbursement at drug launch changed and the Average 
European Price (AEP) was replaced by a negotiation model, applicable to all 
products (Fattore & Jommi, 2008).27 This measure was introduced to contain 
pharmaceutical expenditure, promote competitiveness among companies and 
secure lower prices for consumers. Price setting of reimbursed pharmaceuticals 
involves negotiations between AIFA and manufacturers and is strictly linked 
27 Previously, only the prices of medicines authorized under an EU procedure were set by negotiation.
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to a product’s reimbursement classification, following assessment by AIFA’s 
Technical Scientific Committee on whether it should be included in the PFN 
(see section 5.6.1). 
The following criteria are taken into account to fix the reimbursement 
price28:
• positive cost–effectiveness ratio of the medical product, where no 
alternative therapy exists;
• favourable risk-benefit ratio compared to drugs available with the same 
therapeutic indications;
• evaluation of the financial impact on the SSN;
• costs of the therapy per day, in comparison to products of comparable 
efficacy;
• expected sale volumes;
• prices and consumption in other European countries.
The Technical Scientific Committee is responsible for assessing the 
negotiation outcome between AIFA’s Pricing and Reimbursement Committee 
and pharmaceutical companies, while AIFA’s Management Board is charged 
with giving final approval. Prices are determined at ex-factory level and are 
usually fixed for 24 months. If no agreement on the price can be reached, the 
original reimbursement decision made by the Technical Scientific Committee 
to include the product in the PFN is amended and the medicine is reclassified 
as non-reimbursable (Class C) and, thus, excluded from the positive list.
For non-reimbursable medicines (Class C), prices are freely determined 
(with some limitations) by manufacturers and monitored by AIFA. Reductions 
in price are allowed at any time, while increases are permitted in January of 
odd years.
5.6.3 Pharmaceutical expenditure per capita and defined daily 
dose consumption
Pharmaceutical expenditure is a significant component of public health 
expenditure and there is concern about its sustainability in future years. Two 
driving factors are of particular concern: 
28 The Inter-ministerial Committee on Economic Planning (CIPE) Resolution No. 3, 1 February 2001 regulates 
the negotiation procedure and sets the criteria.
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• the significant growth of the elderly population and the subsequent 
prevalence of comorbidities, resulting in an expansion of drug consumption;
• the introduction of innovative medicines, which are usually more expensive. 
To contain pharmaceutical expenditure regulatory measures were 
introduced in 2002, setting a spending ceiling of 13% of overall health-care 
expenditure (Law No. 326/2003), both at national and regional level. This 
limit was subsequently modified in 2009 and set at 13.3% (Legislative Decree 
No. 78/2009). The expenditure cap does not include hospital pharmaceutical 
expenditure. Furthermore, the Spending Review in 2012 reduced the budget 
for drugs used in non-hospital settings (Law No. 135/2012) from 13.3% of total 
health-care expenditure to 13.1% in 2012 and 11.4% in 2013. Meanwhile, in 2013, 
hospital pharmaceutical expenditure was allowed to increase from 2.4% of the 
total budget to 3.5%. From 2013 the regions (50%) and industry (50%) will cover 
any excess expenditure (over the ceiling) for drugs used in hospital settings.
In 2011 total expenditure on pharmaceuticals reached €26.3 billion, with 
a share of 75% reimbursed by the SSN and distributed mainly by public and 
private pharmacies (AIFA, 2011). Pharmaceutical expenditure per capita 
(including SSN-reimbursed drugs dispensed by public and private pharmacies 
and co-payments) increased overall by 2.5% in the period 2001–2010. A 
difference between northern and southern regions is evident, with all southern 
regions presenting higher levels than the national average of €215 per capita. 
Average national consumption by defined daily dose (DDD) of products 
reimbursed by the SSN is 952 (per 1000), having increased by 2.8% in the 
period 2009–2010 and by 41.3% compared to 2001 (Montilla et al., 2011). Data 
analysis by age group reveals that drug use by people aged 75 and over is 
17 times higher than the group aged 25–34 (Osservasalute, 2012), highlighting 
that age is the most predictive factor of drug consumption. Furthermore, 
drugs acting on the cardiovascular system are the most frequently prescribed 
(47.4% of total consumption). The consumption of generics (by DDD) has more 
than tripled in the period 2002–2010, increasing from 14.0% to 51.5% (of the 
total consumption of SSN). In parallel, during the same period, expenditure 
on generics increased from 7.0% to 30.4% of total pharmaceutical expenditure. 
Finally, analysis of antibiotic consumption shows that Italy is among the 
European countries with the highest use – 27.3 (DDD/1000) in 2010 (Cangini 
et al., 2011). The wide variability between northern and southern regions is also 
worth noting, with higher rates in the south.
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5.6.4 Pharmacies 
Both individual pharmacists and the government can be owners of a pharmacy. 
New requirements were set in 2012, foreseeing one pharmacy per 3300 citizens, 
a ratio far lower than the previous target (one pharmacy per 4000 citizens in 
areas with more than 12 500 inhabitants and per 5000 citizens in areas with 
fewer than 12 500 inhabitants). In 2012, at the national level, a single pharmacy 
served an average of 3364 inhabitants (Table 5.4), which is in line with the 
European average (Pharmaceutical Group of the European Union, 2012). The 
number of inhabitants per pharmacy is relatively low in mountainous regions or 
large rural communities. These regions have deviated from the national targets 
by opening pharmacies in small municipalities to try to adequately provide 
pharmaceutical care. The Autonomous Province of Bolzano is an exception, 
having the highest inhabitants per pharmacy ratio.
Table 5.4
Distribution of public and private pharmacies, 2012
Region Number of pharmacies Inhabitants 
per pharmacy Total  Private  Public
Piedmont 1 538 1 438 100 2 898
Valle d'Aosta 49 43 6 2 617
Lombardy 2 837 2 382 455 3 496
Bolzano-Bozen 124 118 6 4 095
Trento 165 141 24 3 209
Veneto 1 331 1 221 110 3 710
Friuli Venezia Giulia 385 361 24 3 210
Liguria 597 573 24 2 708
Emilia-Romagna 1 245 1 036 209 3 560
Tuscany 1 122 889 233 3 342
Umbria 271 219 52 3 345
Marche 505 424 81 3 100
Lazio 1 491 1 331 160 3 842
Abruzzo 503 465 38 2 669
Molise 170 164 6 1 881
Campania 1 617 1 559 58 3 608
Puglia 1 108 1 080 28 3 692
Basilicata 206 202 4 2 852
Calabria 759 758 1 2 650
Sicily 1 424 1 411 13 3 547
Sardinia 574 565 9 2 919
Italy 18 021 16 380 1 641 3 364 
Source : Federfarma, 2012. 
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5.7 Rehabilitation/intermediate care 
Intermediate care and rehabilitation refer mainly to services used by frail or 
chronically ill people in a home care setting who have a high risk of avoidable 
hospital admission and to services for post-acute patients for rehabilitative 
interventions and health-care support not requiring an acute hospital setting. 
These types of care involve a range of services designed to link primary care, 
acute care and social care in an integrated patient pathway. ASLs are responsible 
for coordinating and delivering rehabilitation and intermediate care, dealing 
with high-complexity medical and non-medical components and coordinating 
a set of multidisciplinary activities aimed at switching the care setting from 
hospital to home care, reducing the length of hospital stay, as well as preventing 
hospitalizations and inappropriate readmissions. 
Physiatrists or rehabilitation medicine specialists, together with other 
health-care professionals, support disabled people through the definition and 
implementation of an Individual Rehabilitation Programme. The Individual 
Rehabilitation Programme is provided on the basis of a comprehensive 
multidisciplinary assessment of each individual’s health and social care profile 
in order to outline the required treatments and the most appropriate treatment 
setting(s) for an active recovery. If ASLs are not able to directly deliver the set 
of services required by the rehabilitation programme, they must contract with 
public or private hospitals to provide them. 
The 1998 Guidelines for Rehabilitation Care issued by the Ministry of Health 
(Ministero della Salute, 1998) attempted to clarify the difference between 
what is known in Italy as ‘intensive care’ and ‘extensive care’ (also called 
‘intermediate care’). The former refers to services provided in the post-acute 
phase of a disease that are usually delivered in hospitals while the latter refers to 
all other non-intensive interventions, generally provided in long-term hospitals, 
outpatient settings, nursing homes and residential and semi-residential homes 
(see section 5.8). In practice, public hospital, equivalent hospital and extra-
hospital facilities for intensive rehabilitative care have been developed 
differently by the regions, with marked variations in how such services are 
organized. Moreover, there has been a tendency for ‘extensive’ rehabilitation 
initiatives to be confused with long-term care or social care interventions. 
In 2010, the Ministry of Health issued a Strategic Plan for Rehabilitation 
(Ministero della Salute, 2010c) that reaffirmed rehabilitation as an integrative 
component of prevention and therapy within an effective integrated patient 
pathway. The persisting problems at regional level associated with differing 
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classifications of rehabilitative structures, pathways and interventions were 
highlighted and the Strategic Plan proposed the establishment of Rehabilitation 
Departments within ASLs to uniformly co-ordinate the provision of care and 
guarantee better integration with providers. To date, implementation differs 
from region to region and from ASL to ASL.
5.8 Long-term care
Long-term care should be analysed taking into account demographic trends, 
which show constant increases in both the average age of the population and 
its mean life expectancy. The 12.5 million Italians who were over 65 in 2012 
are mostly affected by conditions such as osteoarthritis and arthritis, arterial 
hypertension and osteoporosis (women only). The over-80s are estimated to 
account for 9% of the total population by 2030 (ISTAT, 2009). In the context 
of Italy’s rapidly ageing population long-term care represents one of the main 
areas where effective integration between health and social care is needed more 
than ever. However, long-term care is still characterized by multiple providers 
and delivery methods. Historically, local municipalities have been in charge of 
providing social care services and ASLs have been considered responsible both 
for health-care services and some social care. Thus, the provision of long-term 
care is something of a ‘jungle’ where many different actors play according 
to different rules within different care models. In between, GPs act as the 
essential guide for patients, helping them to navigate the different options 
available when dealing with chronic diseases. While legislation has aimed to 
improve integrated care (see section 5.3), effective integrated long-term care is 
still a long way off.
Residential or semi-residential facilities (Residenze Sanitarie Assistenziali – 
RSA) and community nursing homes (case protette) represent the usual 
institutional setting for caring for elderly and disabled people, including those 
with mental health conditions (see section 5.11). RSAs generally care for 
patients who require more intensive use of health-care resources, whereas less 
critical patients are directed towards community nursing homes. In 2011 there 
were 333 091 elderly and disabled patients living within residential facilities, 
with the elderly making up 84% of the total (Osservasalute, 2012). Despite 
the strong financial restrictions of the Spending Review (2012), at national 
level the number of post-acute care beds (in hospitals and including those in 
residential and semi-residential facilities) increased marginally (37 252 beds 
in 2011 compared to 37 153 in 2009) (Ministero della Salute, 2011a). In 2011, 
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the discharge rate for long-term beds remained stable in comparison to the 
previous year, with 1.6 admissions per 1000 inhabitants. The bed rate for elderly 
and disabled patients was 567.8 per 100 000 inhabitants in 2010, with strong 
variations between northern and southern regions: rates are higher than 776.8 
(per 100 000) in the north, while in the south the lowest rate is recorded in 
Campania (180.3 per 100 000) and the highest in Molise (601.0 per 100 000) 
(Osservasalute 2012).
An example of integrated service delivery is represented by the home care 
model (Assistenza Domiciliare Integrata – ADI), which is part of the benefit 
package. The ADI care model is based on the formulation of a Personal Care 
Plan (Piano Assistenziale Individualizzato – PAI), according to an individual’s 
care needs. Once discharged from hospital or in line with a GP’s request, a 
multidisciplinary unit (Unità di Valutazione Multidimensionale – UVM) of 
different health-care professionals (GPs, medical, nursing and rehabilitative 
staff) is activated to assess the patient’s needs. Home care, in terms of timetables, 
services, service providers and responsibilities within the team, is defined 
within the plan and a case manager, who is in charge of tracking the patient’s 
overall health status and treatment, is nominated. Nationally, 597 151 people 
received home care services in 2010; 990 cases per 100 000 were patients 
receiving services under ADI, representing an increase of 11.7% compared to 
2009. There is considerable regional variability in the implementation of ADI 
(Osservasalute, 2012).
Financial support and vouchers for both home care and residential 
facilities (including disabilities support) vary considerably across regions and 
municipalities, where these funds count for 61% of their social expenditures. 
Municipalities spend, on average, €5198 per person to support long-term 
care: typical examples include €2136 per person for home care services and 
€1665 per person for benefits vouchers. In particular, social expenditure for 
residential care can vary hugely from €954 per person in Molise to €21 753 per 
person in Valle d’Aosta; home care financial support ranges from €1000 per 
person in Calabria to €4001 per person in the Autonomous Province of Trento 
(Osservasalute, 2012). 
5.9 Informal and formal carers
Informal care, defined as the provision of unpaid care-giving activities, is not an 
area of focus in terms of specific national policies, although there is increasing 
attention about its fundamental role and implications. The traditional social 
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and culture features of the Italian population makes the role of informal carers, 
mainly women, extremely relevant in the care of fragile elder patients. As a 
matter of fact, a large part of the population, mainly family members, provide 
informal health care without receiving any kind of subsidy from the government 
and professional support (e.g. training). Many patients’ organizations try to 
cope with this deficiency by collecting funding and delivering services to 
patients and informal care-givers.
More recently, the phenomenon of ‘Badanti’ (paid carers) has grown across 
the country, where care for the elderly or the disabled is mainly provided by 
immigrants or women on very low incomes. Quite often such carers do not 
have any formal training to provide appropriate care and they may also incur 
occupational-related problems such as working long hours, and incurring back 
injuries and mental strain. The state provides some cash benefits for disabled 
people, including the elderly, to support care at home, but too often these 
services are paid partially or fully out of pocket by families. Benefits in kind 
and cash benefits are also provided by local municipalities. 
5.10 Palliative care
The development of a palliative care policy in Italy is relatively recent. The 
National Health Plan 1998–2000, for the first time, devoted attention to the 
implementation of a national palliative care programme and Law 39/1999 was 
approved to implement its objectives by earmarking funds to the regions to 
establish residential facilities. More recently, Law 38/2010 introduced broader 
access to palliative care and pain management, which is also based on local 
services managed by ASLs. The most common model is the palliative care unit, 
which operates within the hospital structure to provide care for all types of 
patients (including paediatric patients) suffering from chronic and degenerative 
diseases. The palliative care network involves outpatient care, home care 
services, day hospital, hospitalization in dedicated beds and, mainly, residential 
facilities for terminal patients, mostly suffering from cancer, called hospices. 
In particular, hospice facilities have been developed to provide long-term 
admissions and medical care for dying patients in the last months of their 
disease. However, there is still significant inequality between regions regarding 
the distribution of hospices and the funds allocated for palliative care generally.
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5.11 Mental health care
In 1978, the ground-breaking psychiatric reform law (the ‘Basaglia Law’ 
No. 180/78), marked the switch from institutional care to community mental 
health services, changing the main features of the Italian mental health system. 
The principal element of the reform was the definition of a new approach to 
mental health, adding momentum to prevention and promotion and reducing 
public intervention in terms of control and segregation of people with mental 
health disorders. In addition, the Italian system made a clear distinction between 
mental health care for adults and children, with the former falling under the 
responsibility of general psychiatrists and the latter to other specialists trained 
as infant neuropsychiatrists.
The legislation established a shift away from hospitalization towards 
outpatient care and can be summarized by the following features:
• New admissions to mental health hospitals were prohibited and thus 
discontinued.
• All mental health hospitals were closed down. 
• General hospitals were generally required to have psychiatric wards so 
that acute and post-acute care were delivered in general hospital settings.
• Community-based care for mental disorders was promoted.
• Compulsory ‘health treatment’ was regulated. In order to reduce 
inappropriate admissions to mental health facilities, treatment in hospital 
wards was made compulsory only in the event of mental disturbances 
requiring urgent interventions not accepted by the patient, to safeguard 
patient and community safety and if there is no alternative care option.
Notwithstanding the relevance of this new orientation in the provision 
of mental health services, the lack of strict guidelines and the transfer of 
responsibility to the regions to set up hospital-substitute services resulted in 
different levels of implementation across the country. 
The reform was phased in over a period of time but at the same time the 
process of deinstitutionalization often led to a lack of effective care for people 
with mental health disorders and increased the burden of responsibilities 
on families. 
To overcome these shortcomings, in the mid-1990s, the Ministry of Health 
launched a strategy for the protection of mental health (Tutela Salute Mentale 
1994–1996), establishing a network of services to ensure a continuum of care at 
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the primary care level. Departments of Mental Health (DMHs) were established 
within ASLs to guarantee the promotion and coordination of mental health 
prevention, treatment and rehabilitation, and to deliver outpatient and inpatient 
care. They comprise a complex of integrated facilities and services spread 
throughout the country with a defined catchment area, usually corresponding 
to an ASL, and include different health professionals such as psychiatrists, 
psychologists, nurses, social workers and educators. Patients can have direct 
access or with a GP referral. A few years later, an updated mental health 
strategy (Tutela della salute mentale, 1998–2000) highlighted some critical 
aspects of the system such as the low specialization of the DMHs, which were 
limited to adult psychiatry, the lack of services targeted to child psychiatry 
and to alcohol and drug abuse, and the need for better coordination between 
different health professionals. The updated strategy tried to address these issues, 
devoting more attention to children’s and adolescents’ mental health, promoting 
active participation of patients in the community with parental involvement, 
and fostering the integration of care pathways within multidisciplinary teams.
DMHs provide four type of services (see Fattore et al., 2000 for an example): 
1. Community Mental Health Centres (CMHCs). These units cover all 
activities related to adult psychiatry for outpatient care, coordinating 
interventions across different facilities and settings.
2. Semi-residential facilities for mental health day care services 
(day hospital and day centre).
3. Residential facilities responsible for therapeutic–rehabilitation and 
socio–rehabilitation of mental health patients.
4. Psychiatric units within hospitals, with up to 15 beds, for acute 
admissions. They provide short/medium-term care for urgent 
interventions and are closely linked with the CMHCs to ensure 
continuity of care. 
In 2010 there were 144 DMHs, corresponding to the number of ASLs in 
each region (except for Bolzano and Sicily), and 1464 CMHCs (Ministero della 
Salute, 2013d). In addition, mental health care was provided by 2297 residential 
facilities and 1279 semi-residential facilities nationally, with a higher prevalence 
of private accredited providers. In Italy only a small percentage of people receive 
specialist care and a low percentage of the adult population contacts DMHs. 
According to the National Health Plan for 2011–2013 the priorities for the 
mental health system are:
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– to close the gap between northern and southern regions with regard to 
the provision and quality of services, which remains a major challenge;
– to develop and reinforce services targeted towards children and 
adolescents throughout the country; 
– to ensure an adequate flow of information on mental health and to provide 
high quality data. 
5.12 Dental care
There is very little public provision of dental care, with limited SSN resources 
allocated to reimbursable services. A minimum set of services is included in 
the benefit package. These are preventive and diagnostic services, treatments 
for caries and associated complications, periodontal diseases, dental occlusion 
and dental bone-related complications and emergencies. In order to access 
these services, co-payments are necessary, with exceptions granted to children 
aged 0–14 and vulnerable groups (patients on low incomes or those suffering 
from chronic diseases). Most dental treatments are purchased privately, OOP, 
by patients. Oral health care is provided mainly by private dentists and 
dental hygienists, organized in self-owned and small-size practices or bigger 
organizations involving different specialists, laboratories and technicians. 
5.13 Complementary and alternative medicine
Complementary and alternative medicine (CAM) treatments are not covered 
by the SSN, and thus are usually purchased OOP. In its Guidelines for 
Non-conventional Medicines, the Italian National Federation of Colleges 
of Medical Doctors and Dentists recognized the following CAM therapies: 
homeopathy, phytotherapy, acupuncture, homotoxicology, traditional Chinese 
medicine, anthroposophic medicine, chiropraxis, osteopathy and ayurvedic 
medicine (FNOMCeO, 2009). The regulatory system states that CAM must 
be practised only by physicians who have a degree in medicine or surgery, 
have passed the state examination for practice and must be registered on a 
professional register. There is no recognized medical specialty devoted to 
complementary/alternative medicine. In the treatment of cancer patients the 
most popular remedies are homeopathy, herbal medicine and spiritual therapies. 
While these therapies are not covered by the SSN it is notable that Tuscany 
provides some under additional regional coverage.
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5.14 Health care for specific populations
For over 30 years, Italy experienced large and constantly increasing 
international immigration. According to the most recent estimate, around 
200 000 immigrants were recorded in 1980, 500 000 in 1990, 1.6 million in 
2000, and currently around 4.5 million individuals (Osservasalute, 2012). These 
data refer to documented migrants. Immigrants represent approximately 7.5% 
of the national population (compared to a European average of 6.6%), mainly 
concentrated in the north (61.3%) and they count for 10% of the workforce 
(men mainly engaged in the construction and building sector and women in 
services to people). Most immigrants (27.4%) come from other EU Member 
States and their generic profile includes young and mostly female individuals 
(50% of the total). Minors whose parents are immigrants total about 1 million 
people, 70% of whom were born in Italy (Osservasalute 2012). 
Considering the important economic and demographic impact of immigrants 
(contributing to 12% of GDP growth and doubling the country’s fertility rate), 
integration policies for foreign residents are still inefficient and sub-optimal 
(Associazione di Iniziativa Parlamentare Legislativa per la Salute e Prevenzione, 
2013). Nevertheless, after several years without specific regulations, legislation 
has now been defined to guarantee that immigrants (both documented and 
undocumented) are eligible to receive the same public health-care services that 
are available to Italian citizens (see Chapter 6). This framework (which has 
been ongoing since the late 1990s) has produced, over time, increased access 
to health services (with improvements in terms of maternal and child services 
indicators as well as for certain infectious disease incidence rates). Unfortunately, 
problems remain related to welcoming immigrants and supporting their social 
integration. Moreover, the heterogeneity of health policies adopted by individual 
regions creates inequalities in terms of the availability of services. At the level 
of services, in fact, there is currently little flexibility in reorganizing health-
care structures to make them culturally sensitive and socially responsive to 
emerging priorities, particularly in the areas of preventive and public health.
Prison inmates are considered to have the same health rights as Italian 
citizens and so are registered in the SSN with access to the whole benefit package 
(Legislative Decree No. 230/1999). If such prisoners are also immigrants they 
are registered in the SSN as long as they are in jail. All services provided in 
prison have recently been assigned to the SSN and its organizations (mainly 
ASL and AOs) that are in charge of coordinating, supervising and providing 
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core services. Military personnel have additional services to those generally 
available to citizens and these are directly provided by military facilities 
financed and managed by the Ministry of Defence.
6. Principal health reforms
The National Health Service was established with a radical reform in 1978 and modified in the 1990s and early 2000s. The first reform clearly designed an NHS-type system, fully implemented in the 1980s, that 
guaranteed universal access to health care. With a 1992 reform, backed by the 
2001 constitutional reform that redistributed powers to the regions, the National 
Health Service was regionalized. Now most health policies are developed and 
implemented by regions, with an increasing heterogeneity of institutional 
arrangements, provider payment rules and levels of performance in terms of 
the quantity and quality of care offered to citizens. 
The 1992 reform also envisaged a quasi-market based on patients’ choice 
and competition between public and private providers but this was mitigated 
over time with measures that give strong control to regional authorities over 
the allocation of resources between providers. Another priority was the 
‘managerialization’ of health service organizations; here again, in the last 
decade regional authorities have centralized administrations, reduced the 
discretion of management and not fully supported management development 
in public organizations.
Overall, the last decade has been dominated by two intertwined issues: 
regional fragmentation and the need to maintain financial control within 
regional health systems. Italy’s fiscal crisis has put the health system under 
strain; the central government has acted to control total health expenditures but 
performance in terms of health protection is increasingly governed at regional 
level, with large variations, mainly but not exclusively, between the northern 
and southern parts of the country.
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6.1 Analysis of recent reforms
6.1.1 Establishment and ‘second’ reform of the SSN (1978 and 
1992/93)
The SSN was established in 1978 by replacing a system based on multiple 
social health insurance funds. This was the first major health-care reform in the 
post-Second World War period. The SSN was fully implemented in the 1980s 
through substantial unification and harmonization of regulations, information 
systems and procedures that derived from several independent organizations 
(sickness funds and providers). However, despite full implementation, the 
1980s clearly signalled some major weaknesses of the health system, namely 
the lack of financial control by the central government over expenditure, the 
over-politicization of SSN organizations, the frequent conflicts between the 
three political tiers of government and the lack of specific management systems 
and expertise to run health-care organizations (Ferrera 1995; Mapelli 1999; 
Fattore 1999; Borgonovi, 2001; France, Taroni & Donatini, 2005).
While reform of the SSN’s founding legislation had been on the policy 
agenda since the mid-1980s, it was not until a critical juncture in 1992 that an 
opportunity to design and approve major changes (Law N. 421/92; Decree Law 
N. 502/92; Decree Law N. 517/93) presented itself. In 1992 the country’s main 
governing parties collapsed under the pressure of several corruption scandals, 
including a major one concerning the regulation of pharmaceuticals (Fattore 
& Jommi, 1998). In addition, a severe economic crisis and the high level of 
public debt threatened Italy’s ability to meet the Maastricht criteria on proposed 
European monetary union. Within this context a new government successfully 
managed to steer through the crisis, significantly reduced public expenditure 
in most public sectors, including health care, and regained the confidence of 
financial markets and European institutions. In this window of opportunity a 
reform of the SSN (also called the second reform) was rapidly approved. The 
reform included four main components: (1) regionalization; (2) managerialism; 
(3) quasi-market for specialist care; and (4) opting-out of the NHS (this last 
component was repealed in 1993) (Fattore, 1999). 
(1) Regionalization
Institutional arrangements in health care were reconfigured by virtually 
eliminating the role of municipalities and reducing the powers of the national 
tier of the SSN in favour of the 19 regions and 2 autonomous provinces. While 
the 1992 legislation introduced the idea of ‘basic benefit packages’ (Livelli 
Essenziali di Assistenza – LEA), which are defined by the central government, 
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regions were given new competences to strengthen their fiscal autonomy 
(and responsibility) and the scope of their policies; they were also given new 
organizational powers. The model envisaged by the reform was that the national 
level would define the guaranteed basic benefit package and ensure that regions 
received adequate resources to deliver it. Conversely, regions were mandated 
to provide the nationally guaranteed services, and would have to use their own 
resources if they were unable to do so due to inefficiencies or if they wanted to 
provide additional services beyond those specified in the national basic package. 
In addition, within a rather broad national framework regions were allowed 
to redesign health service supply systems and the boundaries of ASLs, detach 
larger and more specialized hospitals from ASLs, design new systems to pay 
providers, define accreditation systems for both public and private providers, 
and give providers guidelines on their organizational arrangements. Although 
regions already had several powers since the foundation of the SSN, with 
the 1992 reform they become the main owners of the health system. These 
arrangements were confirmed and enhanced, by constitutional changes 
approved in 2001 (Constitutional Law N. 3/2001) (see below).
(2) Managerialism
The second main area of change prompted by the reform concerned the role of 
management in the SSN. Appointed politicians were substituted by professional 
managers as heads of SSN organizations, namely the ASLs and AOs. The 
legislation made it compulsory to appoint general managers with a university 
degree and with management experience (even outside the health-care sector); 
they also had to be selected from a list of potential candidates identified by 
each region. General managers of ASLs are now employed according to fixed-
term private contracts and can be dismissed by the region. General managers 
are responsible for appointing the Health and Administrative directors within 
ASLs (and in most regions, also the Directors for Social Care).
National rules on labour contracts were modified to grant more flexibility 
to local organizational arrangements and to allow more room for performance-
based payments. Factors such as new legislation and directives, increased 
sensitivity of the need to develop adequate systems to run health-care 
organizations and a more competitive environment prompted the introduction 
of new management functions, such as cost accounting, budgeting, strategic 
planning, need assessments and quality control. In addition, the traditional 
financial accounting system, aimed at planning expenditure and measuring 
financial performance, was backed up by an accrual accounting system that 
allows for the measurement of organizations’ economic viability and tracking 
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of their assets and liabilities. However, even in this respect, up to 2011 regions 
were given the freedom to design their own systems, and consequently there 
were important differences across regions’ accrual accounting systems. Since 
2012 uniform accounting standards apply to all public health-care organizations 
throughout the country. Overall, the 1990s was a period of investment in 
managerial systems and competences in the SSN.
(3) Quasi-market for specialist care
The reform designed a quasi-market for specialist care based on three main 
principles (Fattore 1999; Anessi Pessina & Cantù, 2006; France, Taroni & 
Donatini, 2005). Firstly, patients were given complete freedom to choose any 
SSN provider (even outside their region) without the need for prior authorization. 
Secondly, private organizations were included in this competitive arena provided 
that they were accredited by the region in which they operated. Therefore, the 
Italian SSN, at least in theory, established a fair playing field between public 
and private providers. Finally, a fee-for-service payment system (for outpatient 
care) and a DRG system (for inpatient hospital care) were introduced. By 1995 
all regions were required to have an adequate information system to collect data 
for the attribution of each inpatient episode to Italian DRGs. In a relatively short 
period of time the SSN translated and adapted the US Medicare DRG system 
to the Italian context and produced weights and tariffs for each group on the 
basis of a small purposive sample of hospitals (Taroni, 1996; Fattore & Torbica, 
2006). For outpatient specialist care the Nomenclatore Tariffario, basically a 
long list of possible services with their relative tariffs, was issued. 
On paper, the quasi-market system designed by the reform was rather radical 
as it is based on the free choice of providers (including private ones) by patients 
and strong incentives to increase volumes, fill hospital capacity and reduce 
length of stay. As such, the Italian reform was different to that introduced within 
the British NHS under Margaret Thatcher, which was based on contractual 
arrangements between purchasers and providers and did not include official 
tariff systems. However, it should be noted that implementation of this national 
model varied across the regions. At one extreme was Lombardy (the largest and 
most prosperous region), which neatly separated hospital care from ASLs and 
which favoured the role of the private sector, while at the other, some southern 
regions greatly limited the extent of competitive forces and the use of tariff 
systems to fund providers (Cantù & Carbone, 2007). However, since the end of 
the 1990s virtually all regions have reduced the extent of quasi-markets through 
the introduction of a variety of measures that limit market forces, such as the 
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use of targets and ceilings, to directly govern the volume and revenues of both 
public and private providers (Jommi, Cantù & Anessi-Pessina, 2001; Cantù, 
Ferré & Sicilia, 2010). 
(4) Opting out 
A fourth element of the reform, repealed in 1993, was a vague move towards 
granting regions the possibility to allow patients to opt-out of the SSN. The idea 
behind this provision was that citizens would have continued to pay their share 
of taxes for the SSN but they would have been given a voucher to be spent in the 
private insurance market. Had it survived, this measure would have overhauled 
the very heart of the Italian SSN (Ferrera, 1995).
6.1.2 The ‘third’ SSN reform (1999)
A further reform, often labelled the third health-care reform, was approved 
by a centre-left government in 1999 ((Bindi) Reform Law No. 229/1999). It 
included a number of measures and, at a more political level, the attempt to 
reverse the cultural direction of the 1992 reform, especially concerning its 
pro-market orientation. The new legislation began by re-stating that health was 
a citizen’s right and a collective responsibility. It also emphasized that the SSN 
was a universal system under government control. The government’s intent 
in restating these principles was to limit attempts by some regions to deviate 
from the national model (for example, as in Lombardy) and to better control the 
private sector. This attempt was criticized from many quarters (Taroni, 2011) 
and, de facto, had a limited impact on the SSN, which in the following years, 
increased rather than decreased its level of decentralization. 
The most controversial component of the reform was its attempt to better 
regulate the medical profession. It introduced a regime where salaried SSN 
doctors had to choose between two options for private practice (additional 
professional activities outside SSN funding). Intra-moenia doctors were 
authorized to have private practices but only using SSN facilities (hospitals or 
ASL ambulatory clinics) and under the control of their independent hospitals 
or ASLs. As an incentive to choose this option, the new rules stipulated that 
only these doctors could access senior management positions (e.g. being a 
department’s director). The second option was for doctors to operate extra-
moenia – meaning to practise independently – outside of SSN facilities; such 
doctors were prevented from having senior management positions and were 
paid lower salaries. These rules changed several times and are still highly 
debated. Currently, the two options for private practice still exist but the more 
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favourable career advancement conditions attached to intra-moenia practice are 
no longer in place (see section 3.7.2). The 1999 reform also put the provision of 
health care in prisons under the control of the SSN and its structures.
6.1.3 The legacy the 1990s’ reforms
The two reforms approved in the 1990s are still debated as opinions differ about 
their meaning and impacts. Taroni (2011) states that quasi-markets were short 
lived. Indeed, regional policies have limited the extent of competition between 
providers through caps and targets for each provider and funding arrangements 
where DRG and fee-for-service reimbursement are coupled with other lines of 
funding, typically block grants for specific functions and activities. Interestingly, 
competition is stronger for patients seeking health services outside their region 
of residence, with significant flows of resources between regions, especially 
from the south to the north and the centre (Fattore, Petrarca & Torbica, 2014). 
Even the managerialism reforms that initially received wide support were 
weakened over time due to increased centralization of decision-making at 
regional level, which reduced the degrees of autonomy of SSN organizations, 
and limited use of management systems to improve their performance. 
Nevertheless, compared to other sectors of the Italian public administration, 
the SSN – at least in the regions with stronger capacities – has been dynamic 
both at regional and organizational level with new management roles and 
systems that have helped to govern the complexity of health care. While the 
1992/93 reform contained attempts to transform the SSN into a mixed system 
where private initiatives could have put at risk some of the health system’s 
main principles, the overall attempt to overhaul the system was also genuinely 
driven by the search to modernize the system in line with other major reforms 
in Europe.
In the late 1990s it also became apparent that little had been done in 
primary care. Despite a lack of systematic reform, both the national and 
regional governments attempted to improve the performance of primary care 
doctors, mainly through two strategies. The first focused on promoting stricter 
relationships between GPs, and between GPs and district services such as home 
care, social care and public health. In the last 15 years a number of initiatives 
established forms of group practice, mainly based on collaboration rather than 
on sharing facilities, and in many regions GPs were incentivized to work with 
their ASLs and to establish primary care centres (see Chapter 5). Nevertheless, 
the basic solo-practice arrangements prevalent in primary care have not 
radically changed. The other strategy aimed to make GPs more accountable 
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for the expenditure attributable to their professional activities. Several regions 
implemented systems to monitor, control and often incentivize primary care 
physicians to contain pharmaceutical expenditure and to reduce patients’ access 
to unnecessary specialist and emergency care.
6.1.4 Stronger regionalization and health expenditure control
In 2001, a major Constitutional reform (Constitutional Law N. 3/2001) was 
confirmed in a referendum by 64.2% of voters. It introduced the direct election 
of regional governors and redistributed legislative competences between the 
national government and regional governments, framing a quasi-federal 
arrangement for the Italian state (Table 6.1). Public policies were divided into 
three categories: (1) those exclusively under the jurisdiction of the national 
government; (2) those exclusively under the jurisdiction of regional governments; 
and (3) those under the joint jurisdiction of both tiers of government, granting 
the national government general powers and giving regions powers limited by 
national laws. In addition regions were allowed to enforce laws in all sectors 
that the Constitution did not explicitly attribute to the remit of the national 
government (Caravita, 2004).
The ‘right to health’ was assigned to the joint competence of the state and 
regions, while organizational matters were exclusively attributed to regions. 
As a result, regions gained wide legislative autonomy in the field of health, 
with the national government retaining the authority to define the general 
framework. Thus, the central government retains a set of powers revolving 
around health protection and also decides on the basic benefit package (LEAs) 
to be universally guaranteed (Maino, 2003). The scope of the reform was such 
that its implementation has been uncertain and remains controversial. The main 
concern has been that the strengthening of regionalization leads to significant 
regional diversities and risks fragmentation of the SSN (Pellegrino, 2005). 
In the years following the Constitutional reform, agreements between the 
national government and regional governments, such as the three-year Pacts 
for Health agreed upon by the State-Regions Conference, have become the 
main instrument of health policy, although the agenda has been increasingly 
taken over by the need to better control regional health-care expenditure (see 
below). Over time, the reconfiguration of powers between the national and 
regional governments, in a context of fiscal austerity, has created a shift of 
power at national level from the Ministry of Health (MOH) to the Ministry of 
Economics and Finance (MOEF). While most policy powers are now in the 
hands of regions, and national policy-making has to be agreed between the 
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regions themselves and between them and the Ministry of Health, the need 
for expenditure control strengthens the role of MOEF, which now directly 
monitors health-care expenditure and has direct powers over regions that 
overrun their budgets.
In 2001, Law 405 introduced stronger responsibility in the control of health-
care expenditure. In 2004, the first of a series of measures was introduced to 
ensure the financial recovery of regions with large health-care expenditure 
deficits. They include compulsory financial recovery plans, whereby regions 
with deficits are forced to comply with specific terms to improve their financial 
balances within given deadlines (Ferré, Cuccurullo & Lega, 2012). Such regions 
are regularly monitored by national government agencies and can be sanctioned 
if they fail to comply with their recovery plan’s terms. Sanctions include the 
possible appointment of a national government-appointed commissioner 
to temporarily oversee the management of the region’s health-care system, 
temporary suspension of the region’s workforce turnover, as well as mandated 
(by the central government) tax increases. The details of these conditions 
have been continually redefined over the years, towards increasing controls 
and sanctions; for instance, the maximum accepted level for a regional health-
care budget deficit was originally set at 7% but was reduced to 5% in 2009. 
Since 2010, steps have been taken to soften the conditions of the recovery 
plans; regions submitted to this regime are given more time to comply with the 
requirements, and the restrictions on workforce turnover have been partially 
loosened. In 2012, incentives were introduced for regions that introduced better 
budget management measures.
6.1.5 The impact of the economic crisis and cost containment
Since 2009, under pressure from the international financial crisis and amid 
increasing political instability, government interventions in the SSN have taken 
the form of either urgent decrees or entries in the annual state budget law 
rather than systematic reforms, and have mostly consisted of cuts to public 
expenditure (de Belvis et al., 2012). 
Central cost containment policies use a variety of strategies. On the one 
hand, they strengthen control over total expenditure and make use of sanctions 
to ensure that regions do not overspend. On the other, they directly operate 
on the sources of regional spending (input costs) through measures on the 
payment of personnel, recruitment, standards for hospital care (e.g. minimum 
size of hospitals) and expenditure for goods and services. For example, a major 
ongoing policy to contain pharmaceutical expenditure includes measures such 
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as redefining the proportions of the total cost pertaining to pharmaceutical 
companies, wholesalers and pharmacies; a progressive reduction of the cap on 
regional pharmaceutical expenditure in primary and community health care; 
a reduction of the prices of equivalent drugs, along with other measure to promote 
their use; and the introduction and progressive extension of the claw-back 
system which requires pharmaceutical companies to pay back increasing 
amounts of money to regions when the nationally determined expenditure caps 
for pharmaceuticals are exceeded. Another example is the significant reduction 
in the expenditure caps on purchasing medical equipment and services by 
the SSN (2010 to 2013). Such measures were strengthened in 2012, with an 
emphasis on the identification of standard costs for all SSN contracts and a 
reduction of the number of hospital beds from 4 per 1000 inhabitants to 3.7 per 
1000 inhabitants. In addition, the central government has impelled regions to 
significantly reduce expenditure on health-care personnel (see Chapter 4).
During the last months of the Berlusconi government in Autumn 2011, 
additional measures were adopted as part of the 2012 budget law, such as a 
reduction in health funding for the period 2012–2014. In the context of a general 
public spending review that started in 2012 under the technocratic government 
(led by Mario Monti), the health-care budget was reduced by €4.7 billion in 
the following three years (Paterlini, 2013). In addition, the budget cut was 
coupled with the reintroduction of co-payments for outpatient care (€10) and 
for non-necessary emergency admissions (€25) (see section 3.1). 
Table 6.1
Major reform milestones for the Italian National Health Service (SSN)
1978 Decree 833/1978 establishes a tax-funded national health service (SSN) on the basis of universal 
coverage. 
1992–1993 Law N. 421/92, Decree Law N. 502/92 and Decree Law N. 517/93 propel the devolution of health care 
to the regions. In addition, managerial autonomy is granted to local health authorities (ASLs) and 
hospitals (AOs) and elements of an internal market are introduced.
1999 Decree 229/1999 promotes further development of devolution; strengthens cooperation and 
regulation to partially reorient the internal market; establishes the tools for defining the core benefit 
package; introduces intra-moenia practice; regulates the introduction of clinical guidelines for quality 
in health care.
2001 Constitutional Law N. 3 modifies the second part of the Italian Constitution (Title V), giving regions 
more powers, including in health care.
Health systems in transition  Italy128
6.2 Current and future developments 
6.2.1 Fiscal federalism
The 2001 constitutional reform included the general provision of fiscal 
federalism, setting forth the principle that sub-national levels of government – 
regions, provinces and municipalities – should only spend money that they 
collect themselves from their own constituencies and, to a lesser degree, have 
access to resources that reflect their constituencies’ contribution to national 
taxes through personal, corporate and other taxes. Thus, this significant reform 
entails a wholesale redesign of Italy’s fiscal system to make it more decentralized 
and dependent on regional contexts but provides for a redistribution of resources 
across regions if needed in order to guarantee basic services for all citizens. 
Since regions are responsible for the organization and delivery of health care, 
the full implementation of the reform will have a significant impact on resource 
allocation and the funding available to their health systems. However, the 2001 
legislation did not provide details on how the principle of fiscal federalism 
should be implemented, leaving this to subsequent legislation. Since then, 
progress has been piecemeal and is still incomplete. 
A major step was taken in 2009 with the adoption of a framework law 
for fiscal federalism (Law No. 42/2009). The framework law outlined the 
composition of revenues for sub-national levels of government, defined the 
principles for redistributing resources to those with the lowest own revenues 
and identified the processes to ensure coordination between the different 
government levels. One pivotal element for the funding of health-care services 
is the provision to establish an Equalization Fund whereby regions with a tax 
income that is too low to ensure provision of a minimum standard of services 
(standard needs) within a broad spectrum of services (e.g. health, social services, 
education) would be supported by central transfers from wealthier regions and 
the central state. 
The proposed new financing system reflects the current framework but 
with some significant differences. Currently, central transfers are a weighted 
capitation system – that is, they simply maintain a region’s expenditure level 
from the previous year. This arrangement is claimed to cause significant 
inefficiencies, as different regions tend to spend different amounts of resources 
for the same services (i.e. they have different efficiency levels). Under the 
proposed new system, both the difference between the region’s own revenues 
and the costs they have to sustain and, where this difference exists, the amount 
of central transfers, would be computed based on a system of standard costs, 
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identical for all regions. Standard costs of production should be set at the 
level of the average service costs of the best performing regions on health-
care expenditure targets and, in future, be used for resource allocation 
(see section 3.3.3 for further details on the new system of standard costs 
of production).
So far, however, neither the Equalization Fund nor the new resource 
allocation framework has been operationalized. While nine enforcing decrees 
were approved by parliament during 2008–2013, in 2013 a special Parliamentary 
Commission noted that the reform was far from complete: several important 
aspects had either not yet been covered by decrees or had been deferred. Several 
political factors have played a role: firstly, the three changes of government 
since 2011, with the subsequent political instability, have not been conducive 
to reaching consensus on many of the reform’s key aspects; secondly, the 
policy priorities imposed by the international financial crisis and the country’s 
economic difficulties have tended to dominate; and thirdly, other concurrent 
reforms that clash with the principles of the fiscal federalism framework 
legislation (Law 42/2009), such as the possible abolition of the provinces, and 
continual reforms to municipal taxes, have stalled its implementation. It is 
unlikely that the reform will be repealed, as most political parties agree that 
it should be enforced. Nevertheless, uncertain future political scenarios will 
determine both when it will happen, and what the precise content of the reform 
will be. Indeed, several aspects are still open to debate, the most prominent 
being the definition of the standard needs of regions. 
6.2.2 ‘Balduzzi decree’ health system reforms
In 2012, an attempt was made to introduce the most comprehensive reform 
of the health-care system since 1999, the so-called Balduzzi decree – named 
after the health minister at the time. The basic benefit package (LEA) was 
significantly revised for the first time since 2001, with the inclusion of 
treatments for 110 rare diseases and other services such as epidurals during 
childbirth. In addition, the private professional activities of SSN doctors were 
addressed by introducing measures to incentivize specialists to conduct their 
activities within SSN facilities. It was also decided that primary care should 
be reorganized into teams of professionals to provide 24-hour coverage and 
thus ensure continuity of care (group practice), while stronger restrictions were 
introduced on smoking and alcohol consumption for minors. Furthermore, a 
series of policies to contain pharmaceutical costs was followed up by a revision 
of the list of reimbursable pharmaceutical products as well as the introduction 
of health technology assessment to negotiate their prices based on efficacy, 
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according to international best practices. Although the Balduzzi reform was 
successfully passed by parliament, as of 2014 its provisions have not been fully 
implemented, as the political instability following the 2013 election prevented 
the necessary enforcement decrees from being passed. 
6.3 Conclusion
The last decade has been dominated by two intertwined issues: regional 
fragmentation and the need to maintain financial control within regional 
health systems. Backed by the reforms of the 1990s and constitutional changes, 
regions have gained further organizational autonomy. Some of them, due to 
stronger institutional capacities and more favourable socioeconomic conditions, 
have acted to improve their health systems while remaining financially viable; 
others, mostly in the south of the country, have overspent and seem unable to 
improve efficiency and efficacy. The financial crisis has probably exacerbated 
the situation. The most recent data show that current expenditure is under 
control in all regions (Armeni & Ferré, 2013). However, cross-regional flows of 
patients, satisfaction with the health system and other indicators of performance 
(e.g. number of hospital beds, inappropriate hospital admissions and community 
care) suggest that the national right to health care is not homogenously offered 
across regions. 
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7. Assessment of the health system
Italy currently spends less than the OECD average on health care in relation to its GDP (9.2% in comparison to the OECD average of 9.3%), though public spending is increasing at a faster pace than total private spending 
and OOP expenditure.
Despite the country’s federal structure, most regions cannot fund health care 
with their own resources, relying on the central transfers to compensate for the 
differences in regional incomes. Regions also allocate their funds differently, 
with some southern regions still suffering large deficits and with secondary 
care favoured over primary and community health services. 
While equitable access to health care is one of the statutory objectives of 
the health system, severe inequities in health status and health-care provision 
appear to exist across socioeconomic population groups. A significant part of 
these inequities stem from geographical differences: inter-regional disparities 
in population wealth, health-care resources and efficiency of care are especially 
evident between northern and southern regions. This pattern is also substantially 
echoed in the geographical distribution of satisfaction levels with the health-
care system and its performance. Generally, however, over the last few years 
there has been a general decrease in satisfaction levels, and problems such 
as long waiting times for outpatient and diagnostic services exist across the 
country. The current system of specialists providing both public and private 
care might be contributing to waiting lists as well as favouring the wealthier 
over the poorer in terms of access to specialist care. 
Life expectancy of Italians is one of the highest in the world, and their 
mortality profile is comparable to that of the other high-income countries. 
Prevention policies have been successful in increasing coverage for the most 
important vaccinations. Estimates of avoidable mortality suggest a progressive 
improvement and care for chronic conditions compares well at an international 
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level. However, the prevalence of risk factors such as overweight and obesity 
is significant, and health-care outcomes are inequitable across regions, genders 
and socioeconomic groups.
National funds are distributed to regions using formulas that aim to ensure 
coverage of the full scope of public health care, including primary care, hospital 
care and community health services; the age structure of the local population 
and health needs are also considered. However, the allocation formulas have 
been changed frequently and further reforms are currently ongoing. Despite 
increasing financial controls, the costs per patient treated, per service provided 
and per input units (e.g. costs per hospital bed) in secondary care have not 
decreased over the last 25 years but have actually increased and are higher 
than in most other OECD countries. The best explanation available for this is 
the disproportionately high number of hospitals of small size. The median size 
of Italian hospitals is one-third less than that of Germany, France and Austria, 
and around half that of UK hospitals. This could be due to small hospitals 
compensating for poor community health services such as home care and 
long-term care, especially in non-urban areas. Data from primary care also 
suggest wide geographical variations in technical efficiency. The use of generic 
pharmaceuticals has been increasing as a result of targets but their market 
penetration is still lower than in most other OECD countries. Inter-regional 
differences in awareness among the public and general practitioners are also a 
hindrance to greater use of generics.
The national policy agenda has become increasingly aware that availability 
of data is vital to identify problems, monitor performance and ensure 
accountability in the health system. Accordingly, several recent interventions 
have been directed at improving existing information systems and making data 
available to the public but their implementation has been slow in the absence 
of systematic monitoring.
7.1 Stated objectives of the health system
Art. 32 of the 1947 Italian Constitution states that the Republic safeguards 
health as a fundamental right of the individual and collective interest, and 
guarantees free care to the poor. Based on this principle, the founding law of 
the SSN (Law No. 833/1978) outlined the following objectives for the statutory 
health system:
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– public responsibility for health protection; 
– universal and equitable access to health care; 
– global coverage of the care needs of all citizens;
– public financing of health care through general taxation;
– portability of rights across the country and reciprocal care between 
regions. 
The 1992 reform (Decree 502/1992 and 421/1992) was enacted at a time of 
macroeconomic strain and mainly aimed to reduce costs and increase efficiency. 
Accordingly, it introduced decentralization, managerialism and managed 
competition (see Chapter 6). Regions were given full responsibility for the 
provision of health care, though only partial financial independence; hospitals 
were given semi-independent governance; and local health units were given an 
enterprise-like structure and re-named Local Health Authorities (ASLs). For 
the first time, cost constraints were accepted as a possible limitation to the 
provision of care. 
Further reforms in the late 1990s and early 2000s (Decree 229/1999 and the 
Constitutional Reform of 2001) attempted to implement the principles of social 
solidarity and subsidiarity specified by the Constitution. In an attempt to have 
local health needs met by local actions, regions and ASLs received more power, 
including greater spending autonomy. Moreover, while it was acknowledged 
that financial constraints, as specified in the 1992 reform, must be considered 
in strategic planning and when defining the benefit package, the reforms stated 
directly that these considerations should not take precedence over the right to 
health care.
7.2 Financial protection and equity in financing
7.2.1 Financial protection
Total health expenditure in Italy in 2012 was 9.2% of GDP, of which 7.3% 
was covered by public sources and 1.9% by private ones (see Table 3.1). Since 
2007 the growth of total health expenditure as a percentage of GDP has been 
slower than in other OECD countries, and currently is lower than the OECD 
average (see Chapter 3). Growth has been mainly driven by increased public 
expenditure: in 2012, total private expenditure was 19.2% of total health 
expenditure, marking a decline of more than 5.2% since 2000 (OECD, 2014b). 
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On the other hand, private health expenditure per capita calculated on the 
basis of PPP shows a consistently increasing trend over the last few years, 
reaching US$ 548 in 2012 compared to US$ 470 in 2005 (OECD, 2013). The 
proportion of private expenditure as a percentage of total health expenditure 
varies significantly across regions. Private health expenditure equals 15.8% of 
total health expenditure in the poorer southern regions, compared to 21.3% in 
the better-faring centre-northern regions but as a percentage of GDP it is higher 
in the south (2%) than in the north (1.7%). This is explained by the lower GDP 
in southern Italy (ISTAT, 2013a). Historically, OOP payments in Italy have been 
higher than the OECD average, both as a proportion of GDP and in absolute 
terms. Between 2009 and 2010 both indicators were slightly lower than the 
OECD average for the first time in the last 20 years (Fig. 7.1). However, it 
should be noted that the available OECD data do not yet cover the period from 
late 2011 when the new more extensive co-payment system was introduced by 
the regions and which is expected to increase the amount of additional private 
expenditure for services provided by the SSN (de Belvis et al., 2012).
Fig. 7.1
OOP payments as a % of GDP and US$PPP per capita, OECD average and Italy, 
1990–2012 
Source : OECD, 2014b. 
Average monthly expenditure for health care by households decreased from 
EUR€91 to EUR€88 between 2010 and 2012 (ISTAT, 2013b). This decrease was 
more marked among households in central and southern Italy, which widens an 
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existing expenditure gap with northern households. The composition of spending 
shows that households in southern Italy spend more on pharmaceuticals than 
those in the rest of Italy, but less on most other health-related costs, such as 
specialist visits or diagnostic tests. The percentage of households stating in 
2010 that they did not have enough money for health-related expenses is also 
higher in the south, among those with the lowest education levels, and among 
employees. However, these gaps have shown a tendency to slowly decrease over 
the last few years (Table 7.1) (ISTAT, 2013c).
Table 7.1
Percentage of Italian households stating that they did not have enough money for 
health-related expenses, 2004 and 2010
2004 2010
Geographical location North-western Italy 7.0 6.9
Southern Italy 20.7 18.5
Educational level Highest educational level (degree) 4.0 5.0
Lower educational level (lower secondary school 
or no certificate)
19.3 16.9
Type of employment Self-employed 6.3 5.8
Employee 8.7 8.3
Sources : ISTAT, 2013c.
7.2.2 Equity in financing
All regions have a mandate to ensure the same benefit package and the same 
quality of services. Over the last 20 years, the tax autonomy of decentralized 
regional governments has increased significantly (Arachi & Zanardi, 2004). 
However, there are significant differences across regions in terms of economic 
development, tax income and, ultimately, the proportion of health-care spending 
that each can afford to cover with its own tax revenues. The remainder of the 
budget is covered by central transfers or by centrally planned transfers between 
regions with the specific aim of compensating for inter-regional differences in 
tax revenues and guarantees the same minimum level of expenditure. While 
the contribution of regional taxes in financing health care has been steadily 
increasing, the centrally managed fund is still necessary to sustain expenditure 
(Fattore, 1999; Cappellaro, Fattore & Torbica, 2009).
Significant geographical inequalities exist in the distribution of resources 
among different sectors of health care. Several regions, especially in southern 
Italy, devote a disproportional amount of their expenditure to secondary 
care, with a possible underfunding of primary care and long-term care. In 
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2009, beds for older people in residential care ranged from 3.6 per 1000 older 
residents in Campania (in southern Italy) to 47.71 per 1000 older residents in 
the Autonomous Province of Bolzano (in northern Italy). In 2010, only two out 
of the eight southern regions met the goal of providing home care to at least 
3.5 older people per 100 residents, while the national average was 4.1. Moreover, 
several indicators for the appropriateness and efficacy of health care and patient 
satisfaction with hospital care, consistently point to disparities between the 
north and south of the country (ISTAT, 2012a).
7.3 User experience and equity of access to health care
7.3.1 User experience 
In a 2012 Eurobarometer survey of EU-27 countries, Italy had one of the 
lowest scores in terms of citizens’ perception of the quality of health-care 
provision, ranking 20th. In addition, it displayed the second greatest decrease 
(after Greece) from 2011 in the weighted version of the same indicator, and the 
greatest overall shift of citizens from a generally good opinion to a generally 
bad opinion of health-care provision (European Commission, 2012). Nationally, 
a 2010 survey commissioned by the Ministry of Health reported a significant 
geographical variability in citizens’ degree of satisfaction with the health-care 
system (Censis, 2010). Perceived quality and satisfaction indicators for most 
health-care services were consistently higher in northern Italy compared with 
southern Italy, with central Italy displaying intermediate values (Table 7.2). 
Waiting times represent a critical issue in outpatient specialist care and 
diagnostic services, and existing policy initiatives, in contrast with most other 
OECD countries, focus on these areas (Siciliani, Borowitz & Moran, 2013). 
Table 7.3 sets out the waiting times for diagnostic tests reported by respondents to 
a 2010 Ministry of Health survey, showing no significant geographical variation. 
National-tier interventions to reduce waiting times included the introduction of 
maximum waiting times as part of the benefit package in 2002, the obligation 
for all providers to publish waiting lists online and a National Plan for Waiting 
Lists Governance adopted in 2010 in which specific criteria were introduced 
to manage waiting lists and to give priority to patients with certain conditions 
(Ministero della Salute, 2010b). Policy implementation occurs at the regional 
level, with the creation of Central Booking Centres for appointments, the use of 
diagnostic and therapeutic pathways and the piloting of Homogeneous Waiting 
Groups for priority setting (Siciliani, Borowitz & Moran, 2013). Co-payments
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Table 7.2
Perceived quality and satisfaction with a selection of public health-care services in 
different areas of Italy, 2010
Perceived quality of 
general practitioners 
(% of respondents)
Perceived quality of hospital 
emergency services 
(% of respondents)
Opinion on general quality of 
care during hospitalizationa
(% of respondents)
Good Sufficient Poor Good Sufficient Poor Very 
satisfied
Rather 
satisfied
Little 
or not 
satisfied
North-western 
Italy
56.4 38.6 5.0 50.1 41.4 8.5 44.9 51.5 3.6
North-eastern 
Italy
52.7 40.2 7.1 45.6 39.7 14.7 59.5 39.1 1.4
Central Italy 46.3 45.0 8.7 27.7 46.8 25.5 32.5 60.3 7.2
Southern Italy 26.2 54.3 16.5 17.7 55.7 26.6 31.3 59.6 7.2
Total 43.4 48.6 8.0 33.8 47.0 19.2 39.3 54.6 6.1
Source : Censis, 2010. 
Note : aonly for citizens who had been admitted to hospital at least once in the previous 12 months.
for services could have had a containment effect on waiting times but it is 
more likely that broad exemption criteria could have limited this effect to the 
wealthier and healthier part of the population. Local experiences, such as that 
of the Veneto region, were successful in introducing proactive systems aimed 
at reducing waiting times. In Veneto, patients who were expected to wait more 
than three months for services are now actively monitored in ambulatory care; 
this measure is expected to reduce the number of patients abandoning waiting 
lists (de Belvis et al., 2013). It should also be noted that medical specialists might 
lack incentives to cooperate in reducing waiting times in public health care 
because these maintain demand for private practice within public structures 
(dual practice), with possible implications for equity (see section 7.3.2).
Table 7.3
Waiting times for diagnostic tests by geographical area, 2009
 Respondents 
waiting 
<7 days 
(%)
Respondents 
waiting 
7–15 days 
(%)
Respondents 
waiting 
16–30 days 
(%)
Respondents 
waiting 
30–90 days 
(%)
Respondents 
waiting 
>90 days 
(%)
Average 
number 
of days
North-west Italy 20.1 19.6 22.3 24.6 13.4 51
North-east Italy 19.4 22.2 25.0 20.8 12.5 46
Centre 20.0 21.3 22.7 20.0 16.0 54
Southern Italy 
and islands
27.8 15.3 26.4 17.4 13.2 48
Italy 22.3 18.9 24.0 21.1 13.6 50
Source : Ministero della Salute, 2010.
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7.3.2 Equity of access to health care
There is significant evidence that access to specialist and inpatient care 
suffers from significant inequity, with the rich being favoured over the poor 
(Van Doorslaer & Masseria, 2004; Van Doorslaer, Massieria & Koolman, 2006). 
Recent investigations reveal that inter-regional variation in income and 
recourse to health care is one of the main contributors to inequity. Hospital 
inpatient care appears to be relatively equitable as it depends mostly on care 
needs. In contrast, access to general practice was found to be moderately 
inequitable, deviations from equity being mainly caused by income and regional 
variation, and access to both specialist and emergency care severely inequitable, 
with inequity in specialist care being a result of income, education, availability 
of insurance and inter-regional variation, and inequity in access to emergency 
care being entirely explained by inter-regional variation (Masseria & Giannoni, 
2010). Variations in regional health-care supply might also play a significant 
role: physicians, hospital beds, occupancy rates and outpatient care indicators 
are disproportionately concentrated in northern and central regions (Giannoni, 
Rabito & Masseria, 2007). In turn, the utilization of services is heterogeneous, 
with evidence of emergency care being used as a surrogate for specialist care 
in some regions.
A second possible source of income-related differences in access could be 
the current regulation of private specialist care and waiting times in public 
health-care facilities. A recent survey compared the frequency of recourse to 
private care, paid OOP, for services that were also available free-of-charge from 
the SSN in Italy and the NHS in the UK. This practice appeared to be much 
more common in Italy, mainly because of waiting times in public facilities 
(Domenighetti et al., 2010). Italians also appeared to perceive waiting lists 
as a serious problem in contrast to British respondents. No comprehensive 
national data on waiting lists exist as yet as compliance with the obligation to 
publish them online is still incomplete across ASLs (AGENAS, 2010). However, 
data from a large consumer association suggest that waiting times might be 
significantly longer in Italy than in the UK (Tribunale per i diritti del malato-
Cittadinanzattiva, 2006; Hurst & Siciliani, 2003). It has been suggested that 
dual practice (intra-moenia) – where specialists working in public hospitals 
can also work privately within public facilities – contributes adversely to this 
situation. Italian hospital doctors have a lower average income than most other 
Western countries (50% less than their British colleagues), and long waiting lists 
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increase their income from private specialist care29 (Day, 2007). Political debate 
is ongoing as to whether a more complete separation between public and private 
care (making the latter less attractive for physicians than it is currently) would 
be desirable to reduce waiting lists and their effects on equity.
7.4 Health outcomes, health service outcomes and 
quality of care
7.4.1 Population health
In 2011, Italy recorded its highest mortality rate since 1980 (9.8/1000 inhabitants) 
(see Table 1.1). Like other western countries, the population is ageing, with 
the ageing index – that is, the ratio between the population aged 65 and 
under 15 – at 144.5% (ISTAT, 2012b). Infant mortality declined from 4.92 per 
1000 male live births in 2001 to 3.79 in 2008, and from 4.21 to 3.21 for females. 
Significant geographical disparities persist, with composite mortality reaching 
4/1000 live births in the south in 2008, compared to 3.6 in central Italy and 3 in 
northern Italy. 
Chronic degenerative conditions have been responsible for the two most 
frequent causes of death for several years. In 2010, cardiovascular diseases 
ranked first, with a standardized mortality of 256 per 100 000 inhabitants, 
and cancer second with a mortality of 216 per 100 000 (OECD, 2013b). Most 
cancer deaths are concentrated in the more industrialized north, cardiovascular 
deaths in the south. In 2010, 4.9% of the population had diabetes, the peak of 
an upward trend over the last decade. The prevalence is highest in the south, 
with a value of 5.6%, followed by central Italy with 4.8% and northern Italy 
with 4.4%. Table 7.4 shows the most recent data on the prevalence of notable 
lifestyle-related risk factors for chronic diseases.
Pooled analyses of several cancer registries show that the relative five-year 
survival rate for breast cancers diagnosed in the three-year period 2002–2004 
was 87%, having steadily increased from 81% in 1990–1991. The same indicator 
for cervical cancer was 67% for 2000–2004, also increasing from previous years 
and projected at 71% for new diagnoses in 2005–2007. For colon/rectum cancer 
diagnosed between 2000 and 2004, the relative five-year survival rate was 58%, 
29 The British NHS is very different on this point. In the UK, private practice within NHS facilities requires prior 
agreement with the employer under strict criteria and conditions (Department of Health, 2004), and private 
providers have agreed to open their services for NHS patients so as to decrease NHS waiting lists (Dyer, 2004), 
a strategy that might be successful (Jarman & Middleton, 2005; Willcox et al., 2007). 
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Table 7.4
Prevalence of notable risk factors in Italy, latest available year
Risk factors Prevalence rate (%)
Smokers among people aged 14 or over, 2011 22.3
Alcohol consumers, 2010 67.3
Overweight people, 2011 35.8
Obese people, 2011 10.0
Source : Osservasalute, 2012.
Note : prevalence rate of people aged 11 or over who consume alcohol at least once a year.
up from just above 40% for diagnoses in 1999–2003. Small differences exist 
between genders (58% among men, 57% for women) and geographical regions 
(the indicator ranges from 60% in north-eastern Italy to 56% in southern Italy). 
The estimated five-year survival rate for patients of both genders diagnosed in 
2005–2007 is 64% (AIRTUM, 2011)
Data on avoidable mortality – defined as deaths that could have been 
prevented with adequate disease prevention and therapy – show a decreasing 
trend, with the standardized amenable mortality rate estimated at 61.69/100 000 
in 2009, down from 63.86 in 2006 (Osservasalute 2012). However, gender 
differences exist: deaths that could have been avoided by primary prevention in 
2008 were 3.8% of total female deaths above 75 but 14.0% of total male deaths 
above 75 (Ministero della Salute, 2011a). The difference persists in deaths under 
age 75, with 18.5% for women and 36.9% for men. The largest component in 
this group is cancer (43.8%), particularly lung cancer (34.7%). Similar, albeit 
less striking, gender differences exist in relation to hospitalizations for causes 
considered avoidable by primary prevention, which mainly originate from 
external causes (e.g. poisoning and trauma) in women, and from heart disease 
and cancer in men. 
7.4.2 Health service outcomes and quality of care
Table 7.5 shows the main indicators of the quality of preventive care in Italy. 
Coverage for all compulsory vaccinations steadily increased between 2000 
and 2011, is uniform across the country and above the optimal targets set by 
National Health Plans. The only exception is MMR coverage, which is just 
above 90%, lower than the target set by WHO Europe within the plan for 
eradication of measles. 
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Table 7.5
Preventive care indicators in Italy, 2000 and 2011
 2000 2011
DT-DTP vaccination coverage (%) 95.3 96.6
MMR vaccination coverage (%) 74.1 90.8
Flu vaccination coverage, all age groups (%) 12.6a 17.8b
Flu vaccination coverage, age group 65+ season (%) 50.7a 62.7b
Sources : Osservasalute 2012; Ministero della Salute, 2014. 
Notes : aflu season 2000–2001; bflu season 2011–2012.
Tables 7.6 and 7.7 show the main indicators of the quality of care for chronic 
conditions and the management of acute exacerbations of chronic conditions. 
Data on hospital admissions for chronic conditions are better than the OECD 
average, but they do not appear to be improving. For instance, admission rates 
for uncontrolled diabetes are increasing: in 2009 the rate was 33.1/100 000, 
compared to 28.6/100 000 in 2006 (age-sex standardized rates). Table 7.8 shows 
a selection of indicators on patient safety. 
Table 7.6
Key indicators of quality of care for chronic conditions, Italy and OECD average, 2009
Men Women
 Italy OECD 
average
Italy OECD 
average
Hospital admission rate for asthma 14 36 24 66
Hospital admission rate for COPD 187 251 84 154
Hospital admission rate for uncontrolled diabetes 36 54 30 46
Source : OECD, 2014b.
Note : all data are the age–sex standardized rate per 100 000 population aged 15 and over.
Table 7.7
Key indicators of quality of care for acute exacerbations of chronic conditions, Italy 
and OECD average, 2009
Crude rates Age and sex-
standardized rates
 Italy OECD 
average
Italy OECD 
average
In-hospital mortality rate for myocardial infarction 6.5 7.9 3.7 5.4
In-hospital mortality rate for haemorrhagic stroke 22.2 22.6 17.6 19.0
In-hospital mortality rate for ischaemic stroke 7.3 9.0 3.4 5.2
Source : OECD, 2014b.
Note : admission-based rates (same hospital) per 100 000 population aged 45 and over. 
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Table 7.8
Key indicators of patient safety, Italy and OECD average, 2009
Secondary diagnosis-
adjusted standardized rates
Age and sex-
standardized rates 
 Italy OECD 
average
Italy OECD 
average
Foreign body left in during surgical procedure 3.3 5.7 2.0 5.7
Postoperative pulmonary embolism or 
deep vein thrombosis
536 631 215 631
Accidental puncture or laceration 114 220 13a 219
Obstetric trauma for vaginal delivery 
with instrument
2.78b 5.50b n.a. n.a.
Obstetric trauma for vaginal delivery 
without instrument
0.74b 1.61b n.a. n.a.
Source : OECD, 2014b.
Notes : rates per 100 000 hospital discharges; n.a., data not available; aThe average number of secondary diagnoses is <1.5; bcrude rates.
7.4.3 Equity of outcomes
In 2011, life expectancy was estimated at 79.4 years for men and 84.5 years for 
women (ISTAT, 2012b). Overall, life expectancy at birth (across both genders) 
was the second highest in Europe, after Switzerland. Over the last decade, the 
difference between genders in favour of women has been decreasing, with the 
advantage for women down to 5.1 years from 5.8 years in 2001. Geographically, 
central and northern Italy have a higher life expectancy than southern Italy, and 
also perform better in indicators of quality of life such as healthy life expectancy 
and life expectancy with no physical limitations in daily life (ISTAT/Cnel, 2013).
Mortality in Italy is significantly higher among those with a lower education 
level, the most common proxy of socioeconomic position. According to data 
from cohorts followed from 1999 to 2007 and 2011, the most disadvantaged 
subset of the population are women aged between 24 and 64 with the lowest 
education level, whose mortality rate is twice as high as same-aged women 
with the highest education level. Moreover, the mortality rate for all cancers 
is twice as high in adults aged between 25 and 64 of both genders with the 
lowest educational level compared with the same-aged adults with the highest 
educational level. Comparison with similar studies in other European countries 
has shown that the results observed for young women are comparable to 
northern Europe, while those for cancer-specific mortality among adults are 
similar to those observed in other southern European countries (ISTAT, 2012a). 
Risk factors such as being overweight or obese and smoking status are also 
markedly associated with education level, with a disadvantage for the youngest 
age groups and those with lowest education (ISTAT/Cnel, 2013).
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7.5 Health system efficiency
7.5.1 Allocative efficiency
Regional health-care expenditure originates from both regional taxes and 
transfers from central funds. The latter are distributed based on criteria that 
have varied significantly over the last 20 years, and that combine geographical 
allocation and allocation to different health services. Table 7.9 outlines the 
different criteria used between 1982 and 2004.
Table 7.9
National Health Fund allocation mechanisms, 1982–2004
Period Allocation mechanisms 
1982–1984 68–78% based on past expenditure
1985–1991 85–97% based on health-care utilization by age group
1992–1996 96–98% based on resident population
1997 50% based on health-care utilization by age group and need indicators;
58% based on resident population
1998–2010 64–70% based on health utilization by age group
28–33% based on resident population
2011– 59% based on capitation
41% based on age weighted capitation
The specific proportions of the annual national health-care budget have to 
be allocated to three levels of care: (1) prevention; (2) primary and community 
health care (district care); and (3) secondary care (hospital care). In 2011, for 
instance, these proportions were 5%, 51% and 44%, respectively.
Different formulas are used to calculate the specific amount of each of 
these shares for each region. In 2011, the share for prevention activities was 
based on regional population; the share for hospital care was based partly on 
absolute population and partly on absolute population weighted by age; and, 
within primary and community care, the funds for family medicine and other 
community care were based on absolute population, those for specialist care 
on age-weighted population, and those for pharmaceutical care on a region-
specific expenditure cap related to the absolute population. As a result, 59% of 
total funds were assigned to regions on a pure capitation basis, while 41% was 
based on variable age-weighted capitation scores. 
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Since 2005, when it emerged that several regions suffered from severe 
financial deficits due to their health-care expenditure, the allocation of funds to 
regions has been heavily influenced by financial recovery plans (see Chapter 3), 
agreed upon by the central government and the regional administrations, and 
which set conditions for budgetary discipline.
A far-reaching change to the allocation of health-care resources to the regions 
was proposed in Law Decree 68/2011 but its details are still being refined (see 
Chapter 3). Under this new system, all regions will have to use the same set of 
fixed shares for the three levels of care. Moreover, the amount transferred to 
each region for each sector will be determined by the average costs per capita30 
reported by the three (best-performing) regions used as benchmarks in the same 
sector (Caruso & Dirindin, 2011).
7.5.2 Technical efficiency
While the proportion of health-care expenditure in relation to GDP in Italy and 
its evolution over the last two decades are in line with the other OECD countries, 
it is not clear whether the same applies to efficiency.
In secondary care, several cost indicators have shown a steady decrease 
as a result of general reforms. In the 1990s, Italy was among the countries 
that introduced activity-related funding for hospital care, replacing the 
previous system that linked reimbursements to the length of hospital stay. As 
a consequence, the average length of inpatient stay decreased in the late 1990s, 
from 7.2 days in 1997 to 6.8 days in 2001 and has remained stable ever since. In 
2012 the average was still 6.8 days, despite wide interregional variation (from 
5.9 days in Campania to 8.1 days in Veneto) (Ministero della Salute, 2012e). 
The average preoperative bed days for patients awaiting surgery also has been 
decreasing – it was 2 days/patient/procedure in 2006, and 1.81 days/patient/
procedure in 2012 (Ministero della Salute, 2012e) – probably as a consequence 
of the tight goals set by the national Health Pacts and regions’ financial recovery 
plans since 2006. 
At the same time, the number of inpatients treated decreased from 
215/1000 inhabitants/year in 2001 to 163.5/1000 inhabitants/year in 2012, with 
the incidence of day care cases increasing slightly from 24.5% to 26.3%, as 
part of a general trend to avoid hospitalization whenever possible (Ministero 
della Salute, 2012e). The number of hospital beds also gradually decreased, as 
in most other OECD countries during the same period (see Chapter 4). The 
30 Recorded in the previous two years.
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regions with the highest bed-resident ratios reduced their supply faster than 
others – a goal that was also accomplished by reducing the number of hospitals, 
thereby decreasing the pre-existing interregional variation in the availability of 
hospital beds (Table 7.10). 
Table 7.10
Distribution of hospitals and hospital beds, and medical/nonmedical health-care 
personnel ratio, 2002 and 2010
2002 2010
Number of hospitals North 481 431
Centre 345 302
South 552 497
Total Italy 1 378 1 230
Hospitals/100 000 inhabitants North 1.88 1.60
Centre 3.16 2.60
South 2.69 2.40
Total Italy 2.42 2.10
Hospital beds/1 000 inhabitants North 4.60 3.80
Centre 4.90 3.70
South 3.90 3.20
Total Italy 4.40 3.60
Ratio medical/total SSN staff North 0.14 0.14
Centre 0.16 0.17
South 0.18 0.20
Total Italy 0.16 0.17
Source : elaborated from ISTAT, 2005, 2013d, 2014; Ministero della Salute, 2002, 2011b.
Notes : medical staff refers to physicians, nurses and other clinical professionals.
Despite these changes, the costs per patient treated, per service provided and 
per input units (e.g. costs per hospital bed) in secondary care have not decreased 
over the last 25 years but have actually increased and are higher than in most 
other OECD countries (Iuzzolino, 2011). The differences become smaller if the 
number of hospital admissions or output measures is used as the denominator. 
The best explanation available for this is the disproportionately high number 
of small hospitals. The median size of Italian hospitals is one-third less than 
those in Germany, France and Austria, and around half of UK hospitals. This 
could be due to small hospitals compensating for poor community health 
services such as home care and long-term care, especially in non-urban areas. 
A consequence of the high proportion of small hospitals is the high personnel 
density: the ratio of hospital health-care staff per hospital bed increased in 
Italy from 1.8 to 3.1 between 1995 and 2005, faster than in the whole OECD 
in the same period (from 1.8 to 2.3) (Iuzzolino, 2011). This trend might have 
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been emphasized by the fact that, in the context of spending cuts, hospital 
beds can be reduced at a faster rate than personnel. In addition, the proportion 
of doctors is the same in all hospitals, irrespective of their size, while in most 
other OECD countries it is proportional to the size of the hospital. The ratio of 
medical/nonmedical staff is in fact higher in southern Italy, where the density 
of hospitals is higher (Table 7.10). Overall, Italy has a higher proportion of 
doctors than most other OECD countries – 18% of the health-care workforce – 
compared to less than 16% in Spain and Germany and 7.4% in France and 
the UK. This composition of the health-care workforce increases personnel 
costs per hospital bed (Iuzzolino, 2011).
The data available for technical efficiency of expenditure in primary 
care shows a similar geographical variability. In a recent study, technical 
efficiency of general practice, measured by accepted outcome indicators such 
as vaccination coverage and avoidable hospitalization rates, was found to vary 
significantly across regions, with northern regions showing better results than 
southern ones. The reasons for this variation remain elusive and may include 
different combinations of spending sources (public vs private) as well as 
different compositions of primary care workforce (GPs, on-call primary care 
physicians, and paediatricians) (Pelone et al., 2012). 
Since the beginning of the marketing and distribution of generic drugs in 
2002, several incentive regulations have been introduced to promote them, 
including mandatory price reductions and pharmacy-level substitution. The 
proportion of generic drugs, both in terms of total pharmaceutical consumption 
and expenditure, has been steadily increasing over the last few years (see 
section 5.6.3). However, a remarkable geographical variation exists in their 
market penetration, which is higher in northern than southern Italy (OSMED, 
2012). Differences in the pharmaceutical policies of regions do not explain 
this variation: for example, Puglia and Molise, southern regions with a market 
penetration of generic drugs that is lower than the national average, introduced 
a patient co-payment for branded drugs in 2002, while the Province of Trento 
in northern Italy, with the highest national market share of generics, has never 
introduced such a measure (Casula & Tragni, 2013). The cultural preferences 
of doctors, patients and pharmacists might play a more significant role: 
a 2012 study showed that 65% of citizens in northern Italy stated that they were 
well informed about what generic drugs are, compared to only 44% in southern 
Italy (Federconsumatori, 2012). Other studies suggest that the probability of 
GPs prescribing a generic drug follows a similar geographical pattern (Casula 
& Tragni, 2013).
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A series of reforms enacted between 2010 and 2012 to promote the use of 
generics (see Chapter 2) will probably sustain the growing trend. In particular, 
since August 2012 it has been mandatory for GPs to write the name of the active 
ingredients on their prescriptions to facilitate pharmacy-level substitution. 
Analysis of recent data has shown that this measure has significantly boosted 
generic sales in the months following its enforcement, especially in southern 
regions (Assogenerici, 2013).
7.6 Transparency and accountability
In 2010, the Ministry of Health produced a set of guidelines to improve online 
communication by health-care providers (Ministero della Salute, 2011b) but 
a 2012 study analysing all the 245 web sites of the country’s AOs and ASLs 
found that overall compliance was poor (Vanzetta et. al., 2012). A second 
study checked the web sites of 169 hospitals for compliance with the features 
of patient-centredness and public participation in online services set by the Euro 
Health Consumer Index. Web site quality appeared to be significantly variable, 
with better results for public hospitals than private hospitals and for providers 
in northern Italy than in southern Italy (De Feo, 2013).
In 2012, the first results of a permanent programme for the evaluation of 
health-care outcomes – Programma Nazionale Esiti (PNE) (see Chapter 2) – 
were released to the public. They referred to 2010, and included 46 clinical 
outcome indicators: 32 indicators for secondary care collected from 1475 private 
and public hospitals and 13 indicators for primary and community health care. 
The results show that quality of care appears to vary significantly even between 
providers in the same region. While no formal sanctioning or incentive system 
is connected to the indicators, the programme is the first to publish provider-
specific outcome data in Italy, and it represents a powerful instrument for 
transparency, accountability and support for provider choice by patients. 
Since 1995, all health-care providers, including private accredited providers, 
must adopt a Health Charter (Carta dei servizi). The charter describes how the 
provider ensures fair provision of services and equal access to them, how the 
public receives information, the standards of quality and the methods in place 
to evaluate and improve them, what organized forms of protection of patients’ 
rights exist (such as complaint procedures) and how citizens can express 
opinions and feedback. However, the charter has been adopted sparsely and 
with heterogeneous features. In 2000, its diffusion was partly accelerated by 
a provision specifying tools for patient participation as a condition for SSN 
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accreditation. The Ministry of Health is working with the regions to extend 
this instrument and improve standards; the National Health Plan 2011–2013 
acknowledged the need for further monitoring of its implementation (Ministero 
della Salute, 2013c).
Through Law 190/2012, the central and regional governments have adopted 
several actions to prevent and address corruption in public administration, 
including health-care services. The activities targeted against corruption 
complement other recent measures dealing with transparency (e.g. the duty 
of hospitals and ASLs to update waiting times for ambulatory visits and 
hospital admissions), to ensure openness, transparency and public disclosure 
of information (including by health-care delivery). 
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8. Conclusions
Overall performance
In 2000 WHO ranked the Italian health-care system very highly due to high attainment scores in all the dimensions considered, namely health of the population, equity of finance and sensitivity to patients’ expectations 
(WHO, 2000). These attainments were achieved with expenditure levels that 
were significantly lower than in many other affluent countries. The last 15 years 
have not been easy for Italy as the economy has been stagnant, public debt has 
risen and political institutions have shown structural deficiencies. But despite 
this rather unfavourable general scenario, the SSN is still universal, funded by 
general taxation, with limited co-payments and provides free access to primary 
care, specialized care and a variety of other public health and preventive 
services. Reforms have been recurrent, and despite the very difficult times for 
the country, the SSN appears to be rather healthy and is sufficiently valued by 
citizens, even though more scepticism has been manifested since the start of 
the economic, financial and fiscal crisis. No radical or major reforms are on 
the agenda.
The last five years
In the last five years the SSN has been targeted by a number of policies aimed at 
containing or even reducing health expenditure without reducing the provision 
of health services to patients. To a certain extent, these policies have been 
effective as expenditure is now under strict control and industrial relations 
within the SSN have not worsened. However, citizens’ perception of the quality 
of services has declined slightly. Overall, the SSN is clearly strained due to 
the long period of cost cutbacks and there are clear signals that the economic 
crisis has worsened some health outcome indicators and increased demand for 
a variety of services. With some very specific exceptions (e.g. lower number 
of traffic and work injuries), the crisis has generated a double burden for the 
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health-care system: it has increased demand for health care and at the same 
time has reduced available resources due to fiscal constraints. Given current 
financial constraints, waiting times are on the rise and continuity of care and 
intermediate care for chronic diseases is increasingly difficult to ensure. While 
so far the SSN has been able to cope with the crisis, it is unlikely that it can keep 
on offering the present level of services if resources are reduced further. While 
efficiency improvements are always possible, it is unlikely that further cuts can 
be made without reducing the quantity and quality of care provided to patients.
Too much regional heterogeneity
The rich supply of indicators on the performance of regional health-care 
systems clearly shows that the SSN is fragmented into 21 different systems. The 
Italian health system is highly decentralized, with most organizational powers 
governed by regions and rather limited powers at national level. The state 
has full control over the definition of the benefit package (LEA) but there is 
evidence that the actual provision of these services varies greatly across regions 
as shown by the significant flows of patients moving from the south-central 
regions to central-northern ones in order to obtain care. The decentralization 
of the health system has allowed the stronger northern and central regions 
to design their own models and to fully exploit higher degrees of autonomy 
obtained over the last 20 years. Interestingly, these regions have followed 
rather different pathways, without contradicting the basic principles of the 
SSN, and thus they have designed rather different regional SSN models. This 
diversification suggests that there may be different ways to shape a universal 
tax-funded national health system and that important variants may be generated 
by different environmental factors, even within a single nation. The most salient 
issue with the Italian decentralization process is that it benefitted much less 
(if not even harmed) the southern regions of the country. Once the role of the 
central state was weakened, these regions, having to rely only on their own 
institutional capacities, found that these capacities were inadequate to cope with 
the new challenging tasks of governing their health-care systems. The result 
is a widening gap between the southern and the northern parts of the country 
that is mainly attributable to the lower quality of the political, managerial and 
professional capacities available in the southern regions. 
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The future
The future of the health-care system mainly depends on the future of the 
country’s economy. If Italy overcomes the structural crisis and starts growing, 
cost-containment measures can be relaxed and the SSN can receive enough 
resources to meet the expectations of high quality and universal coverage. 
Overall, compared to other European countries, the SSN is already rather 
parsimonious; thus, longer periods of hard cost-containment policies may harm 
the delivery system and may induce popular calls for change. 
To deal with these serious fiscal constraints, the SSN may benefit from a 
better definition of the specific content of the benefit package it guarantees to 
citizens (mainly a more detailed definition of the LEA). A narrower definition of 
the SSN benefit package may help to concentrate resources in the most effective 
and cost-effective areas, maintain high quality in these essential services and, 
at the same time, provide space for complementary insurance schemes. 
Moving to the way the system is organized and services are delivered, three 
main issues deserve to be highlighted. The first concerns the relationship 
between politics and top management. The 1992/93 reforms limited the role of 
professional politicians in running SSN organizations and promoted the role 
of general managers. Indeed SSN organizations have experienced increasing 
professionalism at management level. Nevertheless, the appointment of 
general managers, health directors and administrative directors still appears 
to be mainly driven by local and political considerations. Interestingly, as 
general managers in the SSN tend to work almost exclusively in their region 
of residency, a national market for general managers has yet to materialize. 
Appointments based on political affiliation and without adequate consideration 
of professional qualities are frequent. These appointments limit the potential 
of general management as it makes it very difficult to manage ambitious tasks 
such as the closure of small hospitals, the development of new integrated 
systems of care or the redesign of hospitals. 
A second major issue concerns primary care, which in Italy is still mainly 
based on solo-practice GPs or general paediatricians. This part of the SSN has 
been only modestly addressed by reforms and policy initiatives, mainly aimed 
at promoting its organizational development based on GPs, paediatricians, 
nurses and other professionals working together in primary care teams. There 
is wide agreement that such models should be widely adopted. However, they 
require substantial changes that need to be well promoted, incentivized and 
managed. It is unlikely that new legislation will suffice to make these changes 
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happen on the ground, also due to the lack of fresh resources to motivate 
professionals. More likely, regions and ASLs, adequately supported by regional 
and national frameworks, will be the key actors to manage changes in order 
to make primary care more inter-professional and collaborative than it is now. 
But again, different institutional and managerial capacities may result in very 
heterogeneous solutions across regions.
A third major issue concerns integration, de-integration and re-integration. 
Originally, the SSN was designed to be a very integrated system with virtually 
all services under the control of Local Health Units (the former name of the 
ASLs). Partly due to the attempt to promote a quasi-market, partly due to the 
desire to better recognize the role of private providers and partly because the 
idea of the purchaser–provider split inspired Italian policy making, from the 
mid-1990s the SSN was partly de-integrated, mainly by making hospitals 
independent of ASLs. Currently, however, most regional policies seem to have 
returned to integration, namely through the re-attribution of some hospitals 
to ASLs, the concentration of purchasing activities in regional or supra-
organizational entities and the enlargement of the size of ASLs. In addition, 
most regions have strengthened control over their providers. Overall, in the 
last 10 years regional authorities have increased their grip over provider 
organizations, which in turn, have lost most of their organizational autonomy. 
This trend towards re-integration is probably due to the general conditions of 
austerity and the search for savings. But at the same time, it is also due to the 
search for better integrated care pathways that can overcome barriers deriving 
from the involvement of different organizations in treating the same case. It 
is clear that patients increasingly need a variety of providers working in a 
co-ordinated way and that such co-ordination is essential to ensure quality 
of care as well as cost-containment. But how to experiment, evaluate and 
disseminate good practices in this respect is more an issue of policy design 
developed from the bottom, rather than the results of top-down policies that 
reduce the number of SSN organizations by making them larger. 
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9.2 Principal legislation 
Laws
Law 833/1978 Establishment of the National Health Service
Law 210/1992. Compensation for those harmed by irreversible complications 
due to mandatory vaccinations, blood transfusions and blood products.
Law 405/2001 as revised into the 2010–2012 Healthcare Pact (regional 
standard of average provision of hospital bed numbers)
Law 42/2009. Delegation to the Government on fiscal federalism, 
implementation of Article 119 of the Constitution.
Law 38/2010 Measures to grant access to palliative care and pain management. 
Law 6/2013 Delegation to the Government for the transposition of European 
directives and the implementation of other European Union legislation 
(European delegation law 2013) 
Decrees
Prime Minister’s Decree, DPCM 12 October 1983. Establishment of the 
State-Regions Conference.
Prime Minister’s Decree, DPCM 16 April 2002. Guidelines on criteria for 
priority access to diagnostic and therapeutic services, and waiting times.
Legislative Decree No. 502/1992. Art. 8 on free choice of GP; Art. 8, 
subsection 8 on free choice of provider.
Legislative Decree No. 39/1999. Palliative care and pain therapy
Legislative Decree No. 229/1999. Art. 8 on free choice of GP
Legislative Decree No. 230/1999. Reform of penal medicine, in accordance 
with Art. 5 of Law No. 419 of 30 November 1998
Legislative Decree No. 300/1999. Reforms on the organization of the 
government in accordance with Article 11 of Law No. 59, 15 March 1997 
(including revisions to the functions of the Ministry of Health)
Legislative Decree No. 196/2003. Code on the protection of personal data 
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Legislative Decree No. 150/2009. (Brunetta Law) Implementation of 
Law No. 15, 4 March 2009 regarding on the optimization of public 
labour productivity, public sector efficiency and transparency of public 
administrations.
Legislative Decree No. 28/2010. Implementation of Art. 60 of Law No. 69, 
18 June 2009 regarding mediation aimed at reconciling civil and commercial 
disputes (judicial conciliation mechanism)
Legislative Decree No.15813, September 2012, (‘Balduzzi’ Decree). Urgent 
measures to promote the development of the country through higher health 
protection. Coordinated with Conversion Law, No. 189, 8 November 2012.
Spending Review Decree No. 95/2012 (Art. 15) Urgent provisions for 
the review of public spending with no variation to services for citizens. 
Coordinated with Conversion Law 135/2012 . 
Regional laws
Regione Emilia Romagna. Regional Law n. 29/2004. Norme generali 
sull’organizzazione ed il funzionamento del servizio sanitario regionale 
[General norms on the organization and functioning of the regional 
health service].
9.3 Useful web sites
National Agency for Regional Health Services: 
www.agenas.it
Italian Medicines Agency (AIFA): 
www.agenziafarmaco.gov.it
Ministry of Health: 
www. ministerosalute.it
National Association of Pharmaceutical Companies: 
www.farmindustria.it
National Association of Private Pharmacies: 
www.federfarma.it
National Institute of Health: 
www.iss.it
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National Institute of Statistics: 
www.istat.it
National Plan for Clinical Guidelines: 
www.pnlg.it
9.4 HiT methodology and production process
HiTs are produced by country experts in collaboration with the Observatory’s 
research directors and staff. They are based on a template that, revised periodically, 
provides detailed guidelines and specific questions, definitions, suggestions for 
data sources and examples needed to compile reviews. While the template offers 
a comprehensive set of questions, it is intended to be used in a flexible way to 
allow authors and editors to adapt it to their particular national context. The 
most recent template is available online at: http://www.euro.who.int/en/home/
projects/observatory/publications/health-system-profiles-hits/hit-template-2010.
Authors draw on multiple data sources for the compilation of HiTs, ranging 
from national statistics, national and regional policy documents to published 
literature. Furthermore, international data sources may be incorporated, such as 
those of the OECD and the World Bank. The OECD Health Data contain over 
1200 indicators for the 34 OECD countries. Data are drawn from information 
collected by national statistical bureaux and health ministries. The World Bank 
provides World Development Indicators, which also rely on official sources.
In addition to the information and data provided by the country experts, 
the Observatory supplies quantitative data in the form of a set of standard 
comparative figures for each country, drawing on the European Health for All 
database. The Health for All database contains more than 600 indicators defined 
by the WHO Regional Office for Europe for the purpose of monitoring Health 
in All Policies in Europe. It is updated for distribution twice a year from various 
sources, relying largely upon official figures provided by governments as well 
as health statistics collected by the technical units of the WHO Regional Office 
for Europe. The standard Health for All data have been officially approved 
by national governments. With its summer 2013 edition, the Health for All 
database started to take account of the enlarged EU of 28 Member States.
HiT authors are encouraged to discuss the data in the text in detail, including 
the standard figures prepared by the Observatory staff, especially if there are 
concerns about discrepancies between the data available from different sources.
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A typical HiT consists of nine chapters.
1. Introduction: outlines the broader context of the health system, including 
geography and sociodemography, economic and political context, and 
population health.
2. Organization and governance: provides an overview of how the health 
system in the country is organized, governed, planned and regulated, as 
well as the historical background of the system; outlines the main actors 
and their decision-making powers; and describes the level of patient 
empowerment in the areas of information, choice, rights, complaints 
procedures, public participation and cross-border health care.
3. Financing: provides information on the level of expenditure and the 
distribution of health spending across different service areas, sources of 
revenue, how resources are pooled and allocated, who is covered, what 
benefits are covered, the extent of user charges and other out-of-pocket 
payments, voluntary health insurance and how providers are paid.
4. Physical and human resources: deals with the planning and distribution 
of capital stock and investments, infrastructure and medical equipment; 
the context in which information technology systems operate; and human 
resource input into the health system, including information on workforce 
trends, professional mobility, training and career paths.
5. Provision of services: concentrates on the organization and delivery 
of services and patient flows, addressing public health, primary care, 
secondary and tertiary care, day care, emergency care, pharmaceutical 
care, rehabilitation, long-term care, services for informal carers, palliative 
care, mental health care, dental care, complementary and alternative 
medicine, and health services for specific populations.
6. Principal health reforms: reviews reforms, policies and organizational 
changes; and provides an overview of future developments.
7. Assessment of the health system: provides an assessment based on the 
stated objectives of the health system, financial protection and equity 
in financing; user experience and equity of access to health care; health 
outcomes, health service outcomes and quality of care; health system 
efficiency; and transparency and accountability.
8. Conclusions: identifies key findings, highlights the lessons learned from 
health system changes; and summarizes remaining challenges and future 
prospects.
9. Appendices: includes references, useful web sites and legislation.
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The quality of HiTs is of real importance since they inform policy-making 
and meta-analysis. HiTs are the subject of wide consultation throughout the 
writing and editing process, which involves multiple iterations. They are then 
subject to the following.
• A rigorous review process (see the following section).
• There are further efforts to ensure quality while the report is finalized that 
focus on copy-editing and proofreading.
• HiTs are disseminated (hard copies, electronic publication, translations 
and launches). The editor supports the authors throughout the production 
process and in close consultation with the authors ensures that all stages 
of the process are taken forward as effectively as possible.
One of the authors is also a member of the Observatory staff team and 
they are responsible for supporting the other authors throughout the writing 
and production process. They consult closely with each other to ensure that 
all stages of the process are as effective as possible and that HiTs meet the 
series standard and can support both national decision-making and comparisons 
across countries.
9.5 The review process
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